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Carbon-Carbon bond forming reactions are very important in organic synthesis. 
Preparation of most of the leading drugs on the market involves at least one carbon-
carbon bond forming transformation. However, use of preformed oganometallics for this 
purpose is neither atom economical nor cost effective. Thus, development of  atom 
economical and environmentally benign carbon-carbon bond forming methods is highly 
desirable.   
 Catalytic hydrogenation is one of the most widely used transformations in the 
pharmaceutical and chemical industry. However, for several years the catalytic 
hydrogenation was limited to the carbon-carbon bond forming processes such as alkene 
hydroformylation and the Fischer-Tropsch reactions. In 2004 Krische group 
demonstrated a novel reductive aldol cyclization under rhodium catalyzed hydrogenation 
 vii
conditions. Following this, a variety of reductive carbon-carbon bond forming reactions 
were developed under hydrogenation conditions.         
The first chapter of this dissertation summarizes the reductive couplings of π-
unsaturates to imines. N-heterocyclic compounds are very valuble in pharmaceutical and 
agrochemical industries. In the second chapter a variety of hydrogen mediated reductive 
couplings to aromatic N-heterocycles have been described. Transfer hydrogenation 
represents another important class of reactions in organic chemistry. This process 
employs hydrogen sources other than gaseous dihydrogen, such as isopropanol. Very 
recently, the Krische group reported a number of novel C-C coupling reactions using the 
concept of transfer hydrogenation. Thus, in chapter 3 a very elegant ruthenium catalyzed 
allylation reaction has been described. Finally, chapter 4 focuses on the reactivity of zinc 
enolates toward less reactive electrophiles such as allylic carbonates in the absence of any 
transition metal catalyst. During this process a direct allylic substitution of allylic 
carbonates with diorganozinc reagents has been discovered. These two transformations 
are conceptually very interesting. 
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Transition Metal Catalyzed Reductive C-C Coupling of π-Unsaturates to Imines 
1.1 INTRODUCTION 
 
Carbon-carbon bond forming reactions via transition metal catalyzed coupling of 
two simple molecules to obtain relatively complex structures are elegant and very useful 
processes in organic synthesis. Within a decade, a number of metal catalyzed reductive 
couplings were developed involving π-unsaturated compounds.1 Among these, reductive 
couplings to carbon-heteroatom multiple bonds have gained much attention in recent 
years. 2  Nitrogen containing moieties are found in numerous biologically important 
molecules. 3  Classical methods for the derivatization of imines involve the use of 
preformed organometallic reagents such as organolithiums,4  organomagnesiums,5  and 
organozincs.6 Later on, significant advances have been made in this area and a variety of 
organocatalytic7 and metal catalyzed additions to imines were developed. 8, 9, 10, 11, 12  
Although these coupling reactions provide methods for derivatization of imines, 
these are less desirable due to a stoichiometric amount of waste generation and difficulty 
of reagent preparation. This necessitates the development of novel and atom economical 
catalytic C-C coupling methods involving carbon-nitrogen multiple bonds. This review 
focuses on various transition metal catalyzed reductive couplings of π-unsaturated 
compounds such as alkenes and alkynes to imines. These include reductive Mannich type 
reactions and coupling of conjugated and unconjugated alkynes to imines.  
 
 
 
2 
1.2 ALKENE-IMINE REDUCTIVE COUPLINGS 
 1.2.1 Conjugated alkene-imine couplings (Reductive Mannich couplings) 
 
 The Mannich reaction is one of the most important reactions in organic 
synthesis.13 This reaction is employed in the synthesis of natural products, agrochemicals, 
antibiotics peptides, nucleotides and alkaloids.14 Traditionally, Mannich reactions were 
performed by treatment of aldimines with α-methylene carbonyls in the presence of a 
Brønsted acid catalyst.15 The classical Mannich reactions are efficient but it is hard to 
control both the regioselectivity and stereoselectivity. Hence transition metal catalyzed 
reductive coupling of electron deficient alkenes (enones or enoates) to imines can be an 
attractive alternative to obtain Mannich products with better regio and stereocontrol. 
 The first reductive Mannich reaction was reported by Isayama in 1992 by 
coupling of ethyl crotonate 1.1 to N-methylbenzaldimine 1.2 using a cobalt catalyst and 
phenylsilane as the terminal reductant.16 Upon heating, the coupling product 1.3 cyclized 
to produce the β-lactam 1.4 (Scheme 1.1). 
 
Scheme 0.1.Co-catalyzed reductive Mannich coupling of enoate 1.1 and imine 1.2. 
 
Following Isayama’s work, Matsuda 17  disclosed the silane mediated cationic 
rhodium catalyzed reductive Mannich coupling reaction with enoate 1.5 and imine 1.6 to 
obtain the coupling products with good yields and moderate anti-stereoselection (Scheme 
1.2). 
3 
 
Scheme 0.2. Rh-catalyzed Mannich coupling of acrylate 1.5 and imine 1.6. 
  
 According to the proposed mechanism, the catalytic cycle begins with the 
oxidative addition of the rhodium catalyst to silane followed by hydrometallation of the 
enoate to generate the enolate IV. Nucleophilic addition of the enolate IV to the imine 
produces intermediate V, which upon hydrolysis generates the coupling product VI 
(Scheme 1.3). 
 
Scheme 0.3. Proposed mechanism for Rh catalyzed enoate-imine coupling 
 
In 2002, Morken demonstrated that neutral iridium complexes could effect 
reductive coupling of acrylate 1.11 with imine 1.12 using electron deficient monodentate 
phosphine ligands with moderate to excellent anti-diastereoselectivities.18 Interestingly, 
4 
under the reaction conditions the coupling product cyclized to generate β-lactams 1.13-
1.16 in good yields (Scheme 1.4). 
 
Scheme 0.4. Ir-catalyzed Mannich coupling of acrylate 1.11 and imine 1.12. 
  
In order to understand the mechanism of this reaction, the substituent effects were 
studied. A very good Hammet correlation was observed when the electronics of the 
substituent effects at the acrylate aryloxy group R1 (σ = 1.28) and the imine N-aryl group 
R3 (σ = -0.48) were investigated. This suggested that the rate limiting step was the 
cyclization of intermediate V in catalytic cycle A (Scheme 1.5, left figure). 
An alternative mechanism (Scheme 1.5, right figure) for the formation of β-
lactam V via a [2+2] cycloaddition of the ketene VIII and the imine 1.12 was eliminated 
on the following basis. It is known that the resulting methylketene generated by pyrolysis 
of 2-butanone reacts with N-phenylbenzaldimine affording the corresponding β-lactam in 
a 3:1 (trans:cis) ratio at room temperature. However, under the iridum catalyzed coupling 
reaction conditions the identical β-lactam was obtained in a 20:1 (trans:cis) ratio with the 
coupling partners N-phenylbenzaldimine and ethylacrylate at room temperature. 
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Scheme 0.5. Formation of β- lactum V via Ir-catalyzed reductive coupling. 
  
Later on, Nishiyama reported the anti-selective reductive coupling of acrylates, 
crotonates and cinnamates to N-arylaldimines using a rhodium-bis(oxzolinyl)phenyl 
catalyst in the presence of diethoxymethylsilane as the terminal reductant (Scheme 1.6).19 
The anti-stereoselectivity of the coupling reaction was explained by invoking the 
six membered chair type transition states IIA and IIB during carbon-carbon bond 
formation. The transition state IIA is preferred over IIB due to steric interactions 
between the alkoxy group and the R2 group of the imine (Scheme 1.7). 
 
Scheme 0.6.6 Rh(Phebox)-catalyzed Mannich coupling of enoate 1.17 and imine 1.18. 
6 
 
Scheme 0.7. Proposed stereochemical model for the anti-selective Mannich coupling. 
 
In 2007 Krische reported the first atom economical rhodium catalyzed hydrogen 
mediated reductive Mannich reaction using enones as pronucleophiles. 20  The syn-
selectivities were found to be dependent upon the N- protective group of the imine. The 
reactions were less selective when N-arylaldimes were used as coupling partners. This 
could be due to the facile geometrical isomerism in the presence of the metal catalyst. 
However, reasonably good selectivities were obtained when geometrically more stable N-
sulfonylaldimines were used instead. These coupling reactions were efficient only with 
electron deficient aryl aldimines but not with alkyl imines (Scheme 1.8). 
7 
 
Scheme 0.8. Hydrogen mediated Mannich coupling of enone 1.23 and imine 1.24. 
 
When the reaction was performed under a deuterium atmosphere, the coupling 
product deuterio-1.31 was obtained with single deuterium atom incorporation only at the 
former enone β-position suggesting an irreversible hydrometallation of the enone 
followed by C-C coupling. This result can also be explained by the hydrogenolysis of the 
azarhodacycle generated through an oxidative coupling process (Scheme 1.9). 
 
 
Scheme 0.9. Rh-catalyzed Mannich coupling under deuterium atmosphere. 
 
Recently, Lam disclosed cobalt catalyzed anti-selective reductive Mannich 
reaction employing 4-acryloylmorpholine and N-tosylaryl aldimines as coupling partners. 
In this catalytic transformation a stoichiometric amount of diethylzinc was used as the 
terminal reductant (Scheme 1.10).21 
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Scheme 0.10. Co-catalyzed Mannich coupling of enoate 1.32 and imine 1.33. 
  
Transition metal catalyzed reductive couplings to ketimine electrophiles are very 
challenging due to reduced electrophilicity and steric factors of the ketimine relative to 
the carbonyl electrophiles. Very recently, Shibasaki reported a diastereoselective copper 
catalyzed Mannich reaction using phosphonyl protected ketimines to generate β,β-
disubstituted amino acid derivatives using pincol borane as the terminal reductant.22 The 
coupling reaction was efficient with both aliphatic and aromatic ketimines. Even β-
substituted enones produced the coupling products in good yields and selectivities. When 
the coupling reaction was performed in the presence of a chiral phosphine ligand (R)-
DIFLUROPHOS and triethoxysilane, the coupling product was obtained with good 
enatioselectivities. The reaction was suggested to be going through a reactive copper 
enolate (Scheme 1.11). 
 
9 
 
Scheme 0.11. Cu-catalyzed reductive Mannich coupling of enoate 1.38 and imine 1.39. 
  
1.2.2 Conjuagted alkene-imine couplings (Related reactions)  
 
Cheng demonstrated a novel ene-imine reductive coupling of enoates, 
acrylonitrile and vinylsulfones to N-arylaldimines employing nickel phenonthroline 
catalyst.23 In these coupling reactions, stoichiometric amounts of zinc dust was used as 
terminal reductant and water was used as proton source. (Table 1.6) The regioselectivity 
of this coupling reaction is noteworthy. In contrast to the existing transition metal 
catalyzed conjugated alkene-imine coupling reactions, coupling occurred to the β-carbon 
atom of the conjugated alkene (Scheme 1.12). 
10 
Scheme 0.12. Ni-catalyzed reductive ene-imine couplings. 
  
Formation of the product through coupling to the β-carbon atom of the conjugated 
alkene has some very interesting mechanistic implications. When the coupling reaction 
was performed in the presence of D2O instead of water, a 68% of deuterium 
incorporation was observed α-to the ester group in the coupling product 1.51 (Scheme 
1.13). These results can be explained by invoking azanickelacycle intermediate II 
resulting from the oxidative coupling of the enoate 1.5 and imine 1.50. Hydrolysis of 
intermediate II generates the coupling product and Ni(II) species III, which gets reduced 
to Ni(0) by zinc dust.  
11 
 
Scheme 0.13. Proposed mechanism for Ni-catalyzed alkene-imine reductive coupling. 
 
Formation of the β-coupling product can also be explained by an alternative 
mechanism in which first, the acrylate interacts with Ni(0) to produce oxy-π-
allylnickel(II) intermediate. A β-coupling to the imine and hydrolysis affords the 
coupling product. 
The Krische group reported diastereo as well as enantioselective reductive Aldol24 
and diastereoselective reductive Mannich16 reactions employing enones as latent enolates. 
By realizing the structural resemblance of enones to 2-vinylpyridines, this C-C coupling 
concept was extended to 2-vinylazines. When the coupling partners 1.52 and 1.53 were 
subjected to the reaction conditions above using a cationic rhodium catalyst in the 
presence of gaseous hydrogen, the reductive coupling products 1.54-1.57 were obtained 
in good yields with complete branch selectivity (Scheme 1.14) The coupling reactions 
were efficient with 6-substituted-2-vinylpyridines and 8-bezyloxy-2-vinylquinoline but 
not with the parent 2-vinylpyridine due to the presence of Lewis basic nitrogen atom.25 
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Scheme 0.14. Rh-catalyzed hydrogen mediated 2-vinylazine-imine reductive couplings. 
 
This methodology found application in the synthesis of unnatural amino acids. 
Thus, when 6-bromo-2-vinylpyridine and N-sulfinyliminoacetate were hydrogenated at 
45 oC using 5 mol% of a rhodium precatalyst, the N-heterocyclic-β-methyl-α-amino acid 
ester 1.60 was obtained in 63% yield with 5:1 dr (Scheme 1.15).26 
 
Scheme 0.15. Synthesis of unnatural N-heterocyclic amino acids  
 
To further gain insight into the reaction mechanism, the coupling partners 1.58 
and 1.61 were subjected to the standard reaction conditions in the presence of gaseous 
deuterium and the coupling product deuterio-1.63 was obtained with deuterium 
incorporation at the β-position. This can be explained by deuterolysis of the 
azarhodacycle 1.62 furnished by oxidative coupling of the reactants (Scheme 1.16). A 
hydrometallative mechanism cannot be excluded. An irreversible hydrometallation of the 
vinylarene to form the rhodium enaminate species followed by imine insertion leads to 
the coupling product as well. 
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Scheme 0.16. Reductive coupling of 1.58 and 1.61-deuterium labeling experiment. 
  
1.3 ALKYNE-IMINE REDUCTIVE COUPLINGS  
 
 Imine vinylation is a very important transformation in organic synthesis. In 
addition to the traditional methods, very effective catalytic methods were developed for 
the vinylation of imines. Catalytic imine vinylations by addition of vinylzircocenes to 
imines were reported by Taguchi and Wipf.11c,d The alternative approach for imine 
vinylation is through alkyne-imine reductive couplings. In 1991, Buchwald reported the 
asymmetric alkyne-imine reductive coupling using stoichimetric amounts of low-valent 
zirconocene complexes. 27  Later, a variety of metal catalyzed alkyne-imine reductive 
couplings were disclosed employing different terminal reductants. 
Based on Montgomery’s alkyne-aldehyde reductive coupling strategy,28 Jamison 
reported the first alkyne-imine coupling reaction employing a nickel catalyst in 
conjunction with monodentate phosphine ligands and an alkyborane as the terminal 
reductant.29 Interestingly, the major product resulted from alkylative reductive coupling 
product and the minor product was that of reductive coupling (Scheme 1.17). Rather poor 
enantioselectivities (33-42% ee) were observed when the coupling reactions were 
performed in the presence of chiral monodentate phosphine ligand (S)-
(neomenthyl)diphenylphosphine (NMDPP). Later, a very similar transformation was 
developed with improved enantioselectivities (up to 95%) by employing P-chiral 
ferrocenyl phosphane ligands.30 
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Scheme 0.17. Ni-catalyzed alkyne-imine reductive coupling. 
 
When the coupling reaction was performed in the presence of a chiral phosphine 
ligand both the alkylative and reductive coupling products were obtained with identical 
enantioselectivities (Scheme 1.17).29 This suggests that these two coupling products are 
formed from a common intermediate II derived from the metallacycle I (Scheme 1.18). 
Migration of the ethyl group from boron to the nickel center and cleavage of the Ni-N 
bond generates this intermediate II. Coordination of methanol to II followed by alkyl 
reductive elimination affords alkylative coupling product IV. Alternatively, intermediate 
II can undergo β-hydride elimination to generate species V, which upon C-H reductive 
elimination leads to reductive coupling product VI (Scheme 1.18). 
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Scheme 0.18. Alkylative vs reductive coupling pathways for Ni-catalyzed alkyne-imine 
coupling. 
 
In 2005 Krische reported the first atom economical reductive couplings to N-
sulfinyl iminoacetate using a cationic rhodium catalyst under hydrogenation conditions.31 
Under the reaction conditions conjugated enynes and diynes coupled efficiently with 
good regio and diastereoselectivities to generate some interesting amino acid derivatives. 
For good diastereoselectivities, choice of the N-sulfinyl protective group was very critical 
(Scheme 1.19). 
Based upon the deuterium labeling experimental results, formation of the 
coupling product can be explained by the following mechanism. First, the substrates 
undergo oxidative coupling to generate the metallacycle III. Deuterolysis of the Rh-N 
bond in III leads to the intermediate IV, which upon N-D reductive elimination produces 
the coupling product deuterio-1.74 (Scheme 1.20). A hydrometallative pathway cannot 
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be excluded, however this would require a very regioselective hydrometallation of the 
enyne.  
Scheme 0.19. Rh-catalyzed hydrogen mediated enyne/diyne-iminoacetate couplings. 
  
 
Scheme 0.20. Catalytic cycle for the hydrogen mediated coupling to iminoacetates. 
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In the past the Krische group reported variety of hydrogen mediated couplings to 
vicinal dicarbonyl compounds.32 Realizing the structural resemblance of 2-N-heterocyclic 
aromatic aldehydes and ketones with vicinal dicarbonyl compounds, a highly 
enantioselective 1,3-enyne-2-N-heterocyclic carbonyl coupling reaction was developed.33 
As an extension to these processes, couplings to the corresponding imines were attempted. 
Under rhodium catalyzed hydrogenation conditions using a catalytic amount of 3,5-
dinitrobenzoic acid as a co-catalyst and (S)-Cl-OMe-BIPHEP  as ligand, the coupling 
product 1.82 was obtained with excellent selectivities. However, this reaction turned out 
to be less general than expected and the selectivities were very substrate dependent 
(Scheme 1.21).34    
 
Scheme 0.21. Hydrogen mediated couplings to aromatic 2-N-heterocyclic aldimines. 
 
Generation of complex molecules from simple starting materials is very desirable 
in organic synthesis. In 2007, the Krische group reported a highly enantioselective 
acetylene-imine coupling reaction using chirally modified rhodium catalysts with 
excellent (Z)-selectivities.35 The coupling reaction was efficient with aromatic as well as 
aliphatic aldimines (Scheme 1.22). 
18 
 
Scheme 0.22. Rh-catalyzed hydrogen mediated acetylene-imine reductive coupling. 
 
This coupling reaction is proposed to be going through a rhodiumcyclopentadiene 
intermediate I resulting from the dimerization of acetylene. Imine insertion into 
metallacycle I generates azarhodacycloheptadiene intermediate II, which undergoes the 
Brønsted acid assisted hydrogenolysis to furnish the coupling product (Scheme 1.23).   
 
Scheme 0.23. Proposed mechanism the hydrogen mediated (Z)-dienylation of aldimines. 
 
Later, the first racemic as well as enantioselective hydrogen mediated iridium 
catalyzed alkyne-imine coupling reaction was developed by the Krische group.36 High 
levels of enantioselectivities were observed when the coupling reactions were performed 
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in the presence of a chiral bidentate phoshphine ligand and a Brønsted acid co-catalyst 
improved the chemical yields. This coupling reaction was very regio and enantioselective 
over a wide range of alkynes and imines (Scheme 1.24).  
When 2-butyne was coupled to N-tosyl-4-chlorobenzaldimine under an 
atmosphere gaseous deuterium, the coupling product was obtained with 83% deuterium 
incorporation at the vinylic position. This was explained by formation of metallacycle I 
generated by an oxidative coupling of the substrates followed by a Brønsted acid assisted 
Ir-N bond cleavage to produce vinyliridium carboxylate species II. Intermediate II 
undergoes deuterolysis to afford the deuteriovinyliridium intermediate III which upon C-
D reductive elimination furnishes the coupling product deuterio-1.20 (Scheme 1.25).34a 
 
 
Scheme 0.24. Ir-catalyzed hydrogen mediated alkyne-imine reductive coupling. 
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Scheme 0.25. Iridium catalyzed alkyne-imine coupling-oxidative coupling. 
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1.4 SUMMARY 
 
 Synthesis of a relatively complex molecule from two or more simple π-
unsaturated molecules through transition metal catalysis has gained enormous amount of 
attention. In recent years, a variety of reductive coupling transformations were developed 
employing different transition metal catalysts and terminal reductants. Among them, 
reductive couplings to imines are considered to be very powerful processes for the 
synthesis of biologically important nitrogen containing molecules such as alkaloids, 
aminoacids and aminosugars. Thus, in this review a variety of reductive coupling to 
imines using various transition metal catalysts and terminal reductants were described. 
However, most of the known reductive couplings to imines involve usage of terminal 
reductants that are not environmentally friendly (pyrophoric or generate a lot of waste). 
However, by using elemental hydrogen as the terminal reductant, very useful and atom 
economical transformations can be achieved. So far, a variety of hydrogen mediated 
reductive coupling reactions using imines and π-unsaturated molecules such as enones 
(reductive Mannich), 2-vinylpyridines and conjugated as well as unconjugated alkynes 
were developed. Hydrogen or transfer hydrogen mediated α-olefin-imine reductive 
coupling is yet to be explored. Future efforts will be directed to the development of 
related catalytic processes under hydrogenation conditions using imine coupling partners. 
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Rhodium Catalyzed Hydrogen Mediated Reductive Couplings to Aromatic N-
Heterocycles 
2.1 INTRODUCTION  
 
 Nitrogen-containing heterocycles are among the most common substructures 
found in many natural products, drugs and agrochemicals.1 Recently, GSK, Pfizer and 
Astra Zeneka studied the structures and various reactions used to make the 228 leading 
drug molecules on the market and came up with very interesting data.  It seems that all 
these drugs are small molecules (MW<500). Furthermore, over 90% of these drugs 
contain at least one nitrogen atom and more than 11% of the reactions used to prepare 
these drugs are carbon-carbon bond forming reactions.1 Most of the industrial methods 
currently utilized contain preformed organometallic reagents, which are not atom 
economical, not cost effective and generate large amounts of waste. Thus, we are 
motivated to develop catalytic C-C bond forming methods involving N-heterocycles 
which might improve current synthetic methods. The following chapter describes our 
successful attempts to develop a variety of novel rhodium catalyzed C-C coupling 
reactions involving aromatic N-heterocycles. This includes an enantioselective hydrogen 
mediated reductive coupling of conjugated enynes to 2-N-heterocyclic aromatic 
aldehydes, ketones2 and aldimines,3 and the branch selective reductive coupling of 2-
vinylpyridines and quinolines to aldimines.4   
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2.2 ENANTIOSELECTIVE REDUCTIVE COUPLING OF CONJUGATED 
ENYNES TO 2-N-HETEROCYCLIC AROMATIC ALDEHYDES AND 
KETONES  
2.2.1 Dienyl Allylic Alcohols 
 
 The development of catalytic asymmetric methods for carbonyl addition is one of 
the most important research areas in organic synthesis. Dienylation of carbonyl 
compounds is an important reaction as numerous natural products contain the dienyl 
allylic alcohol moiety.5 Traditionally, dienyl allylic alcohols are prepared by treatment of 
carbonyl compounds with Grignard reagents 6 , organolithium, 7  organozinc,7 
organochromium7 , organoboron8 and stannane9 reagents. In 2004 Takahashi reported the 
stoichiometric addition of zirconacyclopentadienes to aldhydes to form dienyl alcohols 
upon treatment with n-butyllithium.10 Following this work, a number of metal catalyzed 
reductive coupling methods were developed for the preparation of dienyl allylic alcohols. 
Based on Montgomery’s aldehyde-alkyne coupling strategy11, in 2004 Jamison reported 
nickel catalyzed enyne-carbonyl coupling reactions using silane as terminal reductant.12 
Although these methods are useful for the preparation of dienyl allylic alcohols, 
they involve the use of preformed organometallic reagents which can lead to the 
generation of stoichiometric amounts of waste. The first atom economical carbonyl-
enyne coupling reaction was reported by Krische using elemental hydrogen as the 
terminal reductant. 13  Based on this rhodium catalyzed hydrogen mediated reductive 
coupling concept, a variety of novel reactions were discovered.14 These include couplings 
to 1,3-diynes,15 1,3-enynes,16 1,3-dienes17 and alkynes.18 The rhodium catalysis is very 
effective for the intermolecular coupling of conjugated π-unsaturates and vicinal 
dicarbonyls such as glyoxals and pyruvates. Since N-heterocyclic-2-carboxaldehydes are 
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structurally very similar to vicinal dicarbonyls, it was envisioned that these types of 
aldehydes could be engaged in couplings to conjugated enynes using rhodium catalysis. 
Thus, this part of the chapter describes the successful attempts to develop a highly 
enantioselective reductive coupling of conjugated enynes to aromatic N-heterocyclic-2-
carboxaldehydes and ketones and as well as discusses mechanistic insights based on 
chiral Brønsted acid studies.2  
2.2.2 Optimization 
 
Table 0.1. Optimization of hydrogen mediated reductive coupling reaction of enyne 2.1a 
and 2-pyridinecarboxaldehyde 2.2. 
 
Our initial optimization studies were focused on the reductive coupling of enyne 
2.1a (200 mol%) and 2-pyridinecarboxaldehyde 2.2 (100 mol%). Exposure of these 
coupling partners to cationic Rh(COD)2OTf catalyst (2 mol%) and bidentate phosphine 
ligand BIPHEP (2 mol%) under hydrogen atmosphere (1 atm) in DCE (0.2 M) at room 
temperature produced the desired coupling product in 39% yield (Table 2.1, entry 1). 
During the optimization studies of a related hydrogen mediated coupling to pyruvates, it 
was discovered that catalytic amounts of Brønsted acids improved the yields. Thus, by 
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using a catalytic amount of triphenylacetic acid (2 mol%) the yield of the coupling 
product was improved from 39% to 69% (Table 2.1, entry2).  
By increasing the reaction temperature to 40 oC, the coupling product was 
obtained in 92% yield (Table 2.1, entry 3). Having optimized the racemic reaction, 
further efforts were directed towards the development of an enantioselective version of 
this coupling reaction by using chirally modified rhodium catalysts. A variety of chiral 
bidentate phosphine ligands were screened and (R)-Tol-BINAP turned out to be the 
ligand of choice, giving the coupling product in 91% yield with 92% enantioselectivity 
(Table 2.1, entry 6). These conditions represent the standard protocol for our hydrogen 
mediated reductive coupling reaction.  
2.2.3 Substrate Scope 
 
Using the standard protocol the generality of the coupling reaction was studied. 
Conjugated enynes with aromatic (Table 2.2, entry 2.1a), heteroaromatic (Table 2.2, 
2.1d) and aliphatic (Table 2.2, entries 2.1b, 2.1c, 2.1d) substituents were successfully 
coupled with good to excellent yields and selectivities. Next, substrate scope with respect 
to the aldehyde coupling partner was studied. N-heterocyclic-2-carboxaldehydes with 
substitution at the sixth position (Table 2.2, entry 2.10), aldehydes containing more than 
one Lewis basic nitrogen atom (Table 2.2, entries 2.12-2.18), monocyclic (Table 2.2, 
entries 2.3-2.17) as well as bicyclic ring (Table 2.2, entry 2.9) systems with multiple 
heteroatoms were successfully engaged in the coupling reaction. 
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Table 0.2. Hydrogen mediated enantioselective reductive coupling of conjugated enynes 
(2.1a-d) to aromatic N-heterocyclic aldehydes and ketones 
 
aCited yields are of pure isolated material and represent the average of two runs. Yields indicated parenthetically are based upon 
recovered starting material. All reactions simply employ hydrogen balloons and typically require less than 3 hours to reach 
completion. See Supporting Information for detailed experimental procedures. bReaction was run at 65 oC. cReaction was performed 
with 4 mol% catalyst loading. 
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Protective groups like acetate (Table 2.2, entries 2.4, 2.5, 2.9, 2.13), N-phenyl (Table 2.2, 
entry 2.1) and N-4-methoxybenzyl (Table 2.2, entry 2.13) were tolerable under these 
hydrogenation conditions. The reactions which were less selective with (R)-Tol-BINAP 
turned out to be more selective when (R)-Xylyl-BINAP ligand was used. Isomeric 
pyridinecarboxaldehydes did not participate in the coupling reaction under standard 
reaction conditions. 
Catalytic enantioselective methods for the generation of quaternary stereocenters 
are very important in organic synthesis,19 however reductive couplings to ketones is very 
challenging due to reduced electrophilicity and steric factors. The aromatic 2-N-
heterocyclic ketones containing methyl (Table 2.2, entries 2.19-2.24) and cyclopropyl 
(Table 2.2, entry 2.20) substituents were coupled successfully. Under the standard 
reaction conditions excellent selectivities were obtained with 2-pyridyl (Table 2.2, entries 
2.19-2.20), 2-pyrazyl (Table 2.2, entry 2.21), 2-isoxazole (Table 2.2, entry 2.22), 2-
thiazole (Table 2.2, entry 2.23) and 2-benzaxazole ketones (Table 2.2, entry 2.24). For 
the ketone substrates higher catalyst loadings (4 mol%) were necessary to obtain better 
yields (Table 2.2, entries 2.19-2.24, 2.12). 
2.2.4 Stereochemistry 
 
The absolute stereochemical assignment of the coupling products were made 
based on the single crystal X-ray diffraction analysis of the carbamate (Figure 2.1, 
structure 2.25) obtained upon the reaction of coupling product 2.3 (Table 2.2, entry 2.3) 
with the isocyanate derived from phenylalnine methyl ester (Figure 2.1, see structure 
2.25). 
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Figure 0.1. View of the molecule 2.25 showing the atom labeling. Displacement 
ellipsoids are scaled to the 50% probability level. 
 
2.2.5 Functionalization of the coupling products 2.3 and 2.10 
 
 The allylic alcohol and the diene moiety of the coupling product can be 
manipulated to obtain some interesting and synthetically useful building blocks. For 
example, allylic acetate derived from the coupling product 2.3 was subjected to palladium 
catalyzed allylic amination conditions to generate a terminal allylic amine (Scheme 2.1, 
2.26), cross-metathesis of TBS protected allylic alcohol 2.3 with 1,4-diacetoxy-2-butene  
using Grubbs’ second generation catalyst (10 mol%) produced allylic acetate 2.27 in 72% 
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yield (5:1 E:Z ratio) and Johnson-Lemieux oxidation of TBS protected 2.3 followed by 
NaBH4 reduction produced the allylic alcohol 2.28 in 78% over two steps (Scheme 2.1). 
 
Scheme 0.1. Elaboration of the coupling products 2.3 and 2.10. 
  
  
The diene moiety of the coupling product can be partially or completely reduced. 
For instance, the terminal double bond of the diene 2.10 can be selectively reduced to the 
internal olefin using Wilkinson’s catalyst (10 mol%) in 82% yield and a 
diastereoselective hydrogenation of the diene 2.10 was achieved using Crabtree’s catalyst 
(10 mol%) in 86% yield (20:1 dr). Further, the allylic acetate derived from 2.10 was 
ozonolyzed to produce the α-acetoxy ketone 2.31 in 77% yield (Scheme 2.1). 
2.2.6 Mechanistic Studies 
 
A variety of hydrogen mediated coupling reactions involving conjugated enynes, 
diynes, dienes and vicinal dicarbonyl compounds were reported using cationic rhodium 
catalysts. To understand the mechanism of these types of coupling reactions, ESI-MS 
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studies of the coupling reaction of enyne I and gyoxalate II was performed and a 
molecular ion peak corresponding to the rhodacycle III was detected. This could be the 
abundant species in the reaction mixture, suggesting that the hydrogenolysis of this 
rhodacycle III might be the slow step of the reaction (Scheme 2.2, top figure).20 
 
Scheme 0.2. (a) ESI-MS studies of hydrogen mediated coupling reaction of enyne I with 
glyoxal II (top figure). (b) Rhodium catalyzed hydrogenation of carbon dioxide to formic 
acid; four vs six membered transition states of Rh-O bond hydrogenolysis (bottom figure). 
 
It is clear that the Brønsted acid co-catalyst has a significant effect on the yields 
of the rhodium catalyzed hydrogen mediated coupling reaction with 2-
pyridinecarboxaldehyde and enyne 2.1a (Table 2.1, entries 1 and 2). We believe that the 
role of the acid co-catalyst in our reactions could be explained by Sakaki’s computational 
studies related to the hydrogenation of carbon dioxide to formic acid using cationic 
rhodium catalysts (Scheme 2.2, bottom figure).21 It was found that the hydrogenolysis of 
the Rh-O bond via a six-membered transition state (10.2 Kcal/mol) is favored by 11.7 
Kcal/mole over the alternative four-membered one (21.9 Kcal/mole).  
In order to gain more insight into the mechanism of this coupling reaction, the 
coupling partners 2.1a and 2.2 were subjected to the standard reaction conditions using a 
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catalytic amount of Akiyama-List-Terada type phosphoric acid22 in the presence of an 
achiral phosphine ligand BIPHEP (4 mol%). To our surprise the coupling product was 
obtained in 56% yield with 82% ee. The high level of enantioselectivity indicated that 
there was a strong association (hydrogen bonding or protonation) between pyridine-2-
carboxaldehyde and the chiral acid during C-C bond formation. It also indicated that the 
protonated form of the pyridine-2-carboxaldehyde was more reactive compared to the the 
unprotonated aldehyde as otherwise a racemic product would have been obtained by 
coupling to the unprotonated aldehyde (Scheme 2.3). To further investigate the species 
responsible for high levels of enantioselectivities, the coupling reactions were performed 
using ethylglyoxalate and pyruvate. Absolutely no asymmetric induction was noticed in 
these two reactions which suggested that chiral metal complex23 is not responsible for 
high levels of selectivities but it could be the protonated form of pyridine-2-
carboxaldehyde (Scheme 2.3). Based on the chiral acid studies, ESI-MS results of the 
related coupling reaction and Sakaki’s studies, the following mechanism was proposed. 
First, the Brønsted acid associated substrate II undergoes oxidative coupling to 
the rhodium bound enyne to generate the oxarhodacyclopentadiene intermediate IV. 
Brønsted acid assisted cleavage of Rh-O bond in IV generates vinylrhodiumcarboxylate 
species V, which upon acid assisted hydrogenolysis via a six membered transition state 
(vs a four membered transition state in the absence of acid co-catalyst) produces hydrido 
(deuterio)vinylrhodium species VII. Eventually, C-H(D) reductive elimination from VII  
produces the coupling product by regenerating the catalyst (Scheme 2.3). When the 
coupling reaction was performed under the deuterium gas (99.97 % of purity) atmosphere, 
92% of deuterium was incorporated at the vinylic position. This deuterium labeling result 
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can also be explained by a hydrometallative mechanism; however this would necessitate 
a very regioselective hydrometallation of the enyne.   
 
Scheme 0.3. Catalytic cycle for the rhodium catalyzed hydrogenative coupling of 2.1a 
and 2.2. 
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2.2.7 Stereochemical Model 
 
 As shown in scheme 2.4 formation of two metallacycles is possible. The more 
preferred chiral rhodium complex IA forms the metallacycle IIA which undergoes 
hydrogenolysis to generate the major enantiomer (S). On the other hand the less preferred 
rhodium complex 1B in which there are steric interactions between the chiral ligand (Ar 
group) and the enyne leads to the metallacycle IIB. Hydrogenolysis of IIB produces the 
minor enantiomer (R).    
 
 
Scheme 0.4. Stereochemical model for the hydrogen mediated enantioselective coupling 
of 1,3-enyne-2-pyridine carboxaldehyde. 
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2.3 HYDROGEN MEDIATED ENANTIOSELECTIVE (E)-DIENYLATION OF 2-
N-HETEROCYCLIC AROMATIC ALDIMINES  
2.3.1 Dienyl Allylic Amines 
 
The Dienyl allylic amine moiety is a valuable synthetic intermediate in organic 
synthesis. It is a versatile building block which can be used in Diels Alder reactions24. It 
can be synthetically manipulated to produce aminoacids, azasugars and alkaloids.25, 26 
Also, many biologically important molecules such as streptogramine antibiotics contain 
this subunit.27. In 2005 Reginato reported the stereoselective synthesis of dienyl allylic 
amines starting from enantiomerically enriched stannylated allylamines, which are 
derived from amino acids.28  In another report Barluenga described synthesis of 2,4-
pentadienylamine by insertion of vinyl bromide into a propargylamine-zircocene 
complex.29  Very recently, Micalizio disclosed a titanium mediated allene-imine cross 
coupling reaction to generate 1,3-dienyl amines.30 However, there are not many catalytic 
methods known for the preparation of chiral dienyl allylic amines.  
 Transition metal catalyzed 1,3-enyne-imine reductive coupling is an elegant way 
to access chiral dienyl allylic amines. As an extension of hydrogen mediated reductive 
couplings to π-unsaturates, the Krische group reported the first rhodium catalyzed 
asymmetric reductive coupling of iminoacetates to conjugated enynes and diynes. 31 
Furthermore, a very atom economical, highly enantioselective (Z)-dienylation of imines 
was disclosed using gaseous acetylene as one of the coupling partners.32 Very recently, a 
non asymmetric as well as an asymmetric hydrogen mediated vinylation of imines was 
developed using nonconjugated alkynes under iridium catalysis.33 Unfortunately, the 1,3-
enyne-imine reductive couplings were unsuccessful using iridium catalysis. Since 1,3-
enynes were very good coupling partners for vicinal dicarbonyls under rhodium catalysis, 
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it was envisioned that a 1,3-enyne-aromatic-2-N-heterocyclic imine reductive coupling 
could be achieved. This would give access to the enantiopure 2-N-heterocyclic dienyl 
allylic amines. Thus the present section describes the efforts towards the development of 
an enantioselective dienylation of aromatic-2-N-heterocyclic aldimines under rhodium 
catalysis, which is an extension of the previously reported dienylation of the 
corresponding aromatic N-heterocyclic aldehydes and ketones. 
2.3.2 Optimization 
 
Table 0.3. Optimzation of hydrogen mediated (E)-dienylation of imine 2.32a. 
 
 
  
Our optimization studies began with the coupling of enyne 2.1a and tosyl 
protected N-benzyl-2-imidazole aldimine 2.32a.  Hydrogenation of the coupling partners 
2.1a (200 mol%) and 2.32a (100 mol%) using cationic Rh(COD)2BF4
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catalyst, BIPHEP (5 mol%) as ligand in the presence of m-nitobenzoic acid co-catalyst (5 
mol%) at 40 oC produced the coupling product 2.33 in 42% yield (Table 2.3, entry 1). 
Stoichiometric amounts of sodium sulfate (200 mol%) were used as a desiccant to 
suppress imine hydrolysis as well as to prevent formation of catalytically inactive 
rhodium hydroxy bridged dimers.  
The yield of the coupling product was improved to 57% by using a less 
coordinating counter anion34 BARF (BARF = B(3,5-(CF3)2C6H3)4) (Table 2.3, entry 2). 
Several chiral bidentate phosphine ligands were screened and (S)-Cl-OMe-BIPHEP 
produced the coupling product in 62% yield with 90% ee (Table 2.3, entry 8). To our 
surprise, slight increase in temperature to 50 oC improved the enatioselectivities to 97% 
with 65% yield (Table 2.3, entry 9). The chemical yields were further improved to 78% 
by using a relatively stronger acid co-catalyst like 3,5-dinitrobenzoic acid (Table 2.3, 
entry 10). These optimized conditions represent the standard protocol for this asymmetric 
imine dienylation reaction. 
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2.3.3 Substrate Scope 
 
Table 0.4. Hydrogen mediated reductive couplings to aromatic N-heterocyclic imines.a 
 
a. The absolute stereochemistry of the coupling products was assigned arbitrarily.   
  
 Using our standard conditions (Table 2.3, entry 10), three different enynes (Table 
2.4, entries 2.1a, 2.1c and 2.1e) were screened against two aldimines 2.32a and 2.3b and 
it turned out that the selectivities were very substrate dependent. By changing the 
structure of the enyne or heterocycle, the selectivities were drastically affected. However, 
in the case of thiazole imine 2.3b by changing the ligand from (R)-Cl-OMe-BIPHEP to 
(R)-PHANEPHOS yielded the coupling product 2.36 in 59% yield with 94% ee. 
Unfortunately, even this ligand was not general for other substrate combinations (Table 
2.4, entries 2.37 and 2.38).  
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2.3.4 Proposed Mechanism 
 
First, the Brønsted acid associated substrate II undergoes oxidative coupling to 
the rhodium bound enyne III to generate the azarhodacyclopentene intermediate IV. 
Brønsted acid assisted cleavage of Rh-N bond in IV generates vinylrhodium carboxylate 
species V. The acid assisted hydrogenolysis of V via a six membered transition state 24 
(vs a four membered transition state in the absence of acid co-catalyst) generates hydrido 
vinylrhodium species, which upon C-H reductive elimination gives the product and 
regenerates the catalyst (Scheme 2.4).  
 
Scheme 0.5. Proposed mechanism for the rhodium catalyzed hydrogenative coupling of 
1a and 2.32a. 
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2.4 BRANCH SELECTIVE HYDROGEN MEDIATED COUPLING OF 2-
VINYLPYRIDINES TO ALDIMINES 
2.4.1 Pyridylation of Aldimines 
 
 The N-heterocyclic moiety is found in lot of therapeutic agents and agrochemicals. 
According to MDL drug data report, pyridine, imidazole and indole are very prominent 
heterocycles found in many pharmaceuticals.1 Despite the biological importance of 
pyridine35 containing compounds, there are only a handful of catalytic reactions involving 
pyridine and its higher azines. These include metal catalyzed cross-couplings, C-H 
activation followed by biaryl couplings36 and insertion to olefins or alkynes.37 There are 
precedents for the rhodium catalyzed couplings to vinylpyridines. For example, rhodium 
catalyzed conjugate addition of arylboronic acids to vinylpyridines,38 alkynylpyridines39 
and vinylpyridine couplings to alkenes40 and dienes41 via β- sp2 C-H bond activation of 
vinylpyridine moiety. Moreover, rhodium catalyzed coupling reactions like branch 
selective hydroformylation42 and Heck couplings43 involving vinylpyridines are known. 
However, metal catalyzed reductive C-C coupling of vinylpyridines to carbonyls or 
imines is unprecedented.  
 Krische reported a variety of hydrogen mediated reductive couplings involving π-
unsaturates to carbonyls and imines. These examples include a very regioselctive 
hydrogen medited coupling of α-olefins to anhydrides 44  and highly stereoselective 
aldol45and mannich type46 reactions using enones as latent enolates. As an interest to 
expand our hydrogen mediated C-C coupling concept to N-heterocycles, it was 
envisioned that vinylpyrines could be good coupling partners because of their structural 
similarities to enones. Thus this chapter describes the development of the first C-C 
reductive coupling of 2-vinylpyridines and 2-vinylquinolines to aldimines. 
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2.4.2 Synthesis of 2-vinylpyridines (2.41-2.46) 
 
The vinylpyridines 2.41-2.46 were synthesized using very trivial reactions. The 6-
bromo-2-vinylpyridine 2.41 was prepared by a two step sequence (Scheme 2.5). 
Lithiation of 2,6-dibromopyridine47 followed by quenching with acetaldehyde generated 
the secondary alcohol 2.40 in 72% yield, which was subjected to dehydration conditions48 
using concentrated sulfuric acid to produce the desired product 2.41 in 74% yield. The 
vinylpyridine 2.42 was prepared in 52% yield in one step by a palladium catalyzed 
Suzuki coupling reaction using phenylboronic acid.49  
 
 
Scheme 0.6. Synthesis of 2-vinylazines 2.41-2.46. 
 
Sodium borohydride reduction of commercially available 6-vinyl-2-
pyridinecarboxaldehyde in THF followed by TBS protection of the crude alcohol with 
TBSCl and imidazole produced the vinylpyridine 2.44 in 62% yield over two steps. The 
8-benzyloxy-2-vinylquinoline 2.46 was synthesized in 68% yield by Wittig olefination of 
the aldehyde 2.45 with the ylide generated upon treatment of methyl triphenyl 
phosphonium bromide salt with lithium hexamethyldisilazane (LHMDS) in THF at 0 oC 
(Scheme 2.5).50 
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2.4.3 Optimization 
 
Table 0.5. Optimization of reductive coupling of vinylpyridine 2.41 and imine 2.47a. 
NBr
NBr
Me
NHo-Ts
NO2
Rh(I)X (5 mol%)
2-Fu3P (12 mol%)
Solvent, (0.25 M), H2, rt
(o-Ts)N
NO2
2.41
Entry XX (mol%) Na2SO4 (mol%) X Solvent % Yield (dr)
1 150 0 OTf DCE 43 (2:1)
2 300 0 OTf DCE 56 (2:1)
t (h)
48
48
3 300 200 OTf DCE 65 (2:1)48
4 300 200 DCE 78 (3:1)48BARF
5 300 200 DCM 87 (3:1)48BARF
6 300 200 DCM 99 (3:1)72BARF
2.47a 2.48
 
 
 Our optimization studies began with the coupling of 6-bromo-2-vinylpyridine 
2.41 with the N-tosylaldimine 2.47a. Hydrogenating the coupling partners 2.41 (150 
mol%) and 2.47a (100 mol%) with Rh(COD)2OTf catalyst (5 mol%) using tris(2-
trifurylphosphine) as ligand in DCE (0.25 M) at room temperature produced the coupling 
product in 43% yield (2:1 dr) (Table 2.5, entry 1).  
Increasing the loadings of vinylpyridine 2.41 from 150 mol% to 300 mol% 
improved the yields to 56% (2:1 dr) (Table 2.5, entry 2). Sodium sulfate (200 mol%) was 
used as a desiccant to suppress the imine hydrolysis as well as formation of hydroxyl 
bridged rhodium dimmers and the yield of the coupling product improved to 65% (2:1 dr) 
(Table 2.5, entry 3). By switching the counter ion to BARF and solvent to DCM the 
coupling product was isolated in 87% yield (3:1 dr) (Table 2.5, entries 4 and 5). 
Prolonged reaction times further improved the yield of the coupling product to 97% (3:1 
dr) (Table 2.5, entry 6). Further efforts to improve the diastereoselectivities by varying 
the solvent, temperature and ligand were unfruitful.   
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2.4.4 Substrate Scope 
 
Table 0.6. Reductive coupling of 6-bromo-2-vinylpyridine 2.41 to aldimines 2.47a-2.47l. 
 
                                     a Cited yields are of isolated diastereomeric mixtures, b Reaction was performed at 35 oC. 
                                     C 7.5 mol% Rh catalyst and 18 mol % of (2-Fur)3P were used. 
 
Under the optimized reaction conditions (Table 2.5, entry 6) the reactivity of 
various imines 2.47a-2.47l was examined using 6-bromo-2-vinylpyridine 2.41 as the 
coupling partner. Aromatic (Table 2.6, entries 2.48-2.51), heteroaromatic (Table 2.6, 
entries 2.52-2.53) and aliphatic (Table 2.6, entries 2.54-2.59) imines participated in the 
coupling reaction with good to excellent yields and selectivities.  
Heterocycle containing imines produced the coupling products in good to 
excellent yields (72-99%) and with decent selectivities (4:1-7:1 dr). Under the optimized 
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conditions (Table 2.6, entry 6) a variety of aliphatic imines generated the coupling 
products 2.54-2.59 in good yields (67-74%) with moderated to excellent selectivities 
(4:1-13:1 dr). Under the hydrogenative coupling conditions over reduction of coupling 
product 2.55 was not observed. In the case of imines 2.47k and 2.47l, the coupling 
reactions were performed with higher catalyst loadings (7.5 mol%) at slightly elevated 
temperatures (35 oC) for better yields. The yields of the coupling products 2.56 and 2.59 
improved when the reactions were performed at 35 oC as well. In general, aromatic 
imines exhibited excellent reactivity with moderate selectivities but opposite is the case 
with aliphatic imines. 
 Unlike the imine coupling partner, the substrate scope with respect to vinyl 
heterocycle was not very broad. The coupling reactions were efficient only with 
substituted 2-vinylpyridines and 2-vinylquinolines (Table 2.7, entries 2.61-2.69) but 
higher azines like 2,3-diphenylpyrazine with imine 2.47f produced the coupling product 
in a diminished yield (35%).  Under the optimized conditions, the 6-substituted 
vinylpyridines generated the coupling products (Table 2.7, entries 2.61-2.69) with both 
aromatic and aliphatic imines in good to excellent yields (56-94%) and with good 
selectivities (4:1-10:1). 
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Table 0.7. Reductive coupling of vinylarenes 2.61, 2.42, 2.44 and 2.46 to aldimines 2.47f, 
2.47i and 2.47k. 
 
                                     a Cited yields are of isolated diastereomeric mixtures, b  7.5 mol% Rh catalyst and 18 mol % of 
                          (2- Fur)3P were used. 
 
Vinylpyridines having aromatic (Ph) or aliphatic (Me, CH2OTBS and Ac) 
substituent at the sixth position of the pyridine ring were found to be efficient in the 
coupling reaction with the exception of 6-methyl-2-vinylpyridine 2.60. It being less 
reactive higher catalyst loadings (7.5 mol% of Rh) was needed for better yields. The 
bicyclic 8-benzyloxy-2-vinylquinoline 2.46 exhibited very good reactivity with aromatic 
as well as aliphatic imines (Table 2.7, entries 2.68-2.70). However, the parent 2-
vinylpyridine did not participate in the reaction which could be attributd to the Lewis 
basicity of the pyridine ring.  
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Substitution at the sixth position of the pyridine ring seems to influence the 
reactivity of the vinylpyridine (Scheme 2.6). For instance, while 2-vinylpyridine did not 
generate any coupling product with imine 2.47f under the standard reaction conditions, 6-
bromo-2-vinylpyridine produced the coupling product in 72% yield. This can be 
rationalized based on the steric or electronic factors of the substituent on the basicity of 
pyridine nitrogen. After the C-C bond formation, the metal center forms a strong chelate 
(Scheme 2.6, intermediate I) with both the nitrogen atoms of the product thereby 
reducing the catalytic turnover. When a bulky (Br or Ph) or electron withdrawing (Br or 
Ac) substituent is placed next to the pyridine nitrogen the basicity decreases and the 
equilibrium shifts towards the non-chelated form. C-H reductive elimination from 
intermediate II generates the coupling product. 
 
Scheme 0.7. Effect of substituent X on the reactivity of vinylpyridines. 
 
2.4.5 Stereochemistry 
 
 The syn-stereochemical assignment of the coupling products was based on the 
single-crystal X-ray diffraction analysis of the coupling products 2.49 and 2.54 (Figures 
2.2 and 2.3). 
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Figure 0.2. View of 2.48 showing the atom labeling scheme.  Displacement ellipsoids are 
scaled to the 50% probability level. 
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Figure 0.3. View of 2.53 showing the atom labeling scheme. Displacement ellipsoids are 
scaled to the 50% probability level. The disordered thiophene ring is shown. 
 
2.4.6 Proposed Mechanism 
 
 In order to gain more information about the mechanism of the reaction, the 
coupling partners 2.41 and 2.47l were subjected to the reaction conditions in the presence 
of deuterium gas (99.6% purity). The coupling product deuterio-2.59 was isolated in 65% 
yield with exclusive deuterium incorporation (97:7, D:H) at the former β-postion of the 
vinyl moiety (Scheme 2.7). The deuterium labeling experimental results can be explained 
by both hydrometallative (Catalytic cycle A, Scheme 2.7, bottom-left figure) and 
oxidative coupling mechanisms (Catalytic cycle B, Scheme 2.7, bottom-right figure).  
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Scheme 0.8. a) Reductive coupling of vinylarene 2.41 and imine 2.47l under deuterium 
gas atmosphere (top figure). b) Hydrometalltive mechanism (Catlytic cycle A, bottom-
left) and oxidative coupling (Catlytic cycle B, bottom-right). 
  
In the hydrometallative mechanism, first the vinylpyridine undergoes 
regioselective hydrometallation to generate the rhodium enaminate species II, 44 which 
undergoes C-N insertion to the imine to generate the chelated intermediate III. 
Eventually the azarhodium species IV undergoes hydrogenolysis (deuterolysis) via a σ 
bond metathesis or a consecutive oxidative addition followed by N-H(D) reductive 
elimination to give the coupling product  by regenerating the rhodium catalyst (Scheme 
2.7, catalytic cycle A, left figure). 
 The deuterium labeling results are consistent with the oxidative coupling 
mechanism too. In this catalytic cycle, first the imine undergoes insertion to the 
rhodacyclopropane VI to generate the azarhodacycle VII, which upon hydrogenolysis51 
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(deuterolysis) produces the chelated intermediate VIII. N-H(D) reductive elimination 
from hydrido(deuterio)azarhodium species VIII produces the coupling product by 
regenerating the rhodium catalyst (Scheme 2.7, Catalytic cycle B, right figure). 
 The syn-selectivity of the coupling reaction can be explained by the competing 
transition states shown in scheme 2.8. If the reaction proceeds via a hydrometallative 
mechanism, the Z-enaminate II can react via a relatively less crowded boat-like transition 
state III to give the syn-product. The anti coupling product results from the more 
sterically crowded chair type transition state V (Scheme 2.8, top figure).   
If the reaction proceeds via an oxidative coupling mechanism, the syn selectivity 
results from the hydrogenolysis of competing metallacycles VII and IX. The syn product 
syn-IV results from the hydrogenolysis of the relatively more preferred transition state 
VII where both the pyridine moiety and the R group are anti to each other. 
Hydrogenolysis of the less preferred transition state IX leads to the minor product anti-
IV (Scheme 2.8, bottom figure). 
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Scheme 0.9. a) Syn-selectivity via a hydrometallative mechanism (top figure) b) Syn-
selectivity via an oxidative coupling mechanism (bottom figure). 
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2.5 CONCLUSION 
 
 In summary, a variety of rhodium catalyzed hydrogen mediated coupling 
reactions were developed using N-heterocyclic aromatic compounds. The rhodium 
catalysis is very efficient with vicinal dicarbonyls but not with simple aldehydes. 
However, by realizing the structural similarities of these vicinal dicarbonyls to 2-
pyridinecarboxaldehyde a novel hydrogen mediated coupling reaction was developed. 
A variety of N-heterocyclic-2-carboxaldehydes and ketones were coupled to different 
conjugated enynes with excellent selectivities and chemical yields. Valuable mechanistic 
insight was gained through the chiral Brønsted acid studies and high levels of 
enantioselectivities were observed with a Akiyama-List-Terada type phosphoric acid. 
Moreover, through the logical designing of experiments it was shown that the Brønsted -
acid associated pyridinecarboxaldehyde species was responsible for high levels of 
selectivities but not the chiral rhodium complex if at all formed in the reaction. The 
outcome of the chiral Brønsted acid studies under the rhodium catalyzed hydrogenation 
conditions represents a special case in Brønsted acid assisted asymmetric induction in 
transition metal catalysis. Further, this concept was extended to the corresponding 
aromatic N-heterocyclic-2-aldimines. It was realized that for a given chiral ligand, the 
enantioselectivities were very substrate sensitive with respect to both enyne and aldimine.  
Additionally, the first metal catalyzed reductive C-C coupling of 2-vinylpyridines 
and aldimines was discovered. Hydrogenation of 2-vinylazines in the presence of 
aldimines using a tris(2-trifurylphosphine) ligated cationic rhodium catalyst produced the 
coupling products in good to excellent yields with complete branch selectivity. In general 
moderate to good diastereoselectivities were observed with aromatic aldimines and good 
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to excellent selectivities were observed with aliphatic imines. The coupling reactions 
were very efficient with 6-substituted vinylpyridines 2.60, 2.42, 2.44 and 8-benzyloxy-2-
vinylquinoline 2.46. Based on the deuterium labeling experiments, two possible 
mechanisms were proposed and at this point there is not ample evidence to eliminate 
either of them.   
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2.6. EXPERIMENTAL SECTION 
 
2.6.1 General: All reactions were run under an atmosphere of argon, unless otherwise 
indicated. Anhydrous solvents were transferred by an oven-dried syringe. Flasks were 
flame-dried and cooled under a stream of nitrogen. Dichloroethane (DCE) was distilled 
from calcium hydride. Rh(COD)2OTf, (R)-tol-BINAP and (R)-xylyl-WALPHOS were 
used as received from Strem Chemicals. All the 1,3-enynes were prepared following the 
literature procedure. 52  The aldehyde substrates are either commercially available or 
prepared using literature procedure, for example N-4-methoxybenzyl-2-imidazole 
carboxaldehyde 53  N-phenyl-5-pyrazine-2-carboxaldehyde 54  5-methyl-2-
thiazocarboxaldehyde.55 All the ketone substrates used for reductive coupling reactions 
are commercially available. The imines were prepared in accordance with literature 
procedures.56, 57 All the hydrogen mediated reductive coupling reactions were carried out 
in 13 x 100 mm test tubes. Analytical thin-layer chromatography (TLC) was carried out 
using 0.2-mm commercial silica gel plates (DC-Fertigplatten Kieselgel 60 F254). 
Preparative column chromatography employing silica gel was performed according to the 
method of Still. 58  Solvents for chromatography are listed as volume/volume ratios. 
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer. High-resolution 
mass spectra (HRMS) were obtained on a Karatos MS9 and are reported as m/z (relative 
intensity). Accurate masses are reported for the molecular ion [M] or a suitable fragment 
ion. Proton nucolorless magnetic resonance (1H NMR) spectra were recorded with a 
Varian Gemini (400 MHz) spectrometer. Chemical shifts were reported in delta (δ) units, 
parts per million (ppm) downfield from trimethylsilane. Coupling constants were 
reported in Hertz (Hz). Carbon-13 nuclear magnetic resonance (13C-NMR) spectra were 
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recorded with a Varian Gemini 400 (100 MHz) spectrometer. Chemical shifts were 
reported in delta (δ) units, ppm relative to the center of the triplet at 77.0 ppm for 
deuteriochloroform. 13C NMR spectra were routinely run with broadband decoupling. 
 
2.6.2 General procedure for the reductive coupling of conjugated enynes and 2-N- 
heterocyclic aromatic aldehydes and ketones, preparation of 2.3: 
 
To a degassed solution of Rh(COD)2OTf (4.4 mg, 9.3 mol, 2 mol%), (R)-tol-
BINAP (6.3 mg, 9.3 mol, 2 mol%) and triphenylacetic acid (2.7 mg, 9.3 mol, 2 
mol%) in DCE (1.0 mL) in a 13 x 100 mm test tube, a solution of 2-pyridine 
carboxaldehyde (50.0 mg, 0.466 mmol, 100 mol%) and the enyne 2.1a (128.0 mg, 0.932 
mmol, 200 mol%) in DCE (1.4 mL, total volume, 2.4 mL, 0.2 M) was added. The system 
was then purged with argon gas followed by hydrogen gas. The reaction was allowed to 
stir at 40 oC under 1 atm of hydrogen until complete consumption of the aldehyde. The 
solvent was evaporated in vacuo and the crude reaction mixture was purified by flash 
chromatography. 
 
 
2.3 
2-Phenyl-1-pyridin-2-yl-penta-2,4-dien-1-ol (2.3): Rf = 0.20, 35% EtOAc/hexanes; 
colorless oil; 1H NMR (400 MHz, CDCl3): 8.35 (dd, J = 3.2, 1.0 Hz, 1H), 7.46 (dt, J = 
7.2, 1.6 Hz, 1H), 7.15 (m, 3H), 7.03 (m, 3H), 6.96 (m, 2H), 6.50 (d, J = 11.2 Hz, 1H), 
6.22 (ddd, J = 16.8, 10.8, 10.4 Hz, 1H), 5.26 (dd, J = 16.8, 1.6 Hz, 2H), 5.0 (dd, J = 10.0, 
2.0 Hz, 1H). 13C NMR (100 MHz, CDCl3): 159.1, 147.6, 144.0, 143.4, 141.2, 137.1, 
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136.3, 133.6, 129.4, 127.7, 127.0, 122.2, 118.8, 76.7. HRMS Calcd. for C16H15NO (M): 
237.1154, Found: 237.1158. FTIR (NaCl Film): 3374, 3080, 3053, 3017, 2973, 2874, 
1594, 1570, 1470, 1437, 1396, 1208, 1076, 999, 914, 801, 768, 743, 673 cm-1. HPLC 
(Chiralcel OD-H column, 5% i-PrOH/hexanes, 0.3 mL/min, 254 nm): tminor = 31.2 min, 
tmajor = 34.5 min; ee = 92%. 
 
 
2.4 
Acetic acid 2-(hydroxy-pyridin-2-yl-methyl)-penta-2,4-dienyl ester (2.4): Rf = 0.22, 
45% EtOAc/hexanes; colorless oil; 1H NMR (400 MHz, CDCl3): 8.54 (d, J = 4.8 Hz, 1H), 
7.67 (dt, J = 7.6, 1.6 Hz, 1H), 7.29 (t, J = 7.6 Hz, 1H), 7.22 (dd, J = 7.2, 4.8 Hz, 1H), 6.70 
(ddd, J = 16.8, 11.2, 10.4 Hz, 1H), 6.44 (d, J = 11.6 Hz, 1H), 5.41 (dd, J = 16.8, 1.6 Hz, 
1H), 5.32 (dd, J =10.0, 1.2 Hz, 1H), 5.27 (s, 1H) 5.20 (s, 1H), 4.68 (q, J = 12.8 Hz, 2H) 
1.80 (s, 3H). 13C NMR (100 MHz, CDCl3): 170.6, 159.2, 147.8, 136.6, 136.3, 133.9, 
131.5, 122.4, 121.3, 122.1, 76.0, 58.4, 20.5. HRMS Calcd. for C13H15NO3 (M): 233.1052, 
Found: 233.1052. FTIR (NaCl Film): 3384, 3083, 3051, 3011, 2961, 1737, 1592, 1467, 
1436, 1239, 1039, 995, 914, 671. HPLC (Chiralcel AD-H column, 5% i-PrOH/hexanes, 
0.5 mL/min, 254 nm): tminor=32.0 min, tmajor = 38.4 min; ee = 95%. 
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2.5 
Acetic acid 3-(hydroxy-pyridin-2-yl-methyl)-hexa-3,5-dienyl ester (2.5): Rf = 0.25, 
40% EtOAc/hexanes; colorless oil;  1H NMR (400 MHz, CDCl3): 8.54 (d, J = 4.8 Hz, 
1H), 7.67 (dt, J = 7.6, 1.2 Hz, 1H), 7.30 (d, J = 8.0 Hz, 1H), 7.22 (dd, J = 6.4, 5.2 Hz, 
1H), 6.64 (dt, J = 16.8, 10.8 Hz, 1H), 6.35 (d, J = 11.2 Hz, 1H), 5.33 (d, J = 16.8 Hz, 1H), 
5.24 (d, J = 1.0 Hz, 1H), 5.20 (s, 1H) 4.91 (s, 1H), 3.93 (m, 2H) 2.50 (ddd, J = 14.8, 8.4, 
7.2 Hz, 1H), 2.23 (ddd, J = 13.6, 8.4, 6.4 Hz, 1H) 1.97 (s, 3H).13C NMR (100 MHz, 
CDCl3): 170.1, 159.2, 147.6, 138.3, 136.6, 132.1, 131.4, 122.4, 120.9, 119.1, 77.5, 63.5, 
26.1, 20.8. HRMS Calcd. for C14H17NO3 (M): 247.1208, Found: 247.1211. FTIR (NaCl 
Film): 3388, 3085, 3012, 2963, 1737, 1593, 1471, 1435, 1385, 1305, 1245, 1036, 993, 
915, 763, 686 cm-1. HPLC (Chiralcel AD-H column, 5% i-PrOH/hexanes, 0.5 mL/min, 
254 nm): tminor = 38.7 min, tmajor = 32.4 min; ee = 94%. 
 
 
2.6 
2-(Hydroxy-pyridin-2-yl-methyl)-penta-2,4-dienyl]-carbamic acid tert-butyl ester 
(2.6): Rf = 0.22, 45% EtOAc/hexanes; colorless thick syrup; 1H NMR (400 MHz, 
CDCl3): 8.54 (dd, J = 4.8, 1.2 Hz, 1H), 7.67 (dt, J = 7.6, 1.6 Hz, 1H), 7.30 (dd, J = 7.6, 
10.4 Hz, 1H), 7.22 (dd, J = 7.2, 5.2 Hz, 1H), 6.74 (dt, J = 16.4, 10.8 Hz, 1H), 6.31 (d, J = 
10.8 Hz, 1H), 5.36 (dd, J = 16.4, 1.6 Hz, 2H), 5.27 (d, J = 10.4 Hz, 1H), 5.23 (s, 1H), 
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4.91 (s, 1H), 4.0 (dd, J = 7.2, 3.8 Hz  1H) 3.47 (dd, J = 14.0, 4.0, 1H) 1.40 (s, 9H). 13C 
NMR (100 MHz, CDCl3): 159.1, 155.6, 147.8, 138.8, 136.9, 132.0, 131.8, 122.5, 120.8, 
120.3, 79.0, 70.6, 36.5, 28.3. HRMS Calcd. for C16H22N2O3 (M): 290.1630, Found: 
290.1631. FTIR (NaCl Film): 3357, 3053, 2957, 2932, 1701, 1592, 1501, 1435, 1366, 
1249, 1169, 1045, 995, 918, 755, 624 cm-1. HPLC (Chiralcel AD-H column, 5% i-
PrOH/hexanes, 0.5 mL/min, 254 nm): tminor = 32.3 min, tmajor = 34.4 min; ee = 95%. 
 
 
OH
N
HN
 
2.7 
2-(1H-Indol-2-yl)-1-pyridin-2-yl-penta-2,4-dien-1-ol (2.7): Rf = 0.20, 45% 
EtOAc/hexanes; yellow solid; MP = 81-85 oC; 1H NMR (400 MHz, CDCl3): 9.40 (s, 1H), 
8.44 (d, J = 4.8 Hz, 1H), 7.55 (dd, J = 8.0, 1.6 Hz, 1H), 7.52 (t, J = 6.8 Hz, 1H), 7.27 (d, J 
= 8.0 Hz, 2H), 7.0 (m, 2H), 6.96 (m, 2H), 6.52 (d, J = 11.2 Hz, 1H), 6.45 (d, J = 1.0 Hz, 
1H), 5.5 (s, 1H), 5.47 (d, J = 1.2 Hz, 1H), 5.43 (d, J = 1.2 Hz, 1H) 5.27 (dd, J = 10.4, 0.8., 
Hz, 1H). 13C NMR (100 MHz, CDCl3): 158.8, 147.5, 137.0, 137.2, 135.7, 133.8, 133.7, 
133.2, 132.7, 127.7, 122.6, 122.0, 120.8, 120.1, 119.5, 111.0, 104.8, 77.8. HRMS Calcd. 
for C18H16N2O (M): 276.1263, Found: 276.1261. FTIR (NaCl Film): 3274, 3080, 3056, 
2973, 2862, 1593, 1570, 1436, 1400, 1339, 1150, 1078, 1000, 913, 797, 749, 652 cm-1. 
HPLC (Chiralcel AD-H column, 5% i-PrOH/hexanes, 1.0 mL/min, 254 nm): tminor = 38.4 
min, tmajor = 26.0 min; ee = 90%. 
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2.8 
2-(1H-indol-2-yl)-1-pyrazin-2-yl-penta-2,4-dien-1-ol (2.8): Rf = 0.25, 25% 
EtOAc/hexanes; yellow solid; MP = 68-69 oC; 1H NMR (400 MHz, CDCl3): 9.30 (s, 1H), 
8.34 (d, J = 9.2 Hz, 1H), 8.32 (s, 1H), 7.50 (d, J = 8.0 Hz, 1H), 7.23 (d, J = 7.6 Hz, 1H), 
7.10 (t, J = 7.2 Hz, 2H), 7.02 (d, J = 8 Hz, 1H), 6.91(dt, J = 17.2, 10.4 Hz, 1H), 6.50 (d, J 
= 10.8 Hz, 1H), 6.44 (s, 1H), 5.55 (s, 1H), 5.45 (d, J = 16.8 Hz, 1H), 5.30 (d, J = 10.0 Hz, 
1H) 5.10 (s, 1H). 13C NMR (100 MHz, CDCl3): 155.0, 143.2, 143.0, 142.5, 135.8, 133.4, 
133.3, 133.0, 132.0, 127.7, 122.2, 121.5, 120.3, 119.7, 111.0, 105.0, 76.6. HRMS Calcd. 
for C17H15N3O (M): 277.1215, Found: 277.1215. FTIR (NaCl Film): 3400, 3082, 3056, 
1454, 1403, 1339, 1265, 1150, 1084, 1001, 1020, 917, 1020, 917, 917, 824, 737, 657 cm-
1. HPLC (Chiralcel AD-H column, 10% i-PrOH/hexanes, 1.0 mL/min, 254 nm), tminor = 
21.2 min, tmajor = 15.8 min; ee = 91%. 
 
 
2.9 
Acetic acid 2-(hydroxyl-isoquinolin-3-yl-methyl)-penta-2,4-dienyl ester (2.9): Rf = 
0.23, 30% EtOAc/hexanes; yellow solid; MP = 78-82 oC; 1H NMR (400 MHz, CDCl3): 
9.20 (s, 1H), 7.96 (d, J = 8.0 Hz, 1H), 7.80 (d, J = 8.4 Hz, 1H), 7.68 (d, J = 4.0 Hz, 1H), 
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7.67 (d, J = 7.2 Hz, 1H), 7.58 (t, J = 8.0 Hz, 1H), 6.70 (dt, J = 16.8, 10.4 Hz, 1H), 6.49 (d, 
J = 11.2 Hz, 1H), 5.47 (s, 1H) 5.62 (s, 1H), 5.40 (dd, J = 16.8, 1.6 Hz, 1H), 5.30 (d, J = 
10.0 Hz, 1H), 4.71 (q, J = 12.4 Hz, 2H), 1.75 (s, 3H). 13C NMR (100 MHz, CDCl3): 
170.8, 153.0, 151.3, 136.7, 136.2, 133.4, 131.6, 130.7, 127.9, 127.5, 127.2, 126.6, 121.2, 
117.2, 76.2, 59.0, 20.5. HRMS Calcd. for C17H17NO3 (M): 283.1208, Found: 283.1207. 
FTIR (NaCl Film):3366, 3059, 2923, 1732, 1734, 1629, 1591, 1363, 1232, 1025, 962, 
751, 667 cm-1 HPLC (Chiralcel OD-H column, 5% i-PrOH/hexanes, 1.0 mL/min, 254 
nm): tminor = 17.7 min, tmajor = 33.5 min; ee = 95%. 
 
 
2.10 
1-(6-Bromo-pyridin-2-yl)-2-phenyl-penta-2,4-dien-1-ol (2.10): Rf = 0.25, 10% 
EtOAc/hexanes; colorless oil; 1H NMR (400 MHz, CDCl3): 7.40 (t, J = 7.6 Hz, 1H), 7.32 
(d, J = 8.0 Hz, 1H), 7.25 (m, 3H), 7.03 (dd, J = 7.6, 2.0 Hz, 2H), 7.05 (d, J = 7.2 Hz, 1H), 
6.21 (d, J = 11.2 Hz, 1H), 6.26 (dt, J = 16.8, 10.8 Hz, 1H), 5.49 (d, J = 5.2 Hz, 1H), 5.34 
(d, J = 16.8 Hz, 1H) 5.10 (dd, J = 10.0, 0.8 Hz, 1H), 4.35 (d, J = 5.6 Hz, 1H). 13C NMR 
(100 MHz, CDCl3): 161.0, 143.0, 140.6, 138.6, 138.7, 137.0, 130.0, 129.5, 128.0, 127.4, 
126.7, 120.0, 119.4, 76.8. HRMS: Calcd. for C16H14NOBr (M): 315.0259, Found: 
315.0257. FTIR (NaCl Film): 3413, 3079, 3051, 1580, 1553, 1434, 1407, 1158, 1123, 
1072, 994, 915, 808, 705, 670 cm-1. HPLC (Chiralcel OD-H column, 5% i-PrOH/hexanes, 
0.5 mL/min, 254 nm): tminor = 18.1 min, tmajor = 16.6 min; ee = 99%. 
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2.11 
1-(6-Bromo-pyridin-2-yl)-2-phenyl-penta-2,4-dien-1-ol (2.11): Rf = 0.24, 15% 
EtOAc/hexanes; colorless oil; 1H NMR (400 MHz, CDCl3): 7.55 (t, J = 8.0 Hz, 1H), 7.40 
(d, J = 8.0, Hz, 1H), 7.32 (d, J = 8.0 Hz, 1H), 6.67 (dt, J = 16.4, 10.4 Hz, 1H), 5.41 (d, J 
= 10.8 Hz, 1H), 5.54 (m, 2H) 5.27 (d, J = 4.4 Hz, 1H), 4.70 (q, J = 12.8 Hz, 2H), 4.54 (d, 
J = 4.8 Hz, 1H), 1.82 (s, 3H). 13C NMR (100 MHz, CDCl3): 170.5, 161.5, 140.6, 138.8, 
135.5, 133.8, 131.2, 126.6, 121.5, 119.7, 75.8, 58.6, 20.4. HRMS: Calcd. for 
C13H14NO3Br (M) 311.0157, Found: 311.0157. FTIR (NaCl Film): 3436, 2927, 1738, 
1581, 1556, 1434, 1404, 1234, 1157, 1123, 1028, 986, 790, 742, 704 cm-1. HPLC 
(Chiralcel AD-H column, 5% i-PrOH/hexanes, 1 mL/min, 254 nm): tminor = 22.6 min, 
tmajor = 19.0 min; ee = > 99%. 
 
 
 
2.12 
[2-(Hydroxy-[1,2,3]thiadiazol-4-yl-methyl)-penta-2,4-dienyl]-carbamic acid tert- 
butyl ester (2.12): Rf = 0.30, 25% EtOAc/hexanes; yellow syrup; 1H NMR (400 MHz, 
CDCl3): 8.60 (s, 1H), 6.60 (dt, J = 16.8, 10.4 Hz, 1H), 6.25 (d, J = 11.2 Hz, 1H), 5.80 (s, 
1H), 5.30 (d, J = 16.8 Hz, 1H), 5.23 (d, J = 10.0, 1H), 5.16 (d, J = 6.4 Hz, 1H), 4.81 (s, 
1H), 3.86 (dd, J = 15.2, 6.0 Hz, 1H), 3.78 (dd, J = 15.2, 5.6 Hz, 1H), 1.30 (s, 9H). 13C 
NMR (100 MHz, CDCl3): 166.0, 156.5, 138.0, 137.3, 133.1, 131.8, 121.2, 80.0, 72.5, 
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36.7, 28.2. HRMS Calcd. for C13H19N3O3S (M): 297.1147, Found: 297.1138. FTIR 
(NaCl Film): 3361, 2977, 2931, 1690, 1682, 1515, 1367, 1251, 1166, 1046 cm-1. HPLC 
(Chiralcel OJ-H column, 5% i-PrOH/hexanes, 0.5 mL/min, 254 nm): tminor = 32.7 min, 
tmajor = 29.2 min; ee = 94%. 
 
Ph
OH
N
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2.13 
1-[1-(4-Methoxy-benzyl)-1H-imidazol-2-yl]-2-phenyl-penta-2,4-dien-1-ol (2.13): Rf = 
0.18, 2% MeOH/ether; white solid; MP = 146-149 oC;  1H NMR (400 MHz, CDCl3): 7.25 
(m, 2H), 7.04 (dd, J = 7.2, 2.4 Hz, 2H), 7.0 (d, J = 8.8 Hz, 2H), 7.03 (dd, J = 7.6, 2.0 Hz, 
2H), 7.05 (d, J = 8.8 Hz, 2H), 6.81 (dd, J = 4.8, 2.8 Hz, 1H), 6.63 (d, J = 1.2 Hz, 1H), 
6.47 (d, J = 11.2 Hz, 1H), 6.29 (dt, J = 16.8 , 10.0 Hz, 1H) 5.62 (s, 1H), 5.28 (dd, J = 
16.4, 1.6 Hz, 1H), 5.07 (dd, J = 10.0, 2.0 Hz, 1H), 5.02 (d, J = 14.8 Hz, 1H), 4.85 (d, J = 
15.2 Hz, 1H), 3.85 (s, 3H). 13C NMR (100 MHz, CDCl3): 159.28, 147.5, 142.3, 135.7, 
137.3, 133.5, 129.1, 129.0, 128.6, 128.0, 127.3, 126.8, 120.3, 119.1, 114.1, 70.7, 55.2, 
49.0. HRMS Calcd. for C22H22N2O2 (M): 346.1681, Found: 346.1687. FTIR (NaCl Film): 
3418, 3084, 2400, 1529, 1250, 1031, 7021 cm-1. HPLC (Chiralcel AD-H column, 10% i-
PrOH/hexanes, 1.0 mL/min, 254 nm), tminor = 17.1 min, tmajor = 9.8 min; ee = 95%. 
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2.14 
1-(Benzyl-1H-[1,2,3]-triazol-4-yl)-penta-2,4-dien-1-ol (2.14): Rf = 0.30, 50% 
EtOAc/hexanes; colorless syrup; 1H NMR (400 MHz, CDCl3): 7.42 (s, 1H), 7.36 (m, 3H), 
7.27 (m, 2H), 6.66 (ddd, J = 16.8, 10.8, 10.0 Hz, 1H), 6.42 (d, J = 11.2 Hz, 1H), 5.50 (s, 
1H), 5.48 (s, 1H), 5.33 (m, 2H), 4.71 (q, J = 12.4 Hz, 2H), 3.39 (s, 1H), 3.98 (dd, J = 15.2, 
5.6 Hz, 1H) 1.91 (s, 3H). 13C NMR (100 MHz, CDCl3): 171.2, 149.7, 135.3, 134.4, 133.0, 
133.1, 131.4, 129.1, 128.8, 128.1, 121.6, 121.2, 70.2, 59.6, 54.2, 20.7. HRMS Calcd. For 
C18H23N2O4 (M): 13.1658, Found: 313.1659. FTIR (NaCl Film): 3368, 3142, 2925, 1731, 
1455, 1367, 1239, 1047, 724 cm-1. HPLC (Chiralcel AD-H column, 10% i-PrOH/hexanes, 
1.0 mL/min, 254 nm): tminor = 23.8 min, tmajor = 20.6 min; ee = 95%. 
 
 
2.15 
Acetic acid 3-[hydroxy-(5-methyl-thiazol-2-yl)-methyl]-hexa-3,5-dienyl ester (2.15): 
Rf = 0.30, 30% EtOAc/hexanes; colorless oil; 1H NMR (400 MHz, CDCl3): 7.0 (s, 1H), 
6.42 (dt, J = 17.2, 10.4 Hz, 1H), 6.33 (d, J = 10.3 Hz, 1H), 5.32 (s, 1H), 5.28 (d, J = 2.0 
Hz, 1H), 5.22 (dd, J = 10.4, 2.0 Hz, 1H), 4.14 (ddd, J = 14.4, 10.4, 7.2 Hz, 1H), 4.05 (ddd, 
J = 17.2, 10.8, 7.6 Hz, 1H), 3.64 (m, 2H), 2.68 (s, 1H), 2.51 (m, 3H), 2.10 (s, 3H). 13C 
NMR (100 MHz, CDCl3): 171.3, 166.3, 157.0, 137.5, 132.1, 130.8, 119.3, 113.0, 75.3, 
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63.6, 27.1, 21.0, 19.1. HRMS Calcd. for C13H17NO3S (M): 267.0929, Found: 267.0927. 
FTIR (NaCl Film): 3500, 3117, 2960, 1732, 1738, 1470, 1385, 1245, 1187, 1036, 991, 
915, 736, 666 cm-1. HPLC (Chiralcel AD-H column, 5% i-PrOH/hexanes, 0.5 mL/min, 
254 nm): tminor = 40.0 min, tmajor = 33.8 min; ee = 92%. 
 
 
2.16 
1-(5-Methyl-isoxazol-2-yl)-2-phenyl-penta-2,4-dien-1-ol (2.16): Rf = 0.25, 25% 
EtOAc/hexanes; white solid; MP = 88-93 oC; 1H NMR (400 MHz, CDCl3): 7.29 (m, 3H), 
7.15 (d, J = 1.6 Hz, 1H), 7.13 (s, 1H), 6.52 (d, J = 10.8 Hz, 1H), 6.66 (dt, J = 16.8, 10.4 
Hz, 1H), 5.80 (s, 1H), 5.61 (d, J = 4.8 Hz, 1H), 5.34 (dd, J = 16.8, 1.8 Hz, 1H), 5.12 (dd, 
J = 10.4, 2.0 Hz, 1H), 3.06 (d, J = 4.4 Hz, 1H), 2.35 (s, 3H). 13C NMR (100 MHz, 
CDCl3): 166.5, 165.0, 141.8, 136.6, 133.3, 129.3, 129.0, 128.1, 127.6, 119.6, 99.9, 70.9, 
12.2. HRMS Calcd. for C15H15NO2 (M): 241.1103, Found: 241.1100. FTIR (NaCl Film): 
3368, 3081, 1603, 1480, 1442, 1295, 1258, 1088, 1026, 997, 915, 788, 688 cm-1. HPLC 
(Chiralcel AD-H column, 5% i-PrOH/hexanes, 0.5 mL/min, 254 nm): tminor = 25.9 min, 
tmajor = 23.4 min; ee = 94%.  
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2.17 
Acetic acid 3-[(1,5-diphenyl-1H-pyrazol-3-yl)-hydroxy-methyl]-hexa-3,5-dienyl ester 
(2.17): Rf = 0.25, 25% EtOAc/hexane; white solid; MP = 149-152 oC; 1H NMR (400 
MHz, CDCl3): 7.28 (m, 11H), 6.66 (dt, J = 16.8, 10.8 Hz, 1H), 6.43 (d, J = 10.8 Hz, 1H), 
6.41 (s, 1H), 5.40 (d, J = 3.2 Hz, 1H), 5.32 (dd, J = 16.8, 2.0 Hz, 1H), 5.21 (dd, J = 10.4, 
2.0 Hz, 1H), 4.17 (m, 2H), 3.13 (d, J = 3.2 Hz, 1H), 2.61 (dt, J = 6.8, 1.6 Hz, 2H), 2.0 (s, 
1H) 1.72 (s, 1H). 13C NMR (100 MHz, CDCl3): 171.2, 154.0, 144.2, 139.8, 138.1, 132.3, 
130.2, 129.7, 128.9, 128.6, 128.4, 128.3, 127.4, 125.2, 119.0, 109.6, 105.2, 73.5, 63.7, 
39.8, 38.5, 27.2, 21.0. HRMS Calcd. for C24H24N2O3 (M): 388.1787, Found: 388.1786. 
FTIR (NaCl Film): 3500, 3293, 3039, 2928, 1604, 1489, 1440, 1256, 1101, 1000, 919, 
905, 781, 703 cm-1. HPLC (Chiralcel AD-H column, 5% i-PrOH/hexanes, 1.0 mL/min, 
254 nm): tminor = 33.6 min, tmajor = 41.2 min; ee = 92%. 
 
 
2.18 
 [2-(Benzooxazol-2-yl-hydroxy-methyl)-penta-2,4-dienyl]-carbamic acid tert-butyl 
ester (2.18): Rf = 0.29, 40% EtOAc/hexanes; colorless oil; 1H NMR (400 MHz, CDCl3): 
7.71 (m, 1H), 7.51 (m, 1H), 7.33 (m, 2H), 6.69 (ddd, J = 16.8, 10.8, 10.0 Hz, 1H), 6.34 (d, 
J = 10.8 Hz, 1H), 5.49 (s, 1H), 5.40 (dd, J = 16.8, 1.6 Hz, 2H), 5.32 (dd, J = 10.0, 1.6 Hz, 
1H), 5.01 (s, 1H), 4.06 (dd, J = 15.2, 6.8 Hz, 1H), 3.98 (dd, J = 15.2, 5.6 Hz, 1H) 1.45 (s, 
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1H) 1.33 (s, 9H), 5.45 (d, J = 16.8 Hz, 1H), 5.30 (d, J = 10.0 Hz, 1H) 5.10 (s, 1H). 13C 
NMR (100 MHz, CDCl3): 159.1, 147.6, 144.0, 137.1, 136.3, 133.6, 129.4, 127.7, 127.0, 
122.2, 118.8, 76.7, 70.2, 37.5, 28.3. HRMS Calcd. for C18H23N2O4 (M): 313.1658, Found: 
313.1654. FTIR (NaCl Film): 3321, 2976, 2929, 1734, 1611, 1507, 1455, 1367, 1243, 
1167, 1047, 916, 746, 646 cm-1. HPLC (Chiralcel OD-H column, 5% i-PrOH/hexanes, 
1.0 mL/min, 254 nm): tminor = 18.0 min, tmajor = 12.9 min; ee = 96%. 
 
 
2.19 
Acetic acid 3-(1-hydroxy-1-pyridin-2-yl-ethyl)-hexa-3, 5-dienyl ester (2.19): Rf = 0.23, 
25% EtOAc/hexanes; colorless oil; 1H NMR (400 MHz, CDCl3): 8.52 (m, 1H), 7.67 (dt, J 
= 7.6, 2.0 Hz, 1H), 7.29 (dd, J = 8.4, 1.2 Hz, 1H), 7.22 (m, 1H), 6.64 (dt, J = 16.8, 10.8 
Hz, 1H), 6.67 (dt, J = 16.8, 10.0 Hz, 1H), 6.40 (d, J = 10.8 Hz, 1H), 5.70 (s, 1H), 5.33 (dd, 
J = 16.8, 2.0 Hz, 1H) 5.23 (d, J = 10.0, 1.6 Hz, 1H), 3.94 (m, 2H), 2.52 (ddd, J = 12.8, 
9.6, 6.0 Hz, 1H), 2.12 (ddd, J = 12.8, 9.6, 5.6 Hz, 1H), 1.97 (s, 3H), 1.66 (s, 3H). 13C 
NMR (100 MHz, CDCl3): 170.9, 163.1, 147.2, 141.8, 137.0, 132.9, 128.3, 122.2, 120.0, 
119.0, 76.3, 64.1, 28.1, 27.4, 20.9. HRMS Calcd. for C15H19NO3 (M): 261.1365, Found: 
261.1366. FTIR (NaCl Film): 3388, 2976, 2360, 1735, 1672, 1591, 1470, 1432, 1365, 
1244, 1033, 786 cm-1. HPLC (Chiralcel OJ-H column, 5% i-PrOH/hexanes, 0.5 mL/min, 
254 nm): tminor = 46.2 min, tmajor = 24.7 min; ee = 97%. 
 
70 
 
2.20 
 [2-(Cyclopropyl-hydroxy-pyridin-2-yl-methyl)-penta-2,4-dienyl]-carbamic acid tert-
butyl ester (2.20): Rf = 0.22, 30% EtOAc/hexanes; pale yellow oil; 1H NMR (400 MHz, 
CDCl3): 8.49 (d, J = 4.8 Hz, 1H), 7.68 (dt, J = 7.6, 1.6 Hz, 1H), 7.30 (d, J = 8.0 Hz, 1H), 
7.21 (m, 1H), 6.78 (m, 2H), 6.66 (s, 1H), 5.40 (dd, J = 16.4, 2.4 Hz, 1H), 5.29 (d, J = 
10.0, 1.6 Hz, 1H), 4.91 (s, 1H), 4.08 (dd, J = 13.2, 7.6 Hz  1H), 3.15 (dd, J = 13.6, 2.8 Hz, 
1H), 1.64 (s, 1H), 1.37 (s, 9H), 0.54 (m, 2H), 0.38 (m, 1H), 0.24 (m, 1H). 3C NMR (100 
MHz, CDCl3): 162.1, 155.4, 147.0, 142.2, 137.0, 132.8, 130.6, 122.3, 120.1, 78.7, 77.4, 
76.5, 37.9, 28.3, 19.5, 1.8, 0.3. HRMS Calcd. for C19H26N2O3 (M): 330.1943, Found: 
330.1939. TIR (NaCl Film): 3521, 3342, 1709, 1592, 1503, 1469, 1433, 1391, 1366, 
1251, 1168, 1049, 996, 914, 753 cm-1. PLC (Chiralcel AD-H column, 3% i-
PrOH/hexanes, 0.5 mL/min, 254 nm), tminor = 25.0 min, tmajor = 26.2 min; ee = 97%. [ 
 
 
2.21 
 [2-(1-hydroxy-1-pyrazin-2-yl-ethyl)-penta-2,4-dienyl]-carbamic acid tert- butyl ester 
(2.21): Rf = 0.22, 30% EtOAc/hexanes; white solid; MP = 152-155 oC; 1H NMR (400 
MHz, CDCl3): 8.70 (s, 1H), 7.50 (d, J = 8.0 Hz, 1H), 7.30 (dd, J = 7.6, 10.4 Hz, 1H), 6.74 
(dt, J = 16.4, 10.0 Hz, 1H), 6.41 (d, J = 11.2 Hz, 1H), 5.40 (d, J = 16.8 Hz, 1H), 5.31 (d, J 
= 10.8 Hz, 1H), 5.23 (bs, 1H) 4.91 (s, 1H), 4.0 (dd, J = 14.0, 7.2 Hz ,1H) 3.42 (d, J = 13.6 
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Hz, 1H) 1.72 (s, 3H), 1.37 (s, 9H). 13C NMR (100 MHz, CDCl3): 159.0, 155.5, 143.0, 
142.7, 142.0, 141.4, 132.1, 130.2, 127.6, 121.0, 79.3, 77.4, 76.0, 37.3, 29.6, 28.2. RMS 
Calcd. for C16H23N3O3 (M): 305.1739, Found: 307.1745. FTIR (NaCl Film): 3342, 2977, 
2930, 1688, 1503, 1392, 1366, 1250, 1167, 1016, 915 cm-1. HPLC (Chiralcel AD-H 
column, 3% i-PrOH:hexanes, 1.0 mL/min, 254 nm): tmajor = 24.0 min, tminor = 26.9 min; ee 
= 98%. 
 
 
2.22 
Acetic acid 2-[1-hydroxy-1-(5-methyl-isoxazol-3-yl)-ethyl]-penta-2,4-dienyl ester 
(2.22): Rf = 0.27, 30% EtOAc/hexanes; colorless syrup;1H NMR (400 MHz, CDCl3): 
6.65 (ddd, J = 16.8, 11.2, 10.4 Hz, 1H), 6.43 (d, J = 11.2 Hz, 1H), 5.96 (s, 1H), 5.37 (dd, 
J = 16.8, 1.6 Hz, 1H), 5.31 (dd, J = 10.0, 1.6 Hz, 1H), 4.76 (dd, J = 15.6, 12.4 Hz, 1H), 
3.67 (d, J = 7.2 Hz, 1H), 2.39 (d, J = 0.4 Hz, 3H), 2.0 (s, 3H), 1.73 (s, 3H).13C NMR (100 
MHz, CDCl3): 171.2, 169.5, 168.7, 138.1, 131.8, 130.2, 131.7, 121.7, 121.6, 100.1, 73.0, 
59.4, 27.2, 20.7, 12.2. HRMS Calcd. for C15H15NO2 (M): 241.1103, Found: 
241.1101.FTIR (NaCl Film): 3432, 2983, 2933, 1737, 1605, 1452, 1364, 1236, 1136, 
1025, 961, 918 cm-1. HPLC (Chiralcel OJ-H column, 5% i-PrOH/hexanes, 1.0 mL/min, 
254 nm): tminor = 26.8 min, tmajor = 29.5 min; ee = 97% 
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2.23 
3-Phenyl-2-thiazol-2-yl-hexa-3,5-dien-2-ol (2.23): Rf = 0.27, 30% EtOAc/hexanes; 
white solid; MP = 115-120 oC; 1H NMR (400 MHz, CDCl3): 7.71 (d, J = 3.2 Hz, 1H), 
7.25 (m, 4H), 6.90 (m, 2H), 6.55 (d, J = 10.4 Hz, 1H), 5.95 (dt, J = 17.2, 10.4 Hz, 1H), 
5.32 (dd, J = 17.2, 2.0.Hz, 1H), 5.04 (dd, J = 9.6, 1.6 Hz, 1H), 3.45 (bs, 1H) 1.85 (s, 3H). 
13C NMR (100 MHz, CDCl3): 177.0, 146.8, 142.0, 136.8, 134.0, 130.0, 128.1, 127.9, 
127.4, 119.5, 119.3, 78.3, 28.3. HRMS Calcd. for C15H15NOS (M): 257.0874, Found: 
257.0876.FTIR (NaCl Film): 3279, 3080, 2979, 2930, 1601, 1497, 1441, 1367, 1122, 
1058, 996, 912, 773, 708 cm-1.HPLC Chiralcel OD-H column, 5% i-PrOH/hexanes, 0.3 
mL/min, 254 nm): tminor = 26.6 min, tmajor = 30.6 min; ee = 90%. 
 
 
2.24 
2-Benzaxazol-2-yl-3-(1H-indol-2-yl)-hexa-3,5-dien-2-ol (2.24): Rf = 0.24, 20% 
EtOAc/hexanes, yellow thick syrup; 1H NMR (400 MHz, CDCl3): 9.32 (bs, 1H), 7.67 (dd, 
J = 7.6, 2.4 Hz, 1H), 7. 58 (d, J = 8.0 Hz, 1H), 7.54 (dd, J = 6.4, 1.6 Hz, 1H), 7.34 (m, 
2H), 7.17 (dt, J = 6.8, 1.2 Hz, 1H), 7.09 (dt, J = 8.0, 1.2 Hz, 2H), 6.73 (dt, J = 15.2, 10.0 
Hz, 1H), 6.49 (d, J = 1.2 Hz, 1H), 6.18 (d, J= 10.8 Hz, 1H), 5.32 (dd, J = 17.2, 0.8 Hz, 
1H), 5.19 (d, J = 10.0, 1.2 Hz, 1H), 4.75 (bs, 1H), 1.87 (s, 3H). 13C NMR (100 MHz, 
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CDCl3): 169.5, 150.9, 140.0, 136.0, 135.4, 134.0, 132.5, 131.0, 127.7, 125.4, 124.7, 
122.2, 121.4, 120.3, 120.1, 119.7, 111.1, 111.0, 105.8, 75.5, 26.2. HRMS Calcd. for 
C21H18N2O2 (M): 330.1368, Found: 330.1369. FTIR (NaCl Film): 3416, 3058, 2245, 
1609, 1563, 1454, 1319, 1241, 1090, 909, 736 cm-1. HPLC (Chiralcel OJ-H column, 5% 
i-PrOH/hexanes, 1.0 mL/min, 254 nm): tminor = 29.7 min, tmajor = 34.2 min; ee = 97%. 
 
Preparation of OAc-2.3: 
To a solution of 2-Phenyl-1-pyridin-2-yl-penta-2,4-dien-1-ol 2.3 (200.0 mg, 0.858 
mmol) and triethylamine (1.0 mL) in freshly distilled dichloromethane (2.0 mL, 0.42 M) 
in a 10 mL RB, acetic anhydride (0.32 mL, 1.710 mmol) and catalytic amount of DMAP 
were added and stirred at ambient temperature for 1 hour. The reaction mixture was 
quenched with water and extracted with dichloromethane (2 x 20.0 mL) and washed with 
brine solution (10.0 mL). The crude was purified by flash silical chromatography (Rf = 
0.30, 15% EtOAc/hexanse) to afford (221.0 mg, 0.792 mmol) as an yellow oil (94% 
yield). 
 
 
OAc-2.3 
Acetic acid 2-phenyl-1-pyridin-2-yl-penta-2,4-dienyl ester (OAc-2.3): Rf = 0.30, 15% 
EtOAc/hexanse; yellow oil; 1H NMR (300 MHz, CDCl3): 8.35 (ddd, J = 4.8, 1.5, 1.2 Hz, 
1H), 7.56 (dt, J = 7.5, 1.8 Hz, 1H), 7.24 (m,, 3H), 7.15 (m, 2H), 7.05 (m, 2H), 6.61 (s,1H), 
6.48 (d, J = 11.1 Hz, 1H), 6.21 (dt, J = 16.8, 10.2 Hz, 1H), 5.33 (dd, J =  16.8, 1.8 Hz, 
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1H), 2.05 (s, 3H). 13C NMR (75 MHz, CDCl3): 169.7, 157.4, 149.3, 140.1, 137.0, 136.3, 
133.3, 130.6, 129.4, 129.9, 127.3, 122.6, 121.7, 119.8, 79.5, 21.1. HRMS Calcd. for 
C18H17NO2 (M): 279.1259, Found: 279.1257. FTIR (NaCl Film): 3054, 2335, 1748, 1589, 
1572, 1470, 1370, 1228, 1022, 995, 914, 705 cm-1. 
Preparation of 2.26: 
 
A solution of acetic acid 2-phenyl-1-pyridin-2-yl-penta-2,4-dienyl ester (2a) (100 
mg, 0.358 mmol, 100 mol%), potassiumphthalimide salt (132.0 mg, 0.716 mmol, 200 
mol%) and triphenylphosphine (18.0 mg, 0.071 mmol, 20 mol%) in freshly distilled THF 
(3.6 mL, 0.1 M) in 10 mL RB flask was degassed and tetrakis(triphenylphosphino) 
palladium (0) catalyst (41.0 mg, 0.035 mmol, 10 mol%) was added, purged with argon 
gas and refluxed under argon atmosphere for 14 hours.59 TLC showed the disappearance 
of the starting material. The reaction mixture was concentrated in vacuo and purified by 
flash column chromatography (Rf = 0.25, 25% EtOAc/hexanes) to afford (99.0 mg, 0.270 
mmol) of the product as a white solid (76% yield). 
 
 
2.26 
2-(2-phenyl-3-pyridin-2-yl-1-vinyl-allyl)-isoindole-1,3-dione (2.26): Rf = 0.25, 25% 
EtOAc/hexanes; white solid; MP = 178-182 0C; 1H NMR (400 MHz, CDCl3): 8.48 (d, J = 
4.4 Hz, 1H), 7.84 (dd, J = 5.6, 3.2 Hz, 2H), 7.15 (dd, J = 5.6, 3.2 Hz, 2H), 7.35 (m, 4H), 
7.20 (dt, J = 7.6, 1.6 Hz, 1H), 7.11 (dd, J = 7.6, 1.2 Hz, 1H), 6.94 (ddd, J = 7.2, 4.8, 0.8 
Hz, 1H), 6.75 (s, 1H) 6.66 (d, J = 15.2 Hz, 1H), 6.43 (d, J = 8.0 Hz, 1H), 5.39 (dt, J = 
75 
15.6, 6.4 Hz, 1H), 4.36 (d, J = 6.0, Hz, 2H). 13C NMR (100 MHz, CDCl3): 167.8, 155.6, 
149.1, 143.2, 137.9, 137.3, 135.2, 133.9, 132.6, 132.0, 129.1, 128.9, 127.6, 127.3, 123.4, 
123.3, 121.2, 39.3. HRMS Calcd. for C24H18N2O2 (M): 366.1368, Found: 366.1366. 
FTIR (NaCl Film): 2923, 2852, 1770, 1712, 1580, 1458, 1392, 1347, 954, 711 cm-1. 
 
Preparation of OTBS-2.3: 
To a solution of 2-phenyl-1-pyridin-2-yl-penta-2,4-dien-1-ol (2.3) (300.0 mg, 
1.260 mmol, 100 mol%) and imidazole (170.0 mg, 2.520 mmol, 200 mol%) in dry DMF 
(4.2 mL) in 25 mL RB flask, tert-butyldimethylsilyl chloride (370.0 mg, 2.520 mmol) 
was added at 0 oC and and stirred at ambient temperature for 4 hours under argon 
atmosphere. The reaction mixture was quenched with saturated aqueous ammounium 
chloride (5.0 mL) and extracted with diethyl ether (2 x 30.0 mL) and washed with brine 
solution (20.0 mL).The organic layer was dried over anhydrous sodium sulfate and 
concentrated in vacuo. The crude was purified by flash column chromatography (Rf = 
0.30, 10% EtOAc/hexanes) to afford (382.0 mg, 1.088 mmol) as a colorless oil (86% 
yield). 
 
 
OTBS-2.3 
2-[1-(tert-Butyl-dimethyl-silanyloxy)-2-phenyl-penta-2,4-dienyl-pyridine (OTBS-
2.3): Rf = 0.30, 10% EtOAc/hexanes; colorless oil; 1H NMR (400 MHz, CDCl3): 8.43 
(ddd, J = 4.8, 2.0, 0.8 Hz, 1H), 7.52 (dt, J = 8.0, 1.6 Hz, 1H), 7.28 (t, J = 8.0 Hz, 1H), 
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7.18 (m, 3H), 7.06 (m, 1H), 6.93 (m, 2H), 6.48 (d, J = 10.8 Hz, 1H), 6.18 (dt, J = 16.8, 
10.4 Hz, 1H), 5.51 (s, 1H), 5.29 (dd, J = 16.4, 1.6 Hz, 1H), 5.03 (dd, J = 10.4, 2.0 Hz, 
1H), 0.91 (s, 9H), 0.086 (s, 3H), -0.040 (s, 3H). 13C NMR (100 MHz, CDCl3): 162.2, 
148.2, 144.7, 137.5, 136.1, 133.9, 129.6, 128.7, 127.5, 126.8, 121.9, 121.2, 118.4, 80.4, 
25.8, 18.2, -4.8, -5.0. HRMS Calcd. for C22H29NOSi (M): 351.2018, Found: 351.2016. 
FTIR (NaCl Film): 2954, 2928, 2856, 1588, 1570, 1470, 1433, 1254, 1102, 1102, 1079, 
911, 868, 835, 702 cm-1. 
 
Preparation 2.27: To a degassed solution of 2-[1-(tert-butyl-dimethyl-silanyloxy)-2-
phenyl-penta-2,4-dienyl-pyridine (37.0 mg, 0.105 mmol, 100 mol%) and 1,4-diacetoxy-
cis-2-butene (36.0 mg, 0.210 mmol, 200 mol%) in dry toluene (1.0 mL, 0.1 M) Grubbs’ 
catalyst (10.0 mg, 0.0105 mmol, 10 mol%) was added in two portions over a period of 12 
hours and the reaction mixture was heated at 100 oC in a sealed tube.16b Then the reaction 
mixture was concentrated in vacuo and purified by flash column chromatography (Rf = 
0.23, 15 % EtOAc/hexanes) to afford (24.0 mg, 0.057 mmol) as an yellow oil (54 % yield, 
E:Z = 5:1). The major diastereomer has been characterized. 
 
 
2.27 
Acetic acid 6-(tert-butyl-dimethyl-silanyloxy)-5-phenyl-6-pyridin-2-yl-hexa-2,4-
dienyl ester (2.27): Rf = 0.23, 15 % EtOAc/hexanes; yellow oil; 1H NMR (400 MHz, 
CDCl3): 8.41 (d, J = 2.0 Hz, 1H), 7.54 (dt, J = 8.1, 1.8 Hz, 1H), 7.27 (d, J = 7.6 Hz, 1H), 
7.18 (m, 3H), 7.06 (dd, J = 7.2, 5.4 Hz, 1H), 6.92 (m, 2H), 6.48 (d, J = 10.8 Hz, 1H), 6.11 
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(dd, J = 15.6, 11.2 Hz, 1H), 5.85 (m, 1H) 5.53 (s, 1H), 4.57 (m, 1H), 4.47 (d, J = 6.8 Hz, 
1H), 2.19 (t, J = 4.4 Hz, 1H), 1.89 (s, 3H), 0.88 (s, 9H), 0.07 (s, 3H), -0.06 (s, 3H). 13C 
NMR (100 MHz, CDCl3): 170.6, 162.0, 148.2, 137.2, 136.1, 131.2, 129.5, 128.0, 127.7, 
127.5, 127.0, 126.7, 122.0, 121.2, 80.2, 64.8, 63.8, 38.2, 25.7, 18.9, -4.9, -5.0. HRMS 
Calcd. for C25H33NO3Si (M): 422.2230, Found: 422.2232. FTIR (NaCl Film): 2954, 2929, 
2885, 2856, 1742, 1678, 1588, 1471, 1434, 1362, 1227, 1100, 1077, 1024, 836, 703 cm-1. 
 
Preparation of 2.28: 
To a suspension of 2-[1-(tert-butyl-dimethyl-silanyloxy)-2-phenyl-penta-2,4-
dienyl-pyridine (OTBS-2.3) (230.0 mg, 0.650 mmol, 100 mol%) in 2.0 mL of water and 
4.0 mL of THF in a 25 mL RB flask, OsO4 (8.0 mg, 0.032 mmol, 5 mol%) was added and 
then stirred for 5 minutes. While the temperature of the stirred mixture was maintained at 
0 °C, sodium periodate (280.0 mg, 1.310 mmol, 200 mol%) was added in portions over a 
period of 40 minutes. The solution was stirred for an additional 4 hours.16b The reaction 
mixture was extracted thoroughly with ether (2 x 30.0 mL) and the combined organic 
layers were dried (anhydrous Na2SO4). The solvent was removed in vacuo, and then the 
corresponding enal was purified by flash silica gel chromatography (Rf = 0.23, 20% 
EtOAc/hexane) to afford (190.0 mg, 0.788 mmol) as a colorless oil (83% yield). 
To a solution of the enal (prepared as mentioned above) (70.0 mg, 0.198 mmol, 
100 mol%) in THF (1.0 mL, 0.2 M) in a 10 mL RB flask, sodium borohydride (7.2 mg, 
0.198 mmol, 100 mol%) was added at 0 oC and stirred for two hours. The reaction 
mixture was quenched with 0.5N hydrochloric acid (0.5 mL) and extracted with EtOAc 
(2 x 20.0 mL). The organic layer was dried (anhydrous Na2SO4). The solvent was 
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removed in vacuo, and then the corresponding alcohol was purified by flash 
chromatography (Rf = 0.20, 35% EtOAc/hexanes) to afford (66.0 mg, 0.273 mmol) as a 
colorless syrup (94% yield). 
 
 
2.28 
4-(tert-Butyl-dimethyl-silanyloxy)-3-phenyl-4-pyridin-2-yl-but-2-en-1-ol (2.29): Rf = 
0.20, 35% EtOAc/hexanes; colorless syrup; 1H NMR (400 MHz, CDCl3): 8.43 (m, 1H), 
7.57 (dt, J = 8.1, 1.8 Hz, 1H), 7.31 (d, J = 7.8Hz, 1H), 7.18 (m, 2H), 7.10 (m, 2H), 6.90 
(m, 2H), 6.05 (t, J = 6.9 Hz, 1H), 5.5 (s, 1H), 4.01 (d, J = 6.6 Hz, 2H), 2.36 (s, 1H), 0.90 
(s, 9H), 0.08 (s, 3H), -0.04 (s, 3H). 13C NMR (100 MHz, CDCl3): 161.9, 148.1, 144.7, 
136.8, 136.3, 129.1, 128.6, 127.5, 127.0, 122.0, 121.3, 80.1, 59.8, 25.7, 18.2, -4.8, -5.0. 
HRMS Calcd. for C15H15NO2 (M): 241.1103, Found: 241.1104. FTIR (NaCl Film): 3309, 
3055, 2954, 2856, 1593, 1572, 1471, 1434, 1254, 1105, 1054, 1004, 867, 779, 702. 
 
Preparation of 2.29: 
To a degassed solution of 1-(6-Bromo-pyridin-2-yl)-2-phenyl-penta-2,4-dien-1-ol 
(2.10) (180.0 mg, 0.569 mmol, 100 mol%) in toluene (2.8 mL, 0.2 M) in a 13 x 100 mm 
test tube RhCl(PPh3)3 (53.0 mg, 0.057 mmol, 10 mol%) was added. The system was 
purged with argon gas followed by hydrogen gas. The reaction was allowed to stir at 40 
oC under 1 atm of hydrogen for 24 hours.16b The solvent was evaporated in vacuo and the 
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title compound was purified by flash column chromatography (Rf = 0.3, 8% 
EtOAc/hexanes) to afford (152.0 mg, 0.479 mmol) as a pale yellow syrup (82% yield). 
 
 
2.29 
1-(6-Bromo-pyridin-2-yl)-2-phenyl-pent-2-en-1-ol (2.29): Rf = 0.3, 8% 
EtOAc/hexanes; yellow syrup; 1H NMR (300 MHz, CDCl3): 7.41 (t, J = 7.8 Hz, 1H), 
7.29 (d, J = 10.0Hz, 1H), 7.20 (m, 3H), 5.90 (t, J = 14.7Hz, 1H), 5.40 (d, J = 3.6 Hz, 1H), 
4.27 (d, J = 4.8 Hz, 1H), 1.95 (quintet, J = 7.5 Hz, 2H), 0.95 (t, J = 7.2 Hz, 3H). 13C 
NMR (75 MHz, CDCl3): 161.6, 140.6, 140.4, 138.5, 137.1, 129.3, 127.7, 126.8, 126.4, 
120.0, 22.0, 14.1. HRMS Calcd. for C16H16BrNO (M): 317.0415. Found: 317.0417. FTIR 
(NaCl Film): 3405, 3020, 3000, 2980, 1580, 1556, 1493, 1434, 1370, 1227, 1156, 1122, 
986, 702 cm-1. 
 
Preparation of 2.30: 
To a degassed solution of 1-(6-Bromo-pyridin-2-yl)-2-phenyl-penta-2,4-dien-1-ol 
2.10 (100.0 mg, 0.3160 mmol, 100 mol%) in toluene (1.6 mL, 0.2 M) in a 13 x 100 mm 
test tube at ambient temperature Ir(COD)(Pyr)[P(c-Hex)3]PF6 (27.0 mg, 0.0316 mmol, 10 
mol%) was added The system was purged with argon gas followed by hydrogen gas. The 
reaction was allowed to stir at 40 oC under 1 atm of hydrogen for 24 hours.16b The title 
compound was purified by flash column chromatography (Rf = 0.28, 8% EtOAc/hexane) 
to afford (63.0 mg, 0.196 mmol) as a colorless oil (63% yield, 20:1 diastereomeric ratio). 
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2.30 
1-(6-Bromo-pyridin-2-yl)-2-phenyl-pentane-1-ol (2.30): Rf = 0.28, 8% EtOAc/hexane; 
colorless oil; mixture of diastereomers in 20:1 ratio, spectral data is reported for the 
major isomer. 1H NMR (400 MHz, CDCl3): 7.21 (m, 5H), 7.06 (dd, J = 8.4, 1.2 Hz, 2H), 
6.66 (dd, J = 6.0, 3.2 Hz, 1H), 4.68 (t, J = 6.4 Hz, 1H), 3.54 (d, J = 7.2 Hz, 1H), 2.89 (m, 
1H), 1.91 (m, 1H), 1.77 (m, 1H), 1.10 (m, 2H) 0.81 (t, J = 7.2 Hz, 3H). 13C NMR (100 
MHz, CDCl3): 162.6, 141.4, 140.8, 138.1, 128.6, 128.2, 126.5, 126.4, 120.4, 77.4, 53.3, 
32.2, 20.4, 14.0. HRMS Calcd. for C16H18BrNO (M): 320.0650, Found: 320.0645. FTIR 
(NaCl Film): 3424, 2955, 2869, 2348, 1581, 1558, 1436, 1408, 1167, 1126, 1049, 701 
cm-1. 
 
Preparation of 2.31: 
To a solution of 1-(6-bromo-pyridin-2-yl)-2-phenyl-pent-2-en-1-ol 2.29 (100.0 
mg, 0.313 mmol) and triethylamine (0.5 mL) in freshly distilled DCM (2.0 mL) in a 10 
mL RB flask, acetic anhydride (0.1 mL, 0.626 mmol) was added and catalytic amount of 
DMAP were added and stirred at ambient temperature for 1 hour. The reaction mixture 
was quenched with water and extracted with DCM (2 x 10 mL) and washed with brine 
solution (5.0 mL). The organic layer was dried (anhydrous Na2SO4), concentrated and the 
crude material was purified by flash column chromatography (Rf = 0.32, 4% 
EtOAc/hexanes) to afford (109.8 mg, 0.329 mmol) as an yellow oil (97% yield). 
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The acetylated product (90.0 mg, 0.250 mmol, 100 mol%) was dissolved in DCM 
(3.0 mL, 0.2 M), in a 10 mL RB flsk and the solution was cooled to -78 °C. The solution 
was sparged with ozone for 2 min, and sparged with argon for 5 min. Then 
triphenylphosphine (65.0 mg, 0.500 mmol, 200 mol%) was added, and the reaction was 
allowed to stir for 10 hours while warming gradually to ambient temperature. The solvent 
was removed in vacuo. The title compound was purified by flash column 
chromatography (Rf = 0.3, 20% EtOA/hexane) to afford (55.0 mg, 0.165 mmol) as a 
colorless oil (77% yield). 
 
 
2.31 
Acetic acid 1-(6-bromo-pyridin-2-yl)-2-oxo-2-phenyl-ethyl ester (2.31): Rf = 0.3, 20% 
EtOA/hexane; colorless oil; 1H NMR (400 MHz, CDCl3): 8.02 (dd, J = 7.6, 0.8 Hz, 2H), 
7.50 (t, J = 8.0, Hz, 2H), 7.39 (m, 4H), 6.90 (s, 1H), 2.17 (s, 3H). 13C NMR (100 MHz, 
CDCl3): 192.4, 160.7, 154.9, 141.6, 139.3, 134.0, 133.8, 129.2, 128.6, 128.3, 121.8, 78.1, 
20.6. HRMS Calcd. for C15H12BrNO3 (M): 333.0001, Found: 332.9999. FTIR (NaCl 
Film): 3065, 2359, 1747, 1697, 1579, 1557, 1434, 1372, 1227, 1123, 1064, 988, 791, 688 
cm-1. 
 
Preparation of 2.32: 
 
A mixture of 2-phenyl-1-pyridin-2-yl-penta-2,4-dien-1-ol 2.3 (200.0 mg, 0.843 
mmol, 100 mol%) and isocyanate derived from (L)- phenylalanine methyl ester (190.0 
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mg, 0.928 mmol, 110 mol%) was heated in toluene (1.7 mL, 0.5 M) at 90 oC for 26 
hours.60 The solvent was removed in vacuo, and the title compound was purified by flash 
column chromatography (Rf = 0.23, 35% EtOAc/hexanes) to afford (290.0 mg, 0.654 
mmol) as a white solid (78% yield). 
 
 
2.32 
3-Phenyl-2-(2-phenyl-1-pyridin-2-yl-penta-2,4-dienloxycarbonylamino) 
propionicacid methyl ester (2.32):Rf = 0.23, 35% EtOAc/hexanes; white solid; MP = 
121-123 oC; 1H NMR (400 MHz, CDCl3): 8.57 (dd, J = 4.8, 0.8 Hz, 1H), 7.56 (dt, J = 8.0, 
2.0 Hz, 1H), 7.19 (m, 7H), 7.18 (m, 2H), 7.04 (m, 5H), 6.51 (s, 1H), 6.47 (s, 1H), 6.18 (dt, 
J = 16.8, 10.4 Hz, 1H), 5.44 (d, J = 8.0 Hz, 1H), 5.32 (dd, J = 17.2, 1.2 Hz, 1H) 5.01 (dd, 
J = 10.0, 1.6 Hz, 1H), 4.65 (m, 2H), 3.71 (s, 3H), 3.09 (m, 2H). 13C NMR (100 MHz, 
CDCl3): 171.1, 157.7, 154.5, 149.3, 140.2, 137.0, 136.3, 135.6, 133.3, 130.6, 129.5, 
129.3, 129.2, 128.5, 128.4, 127.9, 127.3, 127.0, 122.6, 121.6, 80.3, 54.8, 52.3, 38.0. 
HRMS Calcd. for C27H26N2O4 (M+1): 443.1971, Found: 443.1967. FTIR (NaCl Film): 
3345, 3028, 2951, 1726, 1590, 1496, 1435, 1362, 1253, 1212, 1049, 812, 702.2.6.3. 
Preparation of deuterio-2.3: 
To a degassed solution of Rh(COD)2OTf (4.4 mg, 9.3 mol, 2 mol%), (R)-tol-
BINAP (6.3 mg, 9.3 mol, 2 mol%) and triphenylacetic acid (2.7 mg, 9.3 mol, 2 
mol%) in DCE (1.0 mL) in a 13 x 100 mm test tube, a solution of 2-pyridine 
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carboxaldehyde (50.0 mg, 0.466 mmol, 100 mol%) and the enyne 2.1a (128.0 mg, 0.932 
mmol, 200 mol%) in DCE (1.4 mL, total volume, 2.4 mL, 0.2 M) was added. The system 
was then purged with argon gas followed by deuterium gas. The reaction was allowed to 
stir at 40 oC under 1 atm of deuterium (99.6% pure) until complete consumption of the 
aldehyde. The solvent was evaporated in vacuo and the crude reaction mixture was 
purified by flash chromatography. 
 
deuterio-2.3 
2-Phenyl-1-pyridin-2-yl-penta-2,4-dien-1-ol (deuterio-2.3): Rf = 0.20, 35% 
EtOAc/hexanes; colorless oil; 1H NMR (400 MHz, CDCl3): 8.32 (dd, J = 3.2, 1.0 Hz, 
1H), 7.48 (dt, J = 7.0, 1.6 Hz, 1H), 7.20 (m, 2H), 7.07 (m, 2H), 6.94 (m, 3H), 6.52 (d, J = 
11.2 Hz, 1H), 6.20 (ddd, J = 16.4, 10.8, 10.4 Hz, 1H), 5.25 (dd, J = 16.4, 1.6, 2H), 5.30 
(dd, J = 10.8, 2.0 Hz, 1H). 13C NMR (100 MHz, CDCl3): 159.1, 147.6, 146.5, 144.0, 
137.1, 136.3, 135.2, 133.6, 129.4, 127.7, 127.0, 122.2, 118.8, 76.7. HRMS Calcd. for 
C16H14DNO (M): 238.1216, Found: 238.1215. FTIR (NaCl Film): 3370, 3080, 3054, 
3019, 2972, 2873, 1590, 1572, 1472, 1437, 1395, 1203, 1076, 900, 743, 677 cm-1.  
 
 
84 
2.6.3 General procedure for the reductive coupling of conjugated enynes and 2-N- 
heterocyclic aromatic aldimines, preparation of 2.33: 
To a degassed solution of Rh(COD)2BARF (11.2 mg, 9.4 mol, 5 mol%), (S)-Cl-
OMe-BIPHEP (6.1 mg, 9.4 mol, 5 mol%) and 3,5-dinitrobenzoic acid (2.1 mg, 9.4 
mol, 5 mol%) and aldimine 2.32a (64.2 mg, 0.187 mmol, 100 mol%) in a 13 x 100 mm 
test tube, a solution of the enyne 2.1a (48.5 mg, 0.325 mmol, 200 mol%) in DCE (1.0 mL, 
0.2 M).was added. The system was then purged with argon gas followed by hydrogen gas. 
The reaction was allowed to stir at 50 oC under 1 atm of hydrogen until complete 
consumption of the imine (about 12h). The solvent was evaporated in vacuo and the 
crude reaction mixture was purified by flash chromatography. 
 
 
 
2.33 
 
N-(1-(1-benzyl-1H-imidazol-2-yl)-2-phenylpenta-2,4-dienyl)-4-
methylbenzenesulfonamide (2.33): Rf = 0.25, 40% EtOAc/hexanes; pale brown solid, 
MP = 153-157 0C; 1H NMR (400 MHz, CDCl3): 7.67 (d, J = 8.0 Hz, 2H), 7.19-7.02 (m, 
8H), 6.81 (bs, 1H), 6.77-6.72 (m, 3H), 6.57 (s, 1H), 6.03 (d, J = 10.8 Hz, 1H), 6.01-5.94 
(m, 1H), 5.21 (s, 1H), 5.07 (d, J = 16.4 Hz, 1H), 4.94 (d, J = 9.2 Hz, 1H), 4.73 (dd, J = 
20.0, 16.0 Hz, 2H), 2.27 (s, 3H). 13C NMR (100 MHz, CDCl3): 153.4, 142.8, 138.8, 
137.3, 136.7, 135.1, 134.6, 134.1, 133.0, 130.7, 129.2, 129.1, 128.9, 128.1, 127.5, 127.1, 
126.9, 120.4, 119.8, 55.6, 49.3, 21.4. HRMS Calcd. for C28H27N3O2S (M+1): 470.1824, 
Found: 470.1821. FTIR (NaCl Film): 3258, 2854, 2160, 1978, 1495, 1454, 1329, 1157, 
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1119, 960, 727, 669 cm-1. HPLC (Chiralcel OD-H column, 5% i-PrOH/hexanes, 0.5 
mL/min, 254 nm): tminor = 36.3 min, tmajor = 40.5 min; ee = 98%. 
 
 
2.34 
tert-Butyl-2-((1-benzyl-1-H-imidazol-2-yl)(4-methylphenylsulfonamido)penta-2,4-
dienylcarbamate (2.34): Rf = 0.30, 40% EtOAc/hexanes; white solid, MP = 110-114 0C; 
1H NMR (400 MHz, CDCl3): 7.41 (d, J = 8.0 Hz, 2H), 7.24-7.22 (m, 3H), 7.01 (d, J = 8.0 
Hz, 2H), 6.95-5.98 (m, 2H), 6.82 (d, J = 0.8 Hz, 1H), 6.69 (s, 1H), 6.56-6.47 (m, 2H), 
5.40 (d, J = 10.8 Hz, 1H), 5.21-5.19 (m, 1H), 5.10 (d, J = 10.0 Hz, 1H), 5.01 (d, J = 17.2 
Hz, 1H), 4.95 (s, 1H), 4.89-4.74 (m, 2H), 3.82 (dd, J = 14.8, 4.8 Hz, 1H), 3.68 (dd, J = 
14.8, 5.6 Hz, 1H), 2.27 (s, 3H), 1.32 (s, 9H). 13C NMR (100 MHz, CDCl3): 156.3, 152.7, 
144.0, 143.1, 135.3, 134.0, 131.3, 129.2, 128.9, 128.2, 127.6, 127.4, 127.2, 127.0, 121.1, 
120.9, 79.3, 49.4, 48.1, 39.5, 28.3, 21.4. HRMS Calcd. for C28H34N4O4S (M+1): 
523.2301, Found: 523.2306. FTIR (NaCl Film): 3650, 2977, 2033, 1701, 1455, 1329, 
1159, 988, 712 cm-1. HPLC (Chiralcel OD-H column, 10% i-PrOH/hexanes, 0.5 mL/min, 
254 nm): tminor = 16.8 min, tmajor = 26.9 min; ee = 72%. 
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2.35 
3-((benzyl-1H-imidazol-2yl)(4-methylsulfonamido)methyl)hexa-3,5-dienyl acetate 
(2.35): Rf = 0.20, 25% EtOAc/hexanes; pale yellow solid, MP = 123-128 0C; 1H NMR 
(400 MHz, CDCl3): 7.46 (d, J = 8.0 Hz, 2H), 7.24-7.22 (m, 3H), 7.19 (s, 1H), 6.87 (dd, J 
= 5.6, 2.0 Hz, 2H), 6.85 (s, 1H), 6.67 (s, 1H), 6.37-6.27 (m, 2H), 5.68 (d, J = 5.6 Hz, 1H), 
5.11-5.07 (m, 2H), 4.88 (bs, 1H), 4.81 (dd, J = 23.2, 16.0 Hz, 2H), 3.71-3.57 (m, 2H), 
2.29-227 (m, 5H), 1.85 (s, 3H). 13C NMR (100 MHz, CDCl3): 170.7, 143.8, 142.9, 137.1, 
135.2, 133.8, 132.5, 131.6, 129.1, 129.0, 128.2, 127.5, 127.1, 127.0, 121.0, 120.4, 62.5, 
55.6, 49.3, 26.7, 21.4, 20.8. HRMS Calcd. for C26H29N3O4S (M+1): 479.1879, Found: 
479.1874. FTIR (NaCl Film): 3550, 3033, 2855, 1735, 1598, 1454, 1158, 1118, 917, 666 
cm-1. HPLC (Chiralcel AD-H column, 10% i-PrOH/hexanes, 1.0 mL/min, 254 nm): tminor 
= 51.0 min, tmajor = 58.4 min; ee = 61%. 
 
 
2.36 
4-Methyl-N-(2-phenyl-1-(thiazol-2-yl)penta-2,4-dienyl)benzenesulfonamide (2.36): 
Rf = 0.25, 40% EtOAc/hexanes; brown solid, MP = 132-135 0C; 1H NMR (400 MHz, 
CDCl3): 7.58 (dd, J = 6.0, 3.6 Hz, 2H), 7.19-7.12 (m, 5H), 6.74 (dd, J = 8.0, 1.2 Hz, 2H), 
6.19 (d, J = 8.0 Hz, 1H), 6.03 (ddd, J = 16.4, 10.0, 4.4 Hz, 1H), 5.66 (d, J = 7.2 Hz, 1H), 
5.46 (d, J = 7.6 Hz, 1H), 5.17 (dd, J = 16.8, 2.0 Hz, 1H), 5.01 (dd, J = 10.0, 1.6 Hz, 1H), 
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4.35-4.25 (m, 2H),  2.31 (s, 3H). 13C NMR (100 MHz, CDCl3): 169.2, 143.5, 142.4, 
139.2, 136.9, 135.7, 132.9, 131.7, 129.5, 129.4, 128.2, 127.8, 127.2, 120.5, 120.0, 61.3, 
25.3. HRMS Calcd. for C21H20N2O2S (M+1): 397.0966, Found: 397.0962. FTIR (NaCl 
Film): 3497, 2957, 2039, 1329, 1150, 908, 689 cm-1. HPLC (Chiralcel OD-H column, 5% 
i-PrOH/hexanes, 1.0 mL/min, 254 nm): tminor = 34.3 min, tmajor = 37.9 min; ee = 94%. 
 
 
2.37 
tert-Butyl-2-((4-methylphenylsulfonamido)(thiazol-2-yl)penta-2,4-dienylcarbamate 
(2.37): Rf = 0.20, 35% EtOAc/hexanes; pale yellow solid, MP = 142-144 0C; 1H NMR 
(400 MHz, CDCl3): 7.73 (d, J = 7.6 Hz, 2H), 7.64 (d, J = 3.2 Hz, 1H), 7.26-7.25 (m, 2H), 
7.23 (d, J = 8.4 Hz, 2H), 6.49-6.39 (m, 1H), 5.90 (d, J = 11.2 Hz, 1H), 5.25-5.19 (m, 2H), 
5.12 (d, J = 8.0 Hz, 1H), 4.85-4.78 (m, 1H), 3.73-3.57 (m, 2H), 2.38 (s, 3H), 1.40 (s, 9H).     
13C NMR (100 MHz, CDCl3): 171.2, 159.4, 143.5, 142.6, 139.3, 134.2, 131.7, 130.9, 
129.4, 127.4, 121.5, 120.2, 80.1, 54.5, 34.2, 28.3, 21.5. HRMS Calcd. for C21H27N3O4S2 
(M+1): 450.1443, Found: 450.1444. FTIR (NaCl Film): 3487, 3085, 2978, 2928, 2161, 
1681, 1509, 1392, 1334, 1162, 1092, 814, 669 cm-1. HPLC (Chiralcel OJ-H column, 5% 
i-PrOH/hexanes, 1.0 mL/min, 254 nm): tminor = 24.5 min, tmajor = 18.3 min; ee = 63%. 
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2.38 
3-((4-Methylphenylsulfonamido)(thiazol-2-yl)methylhexa-3,5-dienyl acetate (2.38): 
Rf = 0.30, 40% EtOAc/hexanes; pale yellow solid, MP = 121-126 0C; 1H NMR (400 
MHz, CDCl3): 7.76 (d, J = 8.0 Hz, 2H), 7.64 (d, J = 8.4 Hz, 2H), 7.59 (d, J = 8.4 Hz, 1H), 
6.46-6.36 (m, 1H), 6.30 (d, J = 6.4 Hz, 1H), 5.91 (d, J = 10.8 Hz, 1H), 5.20 (s, 1H), 5.16 
(d, J = 6.4 Hz, 1H), 4.80-4.98 (m, 2H), 3.93-3.81 (m, 2H), 2.49-2.38 (m, 2H), 2.39 (s, 
3H), 2.13 (s, 3H). 13C NMR (100 MHz, CDCl3): 171.0, 168.7, 143.5, 142.3, 139.1, 136.6, 
134.6, 132.9, 129.6, 129.4, 127.3, 126.3, 62.6, 61.4, 27.2, 21.4, 20.9. HRMS Calcd. for 
C19H22N2O4S2 (M+1): 407.1021, Found: 407.1019. FTIR (NaCl Film): 3486, 3256, 2924, 
1724, 1598, 1444, 1329, 1157, 1093, 813, 705, 665 cm-1. HPLC (Chiralcel AD-H column, 
10% i-PrOH/hexanes, 0.5 mL/min, 254 nm): tminor = 31.4 min, tmajor = 25.8 min; ee = 51%. 
 
2.6.4 Preaparation of 2-vinylazines 2.41-2.46   
 
Preparation of 2.40: The following procedure is an adaptation of a known protocol.47 To 
a flame dried 500 mL round bottom flask equipped with a stir bar was added 2,6-
dibromopyridine (19.0 g, 80 mmol, 100 mol%). An addition funnel was attached and the 
vessel was purged with argon. Dry DCM (250 mL) was added and the reaction vessel 
was cooled to -78 oC using a dry ice/acetone bath. A solution of n-BuLi in hexanes (35.5 
mL, 2.5 M, 88 mmol, 110 mol%) was added dropwise via addition funnel over a period 
of 15 minutes. The solution became forest green and was allowed to stir for 1 hour at this 
temperature. Acetaldehyde (6.7 mL, 120 mmol, 150 mol%) was added dropwise over a 
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period of 5 minutes and the reaction was allowed to stir for 30 minutes at -78 oC before it 
was warmed to room temperature. The color changed from green to brown. Saturated 
aqueous NH4Cl (50 mL) was added and the mixture was extracted with DCM (3 x 50 
mL). The combined organic phases were washed with brine (2 x 50 mL), dried (MgSO4) 
and filtered. The solvent was removed in vacuo and the resulting residue was purified by 
flash silica gel column chromatography (Rf = 0.20, 30% EtOAc/hexanes, gradient: 10 - 
30% EtOAc/hexanes) to furnish the title compound (11.4 g, 56.40 mmol) as a brown 
syrup in 72% yield. 
 
 
2.40 
1-(6-Bromo-pyridin-2-yl)-ethanol (2.40): Rf = 0.20, 30% EtOAc/hexanes, gradient: 10 - 
30% EtOAc/hexanes; brown syrup; 1H NMR (CDCl3): δ 7.55 (t, J = 7.5 Hz, 1H), 7.38 (d, 
J = 7.5 Hz 1 H), 4.87-4.97 (m, 1H), 3.35 (br s, 1H), 1.50 (d, J = 6.8 Hz, 3H). 13C NMR 
(CDCl3): δ 165.4, 141.2, 139.4, 126.8, 118.7, 69.3, 24.2.  HRMS Cald. for C7H8BrNO 
(M+1): 200.9764, Found: 202.9768. 
 
Preparation of 2.41: 
This following procedure is an adaptation of a known protocol.48 Compound 2.40 
(11.5 g, 56.90 mmol, 100 mol%) was added to a 250 mL round bottom flask equipped 
with a stir bar. The flask was cooled to 0 oC and concentrated H2SO4 (70 mL, 1260 mmol, 
220 mol%) was added slowly. The reaction mixture became black immediately. The flask 
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was fitted with a reflux condenser and purged with argon and then placed in a 110 oC oil 
bath for 16 hours. The reaction mixture was allowed to reach room temperature and was 
transferred to a 1 L Erlenmeyer flask containing a large stir bar with the aid of water 
(approximately 150 mL). The mixture was cooled to 0 oC. Solid NaOH was added in 
portions until the solution was neutral. At this point, the solution became light brown in 
color. Any solid materials were removed by filtration and the aqueous solution was 
extracted with diethyl ether (3 x 50 mL). The combined organic extracts were washed 
with brine (2 x 50 mL), dried (MgSO4) and filtered. The solvent was removed in vacuo 
and the resulting residue was purified by flash silica gel column chromatography to 
provide the title compound (10.8 g, 58.10 mmol) as a light yellow oil in 74% yield, (Rf = 
0.30, 5% EtOAc/hexanes). 2.41 was stored at -10 oC. Spectral data is consistent with 
prior reports.61 
 
 
2.41 
6-Bromo-2-vinyl-pyridine (2.41): Rf = 0.30, 5% EtOAc/hexanes; light yellow oil; 1H 
NMR (CDCl3): δ 7.43 (dd, J = 7.7, 7.7 Hz, 1H), 7.27 (d, J = 7.7 Hz, 1H), 7.20 (d, J = 7.7 
Hz, 1H), 6.66 (dd, J = 17.3, 10.5 Hz, 1H), 6.17 (dd, J = 17.3, 1.1 Hz, 1H), 5.46 (dd, J = 
10.5, 1.1 Hz, 1H). 13C NMR (CDCl3): δ 157.4, 142.4, 139.1, 135.8, 127, 120.4, 120.3. 
HRMS Cald. for C7H6BrN (M+1): 184.9671, Found: 184.9660. 
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Preparation of 2.42: 
To a degassed solution of 6-bromo-2-vinylpyridine (300 mg, 1.62 mmol, 100 
mol%) in toluene (5 mL) in a 50 mL round bottom flask, [(Ph3P)4Pd] (94 mg, 0.08 mmol, 
5 mol%) was added and stirred for 20 minutes at ambient temperature. A degassed 
suspension of freshly recrystallized phenylboronic acid (300 mg, 1.95 mmol, 120 mol%) 
in methanol (3 mL) and an aqueous solution of Na2CO3 (3 mL, 2 M) were added in 
succession. The reaction vessel was placed in a 100 °C oil bath and was allowed to stir 
under an argon atmosphere for 16 hours.49 The crude reaction mixture was cooled to 
ambient temperature and extracted with diethyl ether (2 x 20 mL). The combined organic 
layers were washed with water (20 mL) followed by brine (20 mL), dried (Na2SO4) and 
filtered. The solvent was removed in vacuo and the residue was purified by flash silica 
gel column chromatography (Rf = 0.25, 2% EtOAc/hexanes) to furnish the title 
compound (152 mg, 0.61 mmol) as a colorless oil in 52% yield. 
 
 
2.42 
6-Phenyl-2-vinylpyridine (2.42): Rf = 0.25, 2% EtOAc/hexanes; colorless oil; 1H NMR 
(400 MHz, CDCl3): δ 7.98 (d, J = 8.4 Hz, 2H), 7.63 (t, J = 7.6 Hz, 1H), 7.53 (d, J = 7.6 
Hz, 1H), 7.41-7.38 (m, 2H), 7.34 (d, J = 7.6 Hz, 1H), 7.20 (dd, J = 7.6, 3.2 Hz, 1H), 6.85-
6.78 (m, 1H), 6.28 (dd, J = 17.2, 1.2 Hz, 1H), 5.44 (dd, J = 11.2, 1.6 Hz, 1H). 13C NMR 
(100 MHz, CDCl3): δ 156.8, 155.4, 139.4, 137.1, 128.8, 128.6, 126.5, 126.9, 119.6, 119.1, 
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118.2. HRMS Calcd. for C13H11N (M+1): 181.0189, Found: 181.0186. FTIR (NaCl Film): 
3058, 1586, 1564, 1456, 1444, 1202, 1160, 922, 821, 764, 690 cm-1. 
 
Preparation of 2.44: 
A stirred solution of 6-vinylpicolinaldehyde62 (540 mg, 4.06 mmol, 100 mol%) in 
THF (5 mL) in a 50 mL round bottomed flask was cooled to 0 °C and sodium 
borohydride (75 mg, 2.02 mmol, 50 mol%) was added and stirring was continued for 15 
minutes at 0 °C. The reaction mixture was quenched with aqueous HCl (0.5 mL, 0.1 M), 
diluted with water (20 mL) and the resulting mixture was extracted with EtOAc (2 x 15 
mL). The combined organic layers were washed with water (20 mL) and brine (20 mL), 
dried (Na2SO4) and filtered. The solvent was removed in vacuo and the crude alcohol 
(480 mg) was used directly in the subsequent next step. 
The crude alcohol (480 mg, 3.55 mmol, 100 mol%) was dissolved in DMF (6 mL) 
in a 50 mL round bottom flask and cooled to 0 °C. Imidazole (360 mg, 5.33 mmol, 150 
mol%) and tert-butyldimethylsilyl chloride (800 mg, 5.33 mmol, 150 mol%) were added 
and the reaction was allowed to warm to ambient temperature and stirring was continued 
for 5 hours under an argon atmosphere. Once the reaction was complete it was diluted 
with water (20 mL) and extracted with diethyl ether (2 x 20 mL). The organic layer was 
separated, washed with brine (20 mL), dried (anhydrous Na2SO4) and filtered. The 
solvent was removed in vacuo and the residue was purified by flash silica gel column 
chromatography (Rf = 0.23, 5% diethyl ether/hexanes) to furnish the title compound (620 
mg, 2.47 mmol) as a colorless oil in 62% yield over two steps. 
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2.44 
6-((tert-butyldimethylsilyloxy) methyl)-2-vinylpyridine (2.45): Rf = 0.23, 5% diethyl 
ether/hexanes; colorless oil; 1H NMR (400 MHz, CDCl3): δ 7.60 (t, J = 7.6 Hz, 1H), 7.34 
(d, J = 8.0 Hz, 1H), 7.16 (d, J = 8.0 Hz, 1H), 6.74 (ddd, J = 17.6, 10.8, 1.2 Hz, 1H), 6.10 
(dd, J = 17.6, 1.2, 1H), 5.40 (dd, J = 11.2, 1.6 Hz, 1H), 4.74 (s, 2H), 0.92 (s, 9H), 0.08 (s, 
6H). 13C NMR (100 MHz, CDCl3): δ 161.1, 154.6, 137.0, 136.9, 119.0, 118.6, 117.9, 
66.1, 25.8, 18.3, -5.4. HRMS Calcd. for C14H23NOSi (M+1): 250.1627, Found: 250.1632. 
FTIR (NaCl Film): 2954, 2928, 2885, 2856, 1582, 1471, 1450, 1254, 1152, 1113, 989, 
929, 835, 808, 775, 749 cm-1. 
 
Preparation of 2.46: 
To a stirred suspension of methyltriphenylphosphonium bromide (4.46 g, 12.5 
mmol, 110 mol%) in THF (20 mL) at 0 °C in a 100 mL round bottom flask was added a 
THF solution (1 M) of LHMDS (12.5 mL, 12.5 mmol, 110 mol%). The mixture was 
allowed to stir under an argon atmosphere for 45 minutes, at which point a THF solution 
(12 mL) of 8-(benzyloxy)quinoline-2-carbaldehyde 2.46 63  (3.01 g, 11.35 mmol, 100 
mol%) at 0 °C was added. The reaction mixture was allowed to warm to ambient 
temperature and was allowed to stir for 30 minutes. Saturated aqueous NH4Cl (15 mL) 
was added and the resulting mixture was extracted with diethyl ether (2 x 50 mL). The 
organic layer was separated, washed with brine solution (20 mL) dried (Na2SO4), and 
filtered. The solvent was removed in vacuo and the title compound was purified by flash 
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silica gel column chromatography (Rf = 0.30, 5% EtOAc /hexanes) to furnish the title 
compound (2.11 g, 8.05 mmol) as a thick brown oil in 68% yield. 
 
 
2.46 
8-(benzoloxy)-2-vinylquinoline 2.46: Rf = 0.30, 5% EtOAc /hexanes; thick brown oil; 
1H NMR (400 MHz, CDCl3): δ 8.00 (dd, J = 8.8, 1.6 Hz, 1H), 7.60 (dd, J = 8.4, 1.6 Hz, 
1H), 7.52 (d, J = 7.2 Hz, 1H), 7.34 (t, J = 7.6 Hz, 1H), 7.29-7.26 (m, 5H), 7.18-7.11 (m, 
1H), 6.98 (dd, J = 6.8, 2.8 Hz, 1H), 6.22 (d, J = 18.0 Hz, 1H), 5.62 (d, J = 10.8 Hz, 1H), 
5.40 (s, 2H). 13C NMR (100 MHz, CDCl3): δ 154.9, 154.2, 140.0, 138.3, 137.0, 136.0, 
128.5, 128.3, 127.5, 126.8, 126.2, 119.7, 119.1, 118.3, 110.6, 70.7. HRMS Calcd. for 
C16H16NO (M+1): 262.1232, Found: 262.1235. FTIR (NaCl Film): 3059, 2968, 1598, 
1610, 1503, 1458, 1431, 1328, 1263, 1092, 1076, 1015, 931, 878, 860, 754, 730, 694 cm-
1. 
2.6.5 General procedure for the hydrogenative reductive coupling of 2-
vinylpyridines to aldimines, preparation of (2.48): 
 
An oven dried test tube (13 x 100 mm) was charged with a stir bar, imine 2.47a 
(80 mg, 0.26 mmol, 100 mol%), [Rh(cod)2BARF] (15.6 mg, 13.20 mol, 5 mol%), tri(2-
furyl)phosphine (7.4 mg, 31.70 mol, 12 mol%), and anhydrous sodium sulfate (75 mg, 
0.53 mmol, 200 mol%). The vessel was sealed with a rubber septum, evacuated and 
placed under an argon atmosphere. A degassed solution of 6-bromo-2-vinylpyridine 1a 
(144 mg, 0.79 mmol) in DCM (0.9 mL) was added to the reaction vessel via syringe and 
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the solution was sparged with argon for 5 seconds. The solution was stirred until 
homogeneous, at which point hydrogen gas was bubbled directly into the solution for 5 
seconds with the aid of a balloon using an 11½ inch 21 gauge needle. The needle was 
pulled above the solution and the reaction mixture was allowed to stir under a hydrogen 
atmosphere for 72 hr. The reaction mixture was concentrated and the title compound (128 
mg, 0.196 mmol) was isolated as a pale yellow solid in 97% yield after purification by 
flash silica gel column chromatography (separable mixture of diastereomers in 3:1 ratio, 
Rf major = 0.23, Rf minor = 0.27, 25% EtOAc/hexanes, gradient: 10 - 25% EtOAc/hexanes). 
 
 
2.48 Major 
N-((1R,2R)-2-(6-bromopyridin-2-yl)-1-(4-nitrophenyl)propyl)-2-
methylbenzenesulfonamide (2.48 Minor). Rf major = 0.23, 25% EtOAc/hexanes, 
gradient: 10 - 25% EtOAc/hexanes; pale yellow solid; MP = 143-145 0 oC; 1H NMR (400 
MHz, CDCl3, Major Isomer): δ 7.76 (d, J = 8.4 Hz, 2H), 7.55 (d, J = 7.6 Hz, 1H), 7.30-
7.19 (m, 3H), 6.98-7.12 (m, 2H), 6.91 (d, J = 8.8 Hz, 2H), 6.78 (d, J = 6.8 Hz, 1H), 6.67 
(d, J = 6.8 Hz, 1H), 4.69 (t, J = 6.4 Hz, 1H), 3.22 (quintet, J = 6.8 Hz, 1H), 2.49 (s, 3H), 
1.20 (d, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 162.1, 146.8, 146.0, 141.2, 
139.0, 137.9, 136.5, 132.6, 132.2, 129.0, 128.2, 126.6, 126.1, 125.9, 122.8, 121.1, 61.6, 
45.3, 20.4, 15.7. HRMS Cald. for C21H20BrN3O4S (M+1): 490.0358, Found: 490.0331. 
FTIR (NaCl Film): 3286, 2952, 2850, 1606, 1581, 1519, 1434, 1346, 1159, 131, 1066, 
910, 853, 760, 733 cm-1. 
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2.48 Minor 
N-((1R,2S)-2-(6-bromopyridin-2-yl)-1-(4-nitrophenyl) propyl)-
2methylbenzenesulfonamide (2.48 Minor): Rf minor = 0.27, 25% EtOAc/hexanes, 
gradient: 10 - 25% EtOAc/hexanes; pale yellow solid; MP = 124-128 0 oC; 1H NMR (400 
MHz, CDCl3, Minor Isomer): δ 7.91 (d, J = 8.4 Hz, 2H), 7.66 (d, J = 7.6 Hz, 1H), 7.34-
7.24 (m, 5H), 7.21 (t, J = 9.6 Hz, 1H), 7.10 (d, J = 9.2 Hz, 2H), 6.73-6.70 (m, 1H), 4.75 (t, 
J = 5.6 Hz, 1H), 3.15-3.08 (m, 1H), 2.67 (s, 3H), 1.24 (d, J = 7.2 Hz, 3H). 13C NMR (100 
MHz, CDCl3): δ 162.6, 147.9, 146.8, 146.1, 141.4, 139.3, 138.6, 136.4, 132.4, 132.3, 
128.6, 127.3, 126.8, 126.1, 125.8, 123.2, 122.1, 61.8, 46.2, 20.4, 14.8. HRMS Calcd. for 
C21H20BrN3O4S (M+1): 490.0358, Found: 490.0329. FTIR (NaCl Film): 3286, 2952, 
2850, 1606, 1581, 1519, 1434, 1346, 1159, 131, 1066, 910, 853, 760, 733 cm-1. 
 
 
2.49 
N-[2-(6-Bromo-pyridin-2-yl)-1-phenyl-propyl]-4-methyl-benzenesulfonamide (2.49): 
Rf = 0.22, 20% EtOAc/hexanes, gradient: 10 - 20% EtOAc/hexanes; colorless liquid; 1H 
NMR (400 MHz, CDCl3): δ 7.43 (d, J = 8.0 Hz, 2H), 7.28-7.20 (m, 3H), 7.10-7.08 (m, 
2H), 7.04 (d, J = 7.6 Hz, 2H), 6.98-6.95 (m, 2H), 6.77 (dd, J = 7.6 Hz, 1.2 Hz, 1H), 6.26 
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(d, J = 6.4 Hz, 1H), 4.54 (t, J = 6.4 Hz, 1H), 3.19-3.12 (m, 1H), 2.31 (s, 3H), 1.22 (d, J = 
6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 163.3, 142.7, 141.2, 139.1, 138.7, 136.9, 
129.1, 127.9, 127.1, 127.08, 126.9, 126.1, 121.2, 61.9, 46.4, 21.4, 14.9. HRMS Calcd. for 
C21H21BrN2O2S (M+1): 444.0507, Found: 445.0580. FTIR (NaCl Film): 3276, 2980, 
2895, 1581, 1598, 1454, 1432, 1322, 1155, 1123, 1091, 1155, 1123, 811, 678 cm-1. 
 
 
2.50 
N-[2-(6-Bromo-pyridin-2-yl)-1-(4-methoxy-phenyl)-propyl]-4-methyl-
benzenesulfonamide (2.50): Rf = 0.25, 30% EtOAc/hexanes, gradient: 10 - 30% 
EtOAc/hexanes; colorless liquid; Inseparable mixture of diastereomers in 5:1 ratio; 1H 
NMR (400 MHz, CDCl3): δ 7.38 (d, J = 8.0 Hz, 2H), 7.20-7.12 (m, 2H), 6.97 (d, J = 8.0 
Hz, 2H), 6.78 (d, J = 8.8 Hz, 2H), 6.69 (d, J = 7.6 Hz, 1H), 6.52 (dd, J = 8.4, 0.8 Hz, 2H), 
6.46 (d, J = 6.4 Hz, 1H), 4.43 (t, J = 6.4 Hz, 1H), 3.63 (s, 3H), 3.06 (quintet, J = 6.4 Hz, 
1H), 2.25 (s, 3H), 1.15 (d, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 163.3, 142.7, 
141.2, 139.1, 138.7, 136.9, 129.1, 127.9, 127.1, 127.08, 126.9, 126.1, 121.2, 61.9, 55.1, 
46.4, 21.4, 14.9. HRMS Calcd. for C21H21BrN2O2S (M+1): 444.0507, Found: 445.0580. 
FTIR (NaCl Film): 3275, 2918, 1581, 1553, 1433, 1409, 1321, 1304, 1248, 1156, 1124, 
1032, 833, 705, 666 cm-1. 
 
 
 
98 
 
2.51 
N-[1-Benzo [1,3]dioxol-5-yl-2-(6-bromo-pyridin-2-yl)-propyl]-benzenesulfonamide 
(2.51): Rf = 0.45, 50% EtOAc, gradient: 10 - 50% EtOAc/hexanes; white solid; 
inseparable mixture of diastereomers in 5:1 ratio; spectral data is reported for the major 
isomer; 1H NMR (400 MHz, CDCl3): δ 7.60 (d, J = 7.6 Hz, 2H), 7.43-7.21 (m, 6H), 6.8 
(d, J = 7.6 Hz, 1H), 6.56- 6.40 (m, 4H), 5.84 (d, J = 1.6 Hz, 1H), 5.82 (d, J = 8.0 Hz, 1H), 
4.51-4.48 (m, 1H), 3.16-3.09 (m, 1H), 1.24 (d, J = 7.2 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): δ 163.2, 147.1, 146.5, 141.1, 139.9, 138.8, 132.9, 132.0, 128.5, 126.9, 126.7, 
126.2, 121.3, 120.8, 107.6, 107.5, 100.8, 61.8, 46.3, 15.2. HMRS: Cald. for 
C21H19BrN2O4S (M+1): 475.0200, Found: 475.0327. FTIR (NaCl film): 3274, 2893, 
1581, 1554, 1503, 1489, 1446, 1433, 1371, 1345, 1239, 1157, 1125, 1092, 1037 cm-1.  
 
 
2.52 
N-[2-(6-Bromo-pyridin-2-yl)-1-furan-2-yl-propyl]-4-methyl-benzenesulfonamide 
(2.52): Rf = 0.45, 20% EtOAc, gradient: 10 - 20% EtOAc/hexanes; colorless oil; 
inseparable mixture of diastereomers in 4:1 ratio; spectral data is reported for the major 
isomer; 1H NMR (400 MHz, CDCl3): δ 7.54 (d, J = 8.0 Hz, 2H), 7.39-7.21 (m, 3H), 7.16-
7.06 (m, 3H), 6.90 (d, J = 7.6 Hz, 1H), 6.02-6.01 (m, 1H), 5.81 (d, J = 8.8 Hz, 1H), 5.79 
(d, J = 2.8 Hz, 1H), 4.68 (dd, J = 6.4, 2.0 Hz, 1H), 3.33-3.26 (m, 1H), 3.34 (s, 3H), 1.33 
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(d, J = 7.4 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 163.4, 152, 143.1, 141.8, 141.4, 
138.9, 137.3, 129.5, 127.1, 126.3, 121.3, 110.2, 108.2, 56.4, 45.1, 44.8, 36.2, 21.7, 15.9. 
HMRS: Cald. for C19H19BrN2O3S (M+1): 435.0368, Found: 435.0373. FTIR (NaCl film): 
3271, 2920, 1581, 1554, 1496, 1433, 1410, 1328, 1231, 1156, 1124, 1092, 1048, 1011 
cm-1.  
 
 
2.53 
N-((1R, 2R)-2-(6-bromopyridin-2-yl)-1-(thiophen-2-yl)propyl)-4-
methylbenzenesulfonamide (2.53): Rf = 0.25, 20% EtOAc/hexanes, gradient: 10 - 20% 
EtOAc/hexanes; white solid; Inseparable mixture of diastereomers in 7:1 ratio; spectral 
data is reported for the major isomer; 1H NMR (400 MHz, CD3SOCD3): δ 8.43 (d, J = 
9.2 Hz, 1H), 7.43 (d, J = 8.4 Hz, 2H), 7.31 (d, J = 7.6 Hz, 1H), 7.15 (d, J = 8.4 Hz, 2H), 
7.10 (dd, J = 4.8, 1.6 Hz, 1H), 7.04 (d, J = 7.2 Hz, 1H), 6.62-6.57 (m, 2H), 4.81 (t, J = 9.2 
Hz, 1H), 3.34 (s, 1H), 3.20-3.12 (m, 1H), 2.27 (s, 3H), 1.27 (d, J = 7.2 Hz, 3H). 13C NMR 
(100 MHz, CD3SOCD3): δ 163.7, 144.3, 141.9, 140.6, 139.5, 138.7, 129.0, 126.0, 125.8, 
124.7, 124.5, 122.4, 57.1, 47.8, 20.9, 17.4. HRMS Calcd. for C21H19BrN2O2S2 (M+1): 
451.0071, Found: 451.0075. FTIR (NaCl Film): 3273, 2973, 2925, 1586, 1434, 1356, 
1328, 1264, 1161, 1091, 895, 814, 733, 703 cm-1. 
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2.54 
 
N-{1-[1-(6-Bromo-pyridin-2-yl)-ethyl]-3-phenyl-allyl}-4-methyl-benzenesulfonamide 
(2.54): Rf = 0.25, 25% EtOAc/hexanes, gradient: 10 - 25% EtOAc/hexanes; white solid; 
Inseparable mixture of diastereomers in 4:1 ratio; spectral data is reported for the major 
isomer; 1H NMR (400 MHz, CDCl3): δ 7.29 (dd, J = 8.0, 0.8 Hz, 2H), 7.39 (d, J = 7.2 Hz, 
2H), 7.34 (d, J = 8.0 Hz, 2H), 7.29 (d, J = 5.6 Hz, 1H), 7.22-7.18 (m, 3H), 7.07-7.01 (m, 
3H), 6.27 (d, J = 15.6 Hz, 1H), 6.15 (d, J = 7.2 Hz, 1H), 5.71 (dd, J = 16.0, 7.6 Hz, 1H), 
4.18 (ddd, J = 8.0, 4.4, 1. 2 Hz, 1H), 3.19-3.12 (m, 1H), 1.30 (d, J = 7.2 Hz, 3H). 13C 
NMR (100 MHz, CDCl3): δ 163.4, 141.0, 140.9, 139.0, 136.1, 133.0, 132.1, 128.8, 128.3, 
127.7, 127.2, 126.4, 126.3, 126.3, 126.26, 121.13, 60.5, 44.7, 15.5. HRMS Calcd. for 
C23H23BrN2O2S (M+1): 457.0507, Found: 457.0586. FTIR (NaCl Film): 3269, 3058, 
2916, 1580, 1553, 1446, 1433, 1324, 1157, 1125, 1092, 984, 833, 721, 688 cm-1. 
 
 
2.55 
N-{1-[1-(6-Bromo-pyridin-2-yl)-ethyl]-butyl}-4-methyl-benzenesulfonamide (2.55): 
Rf = 0.28, 15% EtOAc/hexanes, gradient: 10 - 15% EtOAc/hexanes; colorless liquid; 
Inseparable mixture of diastereomers in 8:1 ratio; spectral data is reported for the major 
isomer;  1H NMR (400 MHz, CDCl3): δ 7.88 (d, J = 10.4 Hz, 2H), 7.35 (t, J = 8.0 Hz, 
1H), 7.26-7.21 (m, 3H), 6.92 (d, J = 7.6 Hz, 1H), 5.34 (d, J = 8.4 Hz, 1H), 3.48-3.42 (m, 
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1H), 2.92 (ddd, J = 14.4, 7.2, 4.8 Hz, 1H), 2.41 (s, 3H), 1.42-1.16 (m, 4H), 1.21 (d, J = 
7.2 Hz, 3H), 0.78 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 164.2, 142.9, 141.2, 
138.6, 137.9, 129.4, 126.9, 125.9, 121.1, 58.2, 43.1, 34.2, 21.5, 18.9, 14.7, 13.7. HRMS 
Calcd. for C18H23BrN2O2S (M+1): 411.0664, Found: 411.0736. FTIR (NaCl Film): 3280, 
2959, 2872, 1579, 1553, 1433, 1408, 1323, 1156, 1120, 1092, 812, 706, 664 cm-1. 
 
 
2.56 
N-((2R,3S)-2-(6-bromopyridin-2-yl)-5-methylhexan-3-yl)-4-
methylbenzenesulfonamide (2.56): Rf = 0.25, 20% EtOAc/hexanes, gradient: 10 - 20% 
EtOAc/hexanes; colorless liquid; inseparable mixture of diastereomers in 6:1 ratio; 
spectral data is reported for the major isomer; 1H NMR (400 MHz, CDCl3): δ 7.70 (d, J 
= 8.4 Hz, 2H), 7.38 (t, J = 7.6 Hz, 1H), 7.27-7.22 (m, 3H), 6.95 (d, J = 7.2 Hz, 1H), 5.43 
(dd, J = 8.4, 1.6 Hz, 1H), 3.53-3.46 (m, 1H), 2.91 (ddd, J = 14.4, 6.8, 4.0 Hz, 1H), 2.35 (s, 
3H), 1.58-1.42 (m, 2H), 1.17 (d, J = 7.2 Hz, 3H), 1.15-1.10 (m, 1H), 0.80 (d, J = 6.8 Hz, 
3H), 0.77 (d, J = 6.4 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 163.9, 142.5, 141.0, 138.6, 
137.9, 129.4, 126.9, 125.8, 120.9, 56.4, 42.8, 41.1, 24.1, 22.9, 21.7, 21.4, 14.5. HRMS 
Calcd. for C19H25BrN2O2S (M+1): 425.0820, Found: 425.0818. FTIR (NaCl Film): 3275, 
2948, 2876, 1578, 1543, 1433, 1408, 1320, 1159, 1123, 1090, 812, 702, 664 cm-1. 
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2.57 
N-[1-Benzyloxymethyl-2-(6-bromo-pyridin-2-yl)-propyl]-4-methyl-
benzenesulfonamide (2.57): Rf = 0.30, 15% EtOAc/hexanes, gradient: 10 - 15% 
EtOAc/hexanes; colorless liquid; inseparable mixture of diastereomers in 5:1 ratio; 
spectral data is reported for the major isomer. 1H NMR (400 MHz, CDCl3): δ 7.64 (d, J 
= 8.4 Hz, 2H), 7.33-7.25 (m, 4H), 7.23-7.16 (m, 5H) 6.97 (d, J = 6.8 Hz, 1H), 5.31 (d, J = 
8.0 Hz, 1H), 4.26 (s, 2H), 3.61 (ddd, J = 11.6, 5.2 , 3.2 Hz, 1H), 3.23-3.13 (m, 3H), 2.37 
(s, 3H), 1.25 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 164.2, 143.0, 141.5, 
138.6, 137.6, 137.3, 129.5, 128.3, 127.7, 126.9, 126.8, 125.9, 121.6, 73.1, 69.3, 57.2, 42.1, 
21.4, 16.0. HRMS Calcd. for C23H25BrN2O3S (M+1): 489.0769, Found: 489.0842. FTIR 
(NaCl Film): 3279, 3001, 1866, 1580, 1553, 1453, 1432, 1328, 1117, 1087, 1022, 812, 
794, 736, 664 cm-1. 
 
 
2.58 
N-((1S, 2R)-2-(6-bromopyridin-2-yl)-1-cyclopropyl)-4-methylbenzenesulfonamide 
(2.58): Rf = 0.30, 15% EtOAc/hexanes, gradient: 10 - 15% EtOAc/hexanes; inseparable 
mixture of diastereomers in 9:1 ratio; spectral data is reported for the major isomer; 1H 
NMR (400 MHz, CDCl3): δ 7.62 (d, J = 8.8 Hz, 2H), 7.33 (t, J = 7.6 Hz, 1H), 7.21 (d, J = 
8.0 Hz, 1H), 7.18 (d, J = 8.0 Hz, 2H), 7.01 (d, J = 7.6 Hz, 1H), 5.47 (d, J = 7.6 Hz, 1H), 
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3.01-2.95 (m, 1H), 2.80 (ddd, J = 12.4, 7.6, 4.8 Hz, 1H), 2.33 (s, 3H), 1.24 (d, J = 7.2 Hz, 
3H), 0.75-0.67 (m, 1H), 0.37-0.30 (m, 1H), 0.18-0.05 (m, 2H), -0.05- -0.11 (m, 1H). 13C 
NMR (100 MHz, CDCl3): δ 164.1, 142.8, 141.0, 138.6, 138.1, 129.4, 126.9, 125.9, 121.3, 
62.5, 45.1, 21.4, 15.3, 13.9, 4.5, 3.2. HRMS Calcd. for C18H21BrN2O2S (M+1): 408.0507, 
Found: 408.0509. FTIR (NaCl Film): 3276, 2973, 2322, 2050, 1581, 1553, 1434, 1326, 
1157, 1093, 814, 706, 666 cm-1. 
 
 
2.59 
N-((2S, 1R)-3-(6-bromopyridin-2-yl) butan-2-yl)-4-methylbenzenesulfonamide 
(2.59): Rf = 0.25, 15% EtOAc/hexanes; colorless liquid; inseparable mixture of 
diastereomers in 13:1 ratio; spectral data is reported for the major isomer; 1H NMR (400 
MHz, CDCl3): δ 7.67 (d, J = 8.4 Hz, 2H), 7.40 (t, J = 7.2 Hz, 1H), 7.26 (d, J = 8.0 Hz, 
1H), 7.22 (d, J = 8.0 Hz, 2H), 7.02 (d, J = 7.6 Hz, 1H), 5.44 (d, J = 7.6 Hz, 1H), 3.60-
3.52 (m, 1H), 2.87 (quintet, J = 6.4 Hz, 1H), 2.39 (s, 3H), 1.23 (d, J = 7.2 Hz, 3H), 1.04 
(d, J = 6.4 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 164.0, 142.9, 141.2, 138.7, 137.4, 
129.4, 126.8, 125.9, 121.0, 53.7, 45.4, 21.4, 19.1, 14.8. HRMS Calcd. for C16H19BrN2O2S 
(M+1): 383.0429, Found: 383.0435. FTIR (NaCl Film): 3275, 2971, 2322, 1581, 1552, 
1430, 1380, 1324, 1126, 1089, 958, 911, 813, 705, 667 cm-1.   
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2.61 
4-methyl-N-((1R,2R)-2-(6-methylpyridin-2-yl)-1-(thiophen-2-
yl)propyl)benzenesulfonamide (2.61): Rf = 0.25, 20% EtOAc/hexanes, gradient: 10 - 
20% EtOAc/hexanes; yellow thick syrup; inseparable mixture of diastereomers in 5:1 
ratio; spectral data is reported for the major isomer; 1H NMR (400 MHz, CDCl3): δ 7.81 
(d, J = 8.0 Hz, 1H), 7.47 (d, J = 8.0 Hz, 2H), 7.41 (t, J = 8.0 Hz, 1H), 7.29 (d, J = 7.6 Hz, 
1H), 7.05 (d, J = 8.0 Hz, 2H), 6.99 (d, J = 7.6 Hz, 1H), 6.95 (dd, J = 4.8, 0.8 Hz, 1H), 
6.74 (d, J = 8.0 Hz, 1H), 6.69 (dd, J = 4.8, 3.6 Hz, 1H), 6.61 (d, J = 4.0 Hz, 1H), 4.88 (dd, 
J = 5.2, 4.4 Hz, 1H), 3.31-3.25 (m, 1H), 2.56 (s, 3H), 2.32 (s, 3H), 1.24 (d, J = 7.2 Hz, 
3H). 13C NMR (100 MHz, CDCl3): δ 160.8, 157.0, 142.4, 137.7, 137.0, 129.6, 129.0, 
126.7, 126.1, 125.7, 124.6, 121.5, 119.3, 58.4, 44.7, 24.3, 21.3, 15.6. HRMS Calcd. for 
C20H23N2O2S2 (M+1): 387.1201, Found: 387.1201. FTIR (NaCl Film): 3268, 2924, 1594, 
1460, 1376, 1327, 1156, 1092, 812, 749, 666 cm-1. 
 
 
2.62 
N-((1S, 2R)-1-cyclopropyl-2-(6-methylpyridin-2-yl) propyl)-4-
methylbenzenesulfonamide (2.62): Rf = 0.23, 25% EtOAc/hexanes, gradient: 10 - 25% 
EtOAc/hexanes; colorless liquid; Inseparable mixture of diastereomers in 10:1 ratio; 
spectral data is reported for the major isomer; 1H NMR (400 MHz, CDCl3): δ 7.72 (d, J 
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= 8.0 Hz, 2H), 7.47 (t, J = 7.6 Hz, 1H), 7.22 (d, J = 8.0 Hz, 2H), 7.19-7.14 (m, 1H), 6.99 
(d, J = 8.0 Hz, 1H), 6.90 (d, J = 7.6 Hz, 1H), 2.95-2.87 (m, 1H), 2.85-2.79 (m, 1H), 2.42 
(s, 3H), 2.38 (s, 3H), 1.29 (d, J = 7.2 Hz, 3H), 0.68-0.63 (m, 1H), 0.40-0.36 (m, 1H), 
0.20-0.17 (m, 2H), 0.15-0.07 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 161.9, 157.2, 
143.4, 139.1, 138.5, 126.9, 126.3, 121.2, 118.9, 62.3, 43.8, 24.4, 21.4, 15.6, 13.1, 3.8, 3.3. 
HRMS Calcd. for C19H25N2O2S2 (M+1): 345.1637, Found: 345.1639. FTIR (NaCl Film): 
3272, 2924, 1595, 1458, 1327, 1158, 1094, 1041, 814, 669 cm-1. 
 
 
2.63 
4-methyl-N-((1R,2R)-2-(6-phenylpyridin-2-yl)-1-(thiophen-2-
yl)propyl)benzenesulfonamide (2.63): Rf = 0.30, 20% EtOAc/hexanes, gradient: 10 - 
20% EtOAc/hexanes; white solid; inseparable mixture of diastereomers in 5:1 ratio; 
spectral data is reported for the major isomer; 1H NMR (400 MHz, CDCl3): δ 8.01 (dd, J 
= 8.8, 1.6 Hz, 1H), 7.75-7.73 (m, 1H), 7.47 (d, J = 8.4 Hz, 2H), 7.58-7.51 (m, 4H), 7.46 
(d, J = 6.8 Hz, 1H), 7.38 (d, J = 8.4 Hz, 2H), 6.96-6.93 (m, 2H), 6.87 (t, J = 4.0 Hz, 1H), 
6.69 (t, J = 3.6 Hz, 1H) 5.64 (d, J = 3.6 Hz, 1H), 4.99 (dd, J = 6.0, 5.2 Hz, 1H), 3.46-3.37 
(m, 1H), 2.25 (s, 3H), 1.32 (d, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 161.2, 
155.9, 142.4, 142.3, 138.6, 137.6, 137.5, 129.2, 128.9, 128.8, 126.7, 126.6, 126.0, 125.8, 
124.6, 120.8, 118.7, 58.4, 45.3, 21.3, 15.6. HRMS Calcd. for C25H24N2O2S2 (M+1): 
449.1357, Found: 449.1360. FTIR (NaCl Film): 3270, 3064, 1591, 1569, 1447, 1327, 
1155, 1091, 908, 853, 761, 694, 666 cm-1. 
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2.64 
4-methyl-N-((2R, 3S)-5-methyl-2-(6-phenylpyridin-2-yl) hexan-3-yl) 
benzenesulfonamide (2.64): Rf = 0.30, 20% EtOAc/hexanes, gradient: 10 - 20% 
EtOAc/hexanes; inseparable mixture of diastereomers in 4:1 ratio; spectral data is 
reported for the major isomer; 1H NMR (400 MHz, CDCl3): δ 8.00-7.98 (m, 2H), 7.79 (d, 
J = 8.0 Hz, 1H), 7.66 (d, J = 8.4 Hz, 2H), 7.62-7.56 (m, 2H), 7.51 (dd, J = 8.0, 1.6 Hz, 
2H), 7.44 (dd, J = 7.6, 2.0 Hz, 1H), 7.14 (d, J = 8.0 Hz, 2H), 6.93 (d, J = 8.4 Hz, 1H), 
6.62 (d, J = 7.6 Hz, 1H) 3.53-3.47 (m, 1H), 2.97 (ddd, J = 14.8, 7.2, 3.6 Hz, 1H), 2.32 (s, 
3H), 1.73-1.66 (m, 1H), 1.23 (d, J = 7.2 Hz, 3H), 1.18-1.05 (m, 1H), 0.84 (d, J = 6.4 Hz, 
3H), 0.84 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 162.0, 155.9, 142.6, 139.4, 
138.0, 137.4, 129.3, 129.2, 129.1, 126.8, 126.7, 120.2, 118.1, 56.5, 44.5, 40.4, 23.9, 23.0, 
22.2, 21.8, 14.9. HRMS Calcd. for C25H31N2O2S (M+1): 423.2106, Found: 423.2111. 
FTIR (NaCl Film): 3278, 2955, 2866, 1590, 1569, 1495, 1447, 1385, 1367, 1325, 1155, 
1092, 960, 763, 731, 693, 662 cm-1. 
 
 
2.65 Major 
N-((1R, 2R)-2-(6-((tert-butyldimethylsilyloxy) methyl) pyridine-2-yl)-1-(thiophen-2-
yl) propyl)-4-methanebenzenesulfonamide (2.65 Major): Rf, major = 0.30, 15% 
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EtOAc/hexanes, gradient: 10 - 15% EtOAc/hexanes; colorless liquid; separable mixture 
of diastereomers in 5:1 ratio; 1H NMR (400 MHz, CDCl3, Major Isomer): δ 7.71 (d, J = 
7.2 Hz, 1H), 7.53 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 7.6 Hz, 1H), 7.09 (d, J = 8.0 Hz, 2H), 
7.14 (d, J = 8.0 Hz, 2H), 6.93 (dd, J = 5.2, 1.6 Hz, 1H), 6.77 (d, J = 7.6 Hz, 1H), 6.67-
6.64 (m, 1H), 6.60 (d, J = 3.2 Hz, 1H), 4.91 (dd, J = 7.2, 5.2 Hz, 1H), 4.82 (q, J = 14.8 
Hz, 2H), 3.21-3.14 (m, 1H), 2.38 (s, 3H), 1.29 (d, J = 6.8 Hz, 3H) 0.98 (s, 9H), 0.16 (s, 
6H). 13C NMR (100 MHz, CDCl3): δ 161.2, 160.5, 145.1, 142.3, 138.4, 137.5, 129.0, 
121.7, 125.9, 125.0, 124.3, 121.8, 118.3, 65.9, 59.5, 46.7, 25.9, 21.4, 19.5, 18.3, -5.2. 
HRMS Calcd. for C26H37N2O3Si S2 (M+1): 517.2015, Found: 517.2015. FTIR (NaCl 
Film): 3273, 2953, 2928, 2855, 1594, 1462, 1449, 1361, 1158, 1117, 1093, 837, 778, 696, 
668 cm-1. 
 
 
2.65 Minor 
N-((1R, 2S)-2-(6-((tert-butyldimethylsilyloxy) methyl) pyridine-2-yl)-1-(thiophen-2-
yl) propyl)-4-methanebenzenesulfonamide (2.65 Minor): Rf, minor = 0.25, 15% 
EtOAc/hexanes; gradient: 10 - 15% EtOAc/hexanes; colorless liquid; separable mixture 
of diastereomers in 5:1 ratio; 1H NMR (400 MHz, CDCl3, Minor Isomer): 7.53 (d, J = 7.6 
Hz, 1H), 7.45 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 1H), 7.04 (d, J = 8.0 Hz, 2H), 7.14 
(d, J = 8.0 Hz, 2H), 6.95 (dd, J = 4.8, 2.0 Hz, 1H), 6.80 (d, J = 8.0 Hz, 1H), 6.69-6.74 (m, 
1H), 6.58 (d, J = 2.8 Hz, 1H), 4.88 (dd, J = 6.8, 4.4 Hz, 1H), 4.83-4.82 (m, 2H), 3.34-
3.27 (m, 1H), 2.32 (s, 3H), 1.28 (d, J = 6.8 Hz, 3H)  0.99 (s, 9H), 0.18 (s, 6H). 13C NMR 
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(100 MHz, CDCl3): 165.3, 160.3, 142.4, 142.2, 137.7, 137.4, 129.1, 126.7, 126.1, 125.7, 
124.7, 120.5, 118.3, 65.9, 58.4, 45.0, 29.6, 25.9, 21.4, 15.8, -0.01, -5.3. HRMS Calcd. for 
C26H37N2O3Si S2 (M+1):517.2015, Found:517.2017. FTIR (NaCl Film): 3270, 2957, 
2929, 2850, 1589, 1460, 1441, 1360, 1156, 1116, 1093, 837, 771, 692, 666 cm-1. 
 
 
2.66 
N-((1S, 2R)-2-(6-((tert-butyldimethylsilyloxy) methyl) pyridin-2-yl)-1-
cyclopropylpropyl)-4-methylbenzenesulfonamide (2.66): Rf = 0.25, 15% 
EtOAc/hexanes, gradient: 10 - 15% EtOAc/hexanes; colorless liquid; Inseparable mixture 
of diastereomers in 6:1 ratio; spectral data is reported for the major isomer; 1H NMR 
(400 MHz, CDCl3): δ 7.80 (d, J = 8.4 Hz, 1H), 7.68 (d, J = 8.0 Hz, 2H), 7.59 ( t, J = 7.6 
Hz, 1H), 7.43-7.30 (m, 1H), 7.20 (d, J = 8.0 Hz, 2H), 6.94 (d, J = 8.0 Hz, 1H), 4.79 (s, 
2H), 2.97-2.90 (m, 1H), 2.81 (ddd, J = 8.0, 6.4, 3.6 Hz, 1H), 2.33 (s, 3H), 1.29 (d, J = 7.2 
Hz, 3H), 1.11-1.09 (m, 1H), 0.96 (s, 9H), 0.70-0.61 (m, 1H), 0.40-0.35 (m, 1H), 0.18-
0.08 (m, 2H), 0.13 (s, 6H). 13C NMR (100 MHz, CDCl3): δ 161.5, 160.3, 142.6, 138.5, 
137.3, 129.6, 127.8, 120.2, 118.0, 66.0, 62.4, 44.1, 25.9, 21.4, 18.3, 15.7, 13.1, 10.6, 3.9, 
3.2, -5.3. HRMS Calcd. for C25H39N2O3SiS (M+1): 475.2451, Found: 475.2453. FTIR 
(NaCl Film): 3285, 2953, 2928, 2855, 1595, 1461, 1326, 1158, 1117, 1093, 1042, 837, 
813, 706, 669 cm-1. 
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2.67 
N-((1R,2R)-2-(8-(benzyloxy)quinolin-2-yl)-1-(thiophen-2-yl)propyl)-4 
methylbenzenesulfonamide (2.67). Rf = 0.27, 25% EtOAc/hexanes, gradient: 10 - 25 % 
EtOAc/hexanes; pale brown liquid; inseparable mixture of diastereomers in 6:1 ratio; 
spectral data is reported for the major isomer; 1H NMR (400 MHz, CDCl3): δ 8.55 (d, J 
= 7.2 Hz, 1H), 7.95 (d, J = 8.4 Hz, 1H), 7.59 (d, J = 7.6 Hz, 2H), 7.42-7.28 (m, 7H), 7.11-
7.08 (m, 2H), 6.89 (d, J = 4.0 Hz, 1H), 6.82 (d, J = 8.0 Hz, 2H), 6.68-6.64 (m, 2H), 5.45 
(dd, J = 18.8, 11.6 Hz, 2H), 4.94 (dd, J = 8.0, 4.0 Hz, 1H), 3.60-3.54 (m, 1H), 2.21 (s, 
3H), 1.34 (d, J = 7.6 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 160.4, 153.8, 142.0, 141.9, 
138.7, 137.9, 136.8, 136.6, 128.7, 128.6, 128.0, 127.8, 127.3, 126.6, 126.5, 126.4, 125.6, 
124.7, 120.5, 129.3, 110.2, 70.6, 58.5, 44.8, 21.2, 15.9. HRMS Calcd. for C30H29N2O3S2 
(M+1): 529.1620, Found: 529.1620. FTIR (NaCl Film): 3063, 2926, 1564, 1503, 1452, 
1430, 1324, 1261, 1157, 1094, 836, 696, 665 cm-1. 
 
 
2.68 
N-((1R, 2R)-2-(8-(benzyloxy) quinolin-2-yl)-1-(cyclopropyl-4-
methylbenzenesulfonamide) (2.68): Rf = 0.32, 15% EtOAc/hexanes, gradient: 10 - 15 % 
EtOAc/hexanes; pale yellow thick syrup; inseparable mixture of diastereomers in 6:1 
ratio; spectral data is reported for the major isomer; 1H NMR (400 MHz, CDCl3): δ 7.98 
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(d, J = 8.4 Hz, 1H), 7.63 (d, J = 8.0 Hz, 2H), 7.59 (d, J = 7.6 Hz, 1H) 7.40-7.23 (m, 7H), 
7.06 (d, J = 7.2 Hz, 1H), 6.98 (d, J = 8.0 Hz, 2H), 5.41 (d, J = 6.4 Hz, 1H), 5.34 (dd, J = 
19.6, 12.0 Hz, 2H), 3.12-3.09 (m, 1H), 2.93 (ddd, J = 10.8, 7.6, 3.6 Hz,  1H), 2.26 (s, 3H), 
1.38 (d, J = 7.6 Hz, 3H), 0.89-0.81 (m, 1H), 0.44-0.38 (m, 1H), 0.31-0.25 (m, 1H), 0.18-
0.11 (m, 1H), 0.07-0.01 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 161.5, 154.0, 142.2, 
139.0, 138.6, 136.7, 136.4, 129.0, 128.5, 128.3, 127.8, 127.7, 127.6, 126.8, 120.5, 119.3, 
109.9, 70.6, 62.0, 44.3, 21.3, 15.9, 12.6, 4.1, 2.8. HRMS Calcd. for C29H31N2O3S (M+1): 
487.2055, Found: 487.2066. FTIR (NaCl Film): 3210, 3063, 2954, 1599, 1562, 1452, 
1322, 1261, 1157, 1098, 834, 730, 669, 663 cm-1. 
 
 
2.69 
N-((1R,2R)-2-(8-(benzyloxy)quinolin-2-yl)-5methylhexan-3-yl)-4-
methylbenzenesulfonamide (2.69): Rf = 0.30, 25% EtOAc/hexanes, gradient: 10 - 25 % 
EtOAc/hexanes; a pale yellow thick syrup; inseparable mixture of diastereomers in 8:1 
ratio; spectral data is reported for the major isomer; 1H NMR (400 MHz, CDCl3): δ 7.97 
(d, J = 8.8 Hz, 1H), 7.63-7.60 (m, 5H), 7.42-7.37 (m, 3H), 7.32-7.30 (m, 2H), 7.16 (d, J = 
8.8 Hz, 1H), 7.11 (dd, J = 7.6, 1.2 Hz, 1H), 6.95 (d, J = 8.4 Hz, 2H), 5.37 (dd, J = 18.8, 
11.6 Hz, 2H), 3.55-3.48 (m, 1H), 3.03 (ddd, J = 14.8, 7.2, 4.0 Hz, 1H), 2.26 (s, 3H), 1.83-
1.73 (m, 1H), 1.27 (d, J = 7.2 Hz, 3H), 1.20-1.16 (m, 2H), 0.87 (d, J = 6.4 Hz, 3H), 0.77 
(d, J = 6.4 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 161.3, 154.0, 142.2, 139.1, 138.4, 
136.7, 136.4, 129.0, 128.6, 128.5, 127.9, 127.8, 127.6, 126.7, 126.2, 120.1, 119.3, 109.8, 
70.6, 56.6, 42.1, 40.2, 23.9, 23.1, 21.7, 15.1. HRMS Calcd. for C30H35N2O3S (M+1): 
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503.2368, Found: 503.2372. FTIR (NaCl Film): 3200, 3063, 2954, 2868, 1599, 1503, 
1453, 1324, 1262, 1160, 1094, 837, 735, 696, 665 cm-1. 
 
Preparation of deuterio-2.60: 
  In accordance with the general procedure, 6-bromo-2-vinylpyridine 1a (144 mg, 
0.79 mmol, 300 mol%) was coupled to imine 2l (52 mg, 0.26 mmol, 100 mol%) under 
deuterium gas (99.6% pure) atmosphere to provide the title compound (66 mg, 0.17 
mmol) as a colorless liquid in 65% yield after purification by flash silica gel column 
chromatography.  
 
Deuterio-2.60 
 
N-((2S, 1R)-3-(6-bromopyridin-2-yl) butan-2-yl)-4-methylbenzenesulfonamide 
(deuterio-2.60): Rf = 0.25, 15% EtOAc/hexanes; colorless liquid; inseparable mixture of 
diastereomers in 11:1 ratio; spectral data is reported for the major isomer; 1H NMR (400 
MHz, CDCl3): δ 7.67 (d, J = 8.0 Hz, 2H), 7.40 (t, J = 7.6 Hz, 1H), 7.26 (d, J = 8.0 Hz, 
1H), 7.22 (d, J = 8.0 Hz, 2H), 7.02 (d, J = 7.2 Hz, 1H), 5.44 (d, J = 7.6 Hz, 1H), 3.61-
3.52 (m, 1H), 2.91-2.82 (m, 1H), 2.39 (s, 3H), 1.25-1.21 (m, 2H), 1.03 (d, J = 6.4 Hz, 
3H). 13C NMR (100 MHz, CDCl3): δ 164.0, 142.9, 141.2, 138.7, 137.4, 129.5, 126.9, 
125.9, 121.0, 53.7, 45.4, 45.3, 21.4, 19.1, 14.8. HRMS Calcd. for C16H18DBrN2O2S 
(M+1): 384.0413, Found: 384.0413. FTIR (NaCl Film): 3272, 2975, 2322, 1580, 1553, 
1433, 1380, 1324, 1126, 1089, 959, 911, 813, 706, 663 cm-1. 
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A Novel Ruthenium Catalyzed Allylation Via sp3 C-H Bond Activation-Formation of 
(Z)-Homoallylic Alcohols 
3.1 INTRODUCTION 
 
The Z-homoallylic alcohol functionality is found in numerous natural products 
and biologically important molecules.1  Traditional methods for the preparation of Z-
homoallylic alcohols include Wittig olefination,2 catalytic hydrogenation of alkynes,3 and 
carbonyl crotylations using crotyl stannanes4 or crotyl borane5 reagents. Most of these 
methods are less desirable because of waste generation, toxicity and difficulties 
associated with reagent preparation. Transition metal catalyzed reductive coupling of 
carbonyls to π-unsaturates like allenes or dienes 6  is an attractive way to prepare 
homoallylic alcohols however, often these coupling methods generate the corresponding 
E-isomer as an exclusive or the major product with the exception of some nickel 
catalyzed diene/allene-aldehyde reductive coupling reactions which exhibit good Z-
selectivity.7  
 Carbon-carbon bond formation via catalytic C-H bond activation is one of the 
most attractive and useful processes in synthetic organic chemistry.8  The methods based 
on C-H activation are superior to traditional methods because of their atom economy.9 In 
recent years a variety of C-C coupling methods have been developed based on the idea of 
C-H bond activation using ruthenium, rhodium, iridium, palladium, platinum, copper and 
gold catalysts.10 Among them, C-C bond forming reactions via ruthenium catalyzed C-H 
bond activation are the most widely employed. A great deal of ruthenium catalyzed C-C 
coupling methods involving the activation of sp and sp2 C-H bonds has been developed.11 
However, only a handful of C-C coupling methods involving sp3 C-H bond activation 
have been reported.11 This may be attributed to the difficulty associated with the 
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activation of an sp3 C-H bond as compared to an sp or sp2 C-H bond. This in turn can be 
attributed to the less coordinating ability of sp3 C-H bonds to the metal center. Currently, 
ruthenium catalyzed C-C couplings via activation of sp3 C-H bonds involve C-H bonds 
that are adjacent to a heteroatom12 or C-H bonds of an active methylene group.13 On the 
other hand, C-C bond formation via propargylic C-H activation using ruthenium catalysts 
is unknown.  This chapter describes the development as well the mechanistic aspects of a 
novel ruthenium catalyzed alkyne-alcohol/aldehyde coupling under transfer 
hydrogenation conditions generating homoallylic alcohols with Z-selectivity. 
3.2 OPTIMIZATION 
 
Recently, the Krische group reported a variety of novel auto transfer and transfer 
hydrogenative C-C couplings.14 Among them, the ruthenium catalyzed vinylation under 
transfer hydrogenation conditions was particularly elegant. It entailed the coupling of 
conjugated and unconjugated alkynes to aldehydes or alcohols.15 When 2-butyne was 
used as the coupling partner, the vinylation product 3.3 was accompanied by small 
amount of allylation product 3.4. However, when the alkyne partner was changed from 2-
butyne to 4-methyl-2-pentyne surprisingly, the homoallylic alcohol 3.6 was obtained as 
the major product in 43% yield (10:1 Z:E) (Scheme 3.1). 
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Scheme 0.1. Diverse behavior of alkynes 3.1 and 3.5 in the ruthenium catalyzed transfer 
hydrogenative coupling with alcohol 3.2. 
  
 Our optimization studies began with the coupling of alkyne 3.5 and alcohol 3.2 
(Table 3.1). When the coupling partners were subjected to the reaction conditions using 
Ru(CO)(TFA)2(Ph3P)2 (5 mol%) and isopropanol (200 mol%) in THF at 95 oC the 
homoallylic alcohol 3.6 was obtained in 43% yield with 10:1 Z:E selectivity (Table 3.1, 
entry 1). Various reaction parameters such as alkyne loadings, isopropanol loadings, 
concentration, reaction temperature, reaction duration, various catalysts and ligands were 
examined. It was concluded that 300 mol% of alkyne was optimal and with lower (150 
mol%) or higher (400 mol%) alkyne loadings the reaction was low yielding (Table 3.1, 
entries 2, 3, and 4). When the amount of isopropanol was raised, the best yields were 
obtained with a 200 mol% loading. When lower loadings or the absence of isopropanol 
were used lower yields were observed (Table 3.1, entries 5, 6 and 7). Concentration of 
the reaction had a great influence on the Z:E ratio. At lower substrate concentrations 
(0.05 M, 0.1 M and 0.2 M) the product was obtained with reasonably good Z:E 
selectivities (Table 3.1, entries 7, 8 and 9). However, at higher concentrations (0.4 M, 0.6 
M and 1 M) the coupling product was obtained with diminished Z:E selectivities (Table 
3.1, entries 11, 12, and 13).  
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Table 0.1. Optimization-coupling of alkyne 3.5 with alcohol 3.2. 
 
 
Both an increase in temperature and reaction times failed to improve the product 
yield (Table 3.1, entries 14 and 15). Examination of different ruthenium complexes, 
(Table 3.1, entries 16 and 17) phosphine ligands (Table 3.1, entries 18, 19, 20 and 21) 
and additives (Table 3.1, entries 22, 23 and 24) also failed to improve chemical yields or 
selectivities. Finally, at higher catalyst loadings (10 mol%) the yield was improved to 
70% with 10:1 Z:E ratio (Table 3.1, entry 25).  
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3.3 SUBSTRATE SCOPE 
 
Under the optimized reaction conditions (Table 3.1, entry 25) the substrate scope 
with respect to alcohol, aldehyde and alkyne was studied. Aromatic as well as aliphatic 
alcohols were successfully engaged in the coupling reactions giving the corresponding 
homoallylic alcohols in decent to good yields. Aliphatic alcohols with a bezyloxy 
protective group (Table 3.2, entries 3.6 and 3.7), aromatic substituents (Table 3.2, entries 
3.9-3.12) and a chloro group (Table 3.2, entry 3.14) produced the coupling products in 
good yields and selectivities. 4-pentene-1-ol generated the homoallylic alcohol (Table 3.2, 
entry 3.15) in 65% yield (Z:E, 8:1) with olefin migration. Alcohols with a long chain 
substituent or a cyclopentyl group produced the coupling products in decent yields and 
selectivities (Table 3.2, entries 3.8 and 3.13). In the case of benzylic alcohols, shorter 
reaction times and higher isopropanol loadings were needed to suppress over-oxidation of 
the coupling products (Table 3.2, entries 3.16 and 3.17). Finally, under the standard 
reaction conditions both 2-hexyne and 3-hexyne produced mixture of vinylation, 
allylation and olefin migration products. On the other hand, coupling of phenyl propyne 
with 4-benzyloxy-1-butanol 3.2 merely generated the vinylation product in 28% (2:1 
regioselectivity, favoring coupling to the carbon atom proximal to the Ph group). 
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Table 0.2. Ruthenium catalyzed allylation via transfer hydrogenation-substrate scope.a,b 
 
a Yields of the purified materials b Z/E selectivities were determined from 1H NMR of the purified 
compound c 400 mol% of IPA was used d Reaction was run for 24h e Approaximately 5% of vinylation 
product was observed 
 
The coupling reactions were also successfully performed from the aldehyde 
oxidation level in good yields (Table 3.2, entries 3.6, 3.11, 3.13). Finally, the substrate 
scope with respect to alkyne was examined. Under the standard reaction conditions 
(Table 3.1, entry 25) the coupling reactions of 4,4-dimethyl-2-pentyne, 1-cyclopentyl 
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propyne and 1-cyclohexyl propyne against  4-benzyloxy-1-butanol and 4-bromobenzyl 
alcohol were studied. The coupling reaction of 4,4-dimethyl-2-pentyne with 4-benzyloxy-
1-butanol 3.2 was efficient, giving the coupling product in 76% yield however this 
reaction exhibited a poor Z:E ratio (1.3:1). However, by reducing the isopropanol 
loadings to 100 mol% from 200 mol% and shortening the reaction time to 24 hours the 
coupling product was obtained in 71% yield with 7:1 Z:E selectivity (Table 3.3, entry 
3.18). 1-cyclohexyl and 1-cyclopentyl propynes were successfully engaged in the 
coupling reactions with aliphatic and benzylic alcohols in good yields and selectivities 
(Table 3.3, entries 3.19-3.23). Reactions with 4-bromobenzyl alcohol were stopped after 
24 hours to prevent over-oxidation of the product. Most of these homoallylic alcohol 
coupling products were accompanied by trace amounts (~5%) of the corresponding 
allylic alcohols resulting from carbonyl vinylation.  
Table 0.3. Ruthenium catalyzed allylation via transfer hydrogenation-substrate scope.a, b 
 
a Yields of the purified materials b Z/E selectivities were determined from 1H NMR of the purified 
compound c 100 mol% of IPA was used d Reaction was run for 24h e Approaximately 5% of vinylation 
product was observed. 
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3.4 MECHANISTIC STUDIES 
 
 Since in most of the cases studied the allylation product was accompanied by a 
small amount of the vinylation product and vice-versa, the proposed mechanism whether 
it be a hydrometallative or oxidative coupling, should be able to explain the formation of 
both products. 
3.4.1 Vinylation-Proposed Mechanism 
 
 In order to understand the mechanism of the vinylation reaction, deuterium 
labeling experiments were performed under the optimized reaction conditions. When 
alcohol 3.24 and 2-butyne 3.1 were subjected to the reaction conditions using catalytic 
amount of Ru(CO)(TFA)2(Ph3P)2 (5 mol%) in the presence of deuterated isopropanol the 
vinylation product 3.25 was obtained in 73% yield with deuterium incorporation at the 
vinylic position (H:D, 85:15), the terminal methyl group (H:D, 20:80) and a trace amount 
(<5%) of the allylation product (Scheme 3.2,  Eq. 3.1). With deuterated alcohol 3.24 in 
the presence of isopropanol, a 10% D incorporation was observed at the terminal methyl 
group (Scheme 3.2, Eq. 3.2). However, when the reaction was performed with a 
deuterated alcohol 3.24 in the absence of isopropanol the allylic alcohol deuterio-3.25 
was isolated with a net deuterium incorporation at the vinylic position (H:D, 90:10), and 
at the terminal methyl group (H:D, 45:55). Significant amount (~15%) of allylation 
product deuterio- 3.26 was also obtained (Scheme 3.2, Eq. 3.3). 
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Scheme 0.2. Ruthenium catalyzed vinylation reactions-Deuterium labeling experiments. 
 
Though there are two mechanistic possibilities which can explain formation of the 
allylic alcohol 3.25, based on the deuterium labeling experimental results the 
hydrometallative pathway (Scheme 3.3, left figure) can be eliminated as it cannot explain 
deuterium incorporation at the terminal methyl group (See Scheme 3.2, Eq. 3.2 and 3.3). 
On the other hand, the oxidative coupling mechanism (Scheme 3.3, right figure) is 
consistent with the deuterium labeling results. The oxidative coupling catalytic cycle is 
initiated by the Ru(0) species generated from the Ru(CO)(TFA)2(Ph3P)2 as shown in the 
scheme 3.3 (right figure). The deuterated alcohol II displaces one of the triflate groups 
from the catalyst to generate species III, which upon β-hydride elimination and reductive 
elimination of TFA-d produces the Ru(0) catalyst. 16  The Ru(0) undergoes oxidative 
coupling to the substrates to generate the metallacycle XII, which upon TFA-d assisted 
Ru-O bond cleavage generates the vinylruthenium species XIII. Intermediate XIII then 
undergoes allylic C-H activation17 followed by regioselective C-H reductive elimination 
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generating allyly ruthenium species XV. Displacement of the triflate group from XV 
followed by β-hydride elimination and C-D reductive elimination produces allylic alcohol 
XVIII, with deuterium incorporation at the terminal methyl group (Scheme 3.3, right 
figure). 
 
Scheme 0.3. Ruthenium catalyzed vinylation reaction a) Hydrometallative catalytic cycle 
(left figure) b) Oxidative coupling catalytic cycle (right figure). 
  
Deuterium incorporation at the vinylic position (Scheme 3.2) can also be 
explained. Intermediate XIII can potentially choose an alternate pathway, where it can be 
attacked by deuterated alcohol II rather than undergoing an allylic C-H activation, 
generating (alkoxy)vinylruthenium species XIX. β-hydride elimination from XIX and 
subsequent D-H reductive elimination from XX affords product XXI and regeneration of  
the Ru(0) catalyst.18 A similar type of mechanism can be proposed involving Ru(II)-
Ru(IV) cycle but a Ru(VI) oxidation state has to be invoked for intermediate XIV.19 
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3.4.2 Allylation-Proposed Mechanism 
 
 When the reaction was performed with deuterated alcohol 3.24 in the absence of 
isopropanol, along with allylic alcohol deuterio-3.25, a significant amount (~15% from 
1H NMR) of homoallylic alcohol deuterio-3.26 was obtained with deuterium 
incorporation both at the vinylic and the allylic positions (H:D, 95:5) (Scheme 3.2, eq. 
3.3). Interestingly, a significant amount (60-100%) of deuterium incorporation was 
noticed when the reactions were performed with 4-methyl-1-pentyne 3.5 as the coupling 
partner (Scheme 3.4, eq. 3.2 and 3.3).  
 
Scheme 0.4. Deuterium labeling experiments for the ruthenium catalyzed allylation 
reactions 
 
From the deuterium labeling results it can be envisioned that a propargylic C-H 
activation20 of alkyne I could generate species III. Intermediate II can either directly 
hydrometallate the alkyne or undergo deuterium exchange via intermediates VI and VII 
as shown in scheme 3.5. The ruthenocyclopropene species IX undergoes carbonyl 
insertion21 to produce metallacycle X. TFA-d assisted cleavage of Ru-O bond followed 
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by allylic C-H activation generates intermediate XII. Regioselective C-H reductive 
elimination of XII produces allyl ruthenium species XIII. Nucleophilic attack of the 
deuterated alcohol on intermediate XIII followed by β-hydride elimination gives 
intermediate XIV. Finally D-H reductive elimination from XIV explains the deuterium 
incorporation at the allylic position as well as the terminal vinylic position (see XV in 
Scheme 3.5). 
 
 
Scheme 0.5.Oxidative coupling mechanism for the ruthenium catalyzed allylation. 
 
The deuterium incorporation at the vinylic position proximal to the carbinol 
carbon (See, Scheme 3.4, Eq. 3.2 and 3.3) can also be explained. The vinyl ruthenium 
species XI can alternatively be attacked by deuterated alcohol II rather than undergoing 
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an allylic C-H activation to generate (alkoxy)vinylruthenium species XVI. Consecutive 
β-hydride elimination and D-H reductive elimination from XVI produces the product 
XVII by regenerating the Ru(0) catalyst. This mechanism also helps to explain the Z-
selectivity of the coupling product (see intermediates E and F, Scheme 3.5). In order to 
understand if the kinetically formed Z-homoallylic alcohol was isomerzing to the 
thermodynamically more stable E-isomer, the allylation product 3.6 was subjected to the 
reaction conditions. Indeed the Z-isomer completely isomerized to give the corresponding 
E-isomer along with olefin migration product (Scheme 3.6, top figure). In order to 
eliminate the possibility of C-C bond formation via an allene intermediate, the 1-
isopropyl-1,3-allene 3.27 was subjected to the reaction conditions but formation of 
homoallylic alcohol 3.6 was not observed (Scheme 3.6, bottom figure). 
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Scheme 0.6. a) Isomerization of homoallylic alcohol 3.6 under the reaction conditions 
(top figure). b) Ruthenium catalyzed allylation via allene intermediate (bottom figure). 
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3.4.3 Allylation Vs Vinylation 
 
  Allylation and vinylation reactions compete. For a given alcohol, the product 
distribution depends upon the structure of the alkyne coupling partner. As shown in 
scheme 3.7, (top figure) under similar reaction conditions 2-butyne 3.1 produced allylic 
alcohol 3.3 in 65% yield, while the relatively bulky alkynes 3.5 and 3.27 generated 
homoallylic alcohols 3.7 and 3.18 respectively. 
 
Scheme 0.7. a) Transfer hydrogenative coupling reactions of alcohol 3.2 with alkynes 3.1, 
3.5 and 3.25 (top figure) b) Proposed rationale for Allylation vs vinylation. 
 
These results can be explained by the mechanism proposed from the deuterium 
labeling experiments (Schemes 3.2 and 3.4). With less bulkier alkynes, like 2-butyne, the 
metallacycle II formation is more facile giving the allylic alcohol as the major product. 
However, in the case of more sterically hindered alkynes 3.5 and 3.28 (Scheme 3.7, top 
figure) metallacycle formation leading to the vinylation product becomes slow due to 
steric reasons. Thus, the C-H activation pathway dominates giving allylation product VI.  
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Under the standard reaction conditions a competition experiment was performed 
using alcohol 3.2 (100 mol%), 2-butyne 3.1 (150 mol%) and 3-methyl-2-pentyne 3.5 (150 
mol%). Indeed 2-butyne produced allylic alcohol 3.3 in 15% yield along with a 
significant amount (40%) of over-oxidation product 3.30 and the relatively bulky 3-
methyl-2-pentyne 3.5 generated the allylation product 3.7 in 25% yield (Scheme 3.8). 
These results further support the proposed steric arguments of alkyne invoked above. 
Scheme 0.8. Competition experiment for the coupling of alcohol 3.2 with alkynes 3.1 and 
3.5. 
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3.5 CONCLUSION 
 
 In summary, a conceptually novel ruthenium catalyzed allylation reaction was 
developed from both the alcohol and aldehyde oxidation levels. Various alcohols, 
aldehydes and alkynes participated in the coupling reaction generating the coupling 
products in good yields with moderate to good selectivities. Formation of the 
thermodynamically less stable Z-homoallylic alcohol as the major product is interesting. 
Based on the deuterium labeling experimental results an oxidative coupling mechanism 
was proposed involving a propargylic C-H activation of the alkyne. Moreover, through 
logical experimentation the possibility of the intermediacy of allene was eliminated. Thus, 
this allylation reaction represents the first ruthenium catalyzed C-C bond forming process 
via propargylic C-H activation followed by carbonyl insertion.   
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3.6 EXPERIMENTAL SECTION 
 
3.6.1 General: All reactions were run under an atmosphere of argon in resealable 
pressure tubes (ca. 13 mm x 100 mm). Anhydrous solvents were transferred via oven-
dried syringe. Flasks were dried in oven and cooled under an argon atmosphere. 
Ru(CO)(OCOCF3)2(PPh)3 was prepared by using literature procedure.22 4,4-Dimethyl-2-
pentyne (Alfa-Aesar) and 4-Methy-2-pentyne (Aldrich) were used as received. Isopropyl 
alcohol was used directly from sure sealed bottle as received (Acros). Commercially 
available alcohols and aldehydes were purified by distillation or recrystallization. Both 
cyclohexyl and cyclopentyl-1-propynes were prepared according to the literature 
procedure.23 Analytical thin layer chromatography (TLC) was carried out using 0.2 mm 
commercial silica gel plates. Preparative column chromatography employing silica gel 
was performed according to the method of still.24 Infrared spectra were recorded on a 
Perkin-Elmer 1600 spectrometer. High resolution mass spectra (HRMS) were obtained 
and reported as m/z (relative intensity). Accurate masses are reported for the molecular 
ion [M+H]+ or a suitable fragment ion. Proton nuclear magnetic resonance (1H NMR) 
spectra were recorded with a Varian Gemini (400MHz or 300MHz) spectrometer. 
Chemical shifts are reported in delta (δ) units, parts per million (ppm) downfield from 
trimethylsilane, where mixtures of isomers have been characterized together, integrals are 
normalized to the major isomer. Carbon-13 nuclear magnetic resonance (13C NMR) 
spectra were recorded with a Varian Gemini 300 (75 MHz) or 400 (100 MHz) 
spectrometer. Chemical shifts are reported in delta (δ) units, ppm relative to the center of 
the triplet at 77.0 ppm for deuteriochloroform. 13C NMR spectra were routinely run with 
broadband decoupling.  
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3.6.2 General procedure for the coupling of alcohols and alkynes: To a resealable 
pressure tube (ca. 13 x 100) was added Ru(CO)(OCOCF3)2(PPh)3 ( 17.6 mg, 0.002 mmol, 
10 mol %). At this stage solid alcohol coupling partners (0.20 mmol, 100 mol %) were 
added. The tube was then sealed with a rubber septum and purged with argon. THF (2.0 
mL, 0.1 M concentration with respect to alcohols unless otherwise noted) was then added. 
At this stage, liquid alcohol coupling partners (0.20 mmol, 100 mol %) were added. 
Isopropyl alcohol (30 µL, 0.40 mmol, 200 mol %) was then added. Alkynes (0.60 mmol, 
300 mol %) was added via syringe and the rubber septum was quickly replaced with a 
screw cap. The mixture was then heated at 95 °C for the time stated. After cooling to 
room temperature, the mixture was concentrated in vacuo and purified by flash column 
chromatography (SiO2), under the conditions noted, to afford the corresponding allylic 
alcohols. 
 
 
3.6 
(Z)-1-(Benzyloxy)-8-methylnon-6-en-4-ol (3.6): Rf = 0.25, 10% EtOAc/hexanes; 
colorless oil; Z:E ratio, 10:1; spectral data is reported for the major isomer; 1H NMR (400 
MHz): 7.34-7.33 (m, 5H), 5.36 (t, J = 10.4 Hz, 1H), 5.27 (td, J = 10.8, 7.6 Hz, 1H), 4.51 
(s, 2H), 3.64-3.58 (m, 1H), 3.51 (t, J = 5.6 Hz, 2H), 2.60 (ddd, J = 15.6, 13.2, 6.4 Hz, 1H), 
2.25-2.20 (m, 2H), 1.79-1.62 (m, 4H), 1.53-1.44 (m, 1H), 0.95 (d, J = 2.8 Hz, 3H), 0.93 
(d, J = 2.8 Hz, 3H).13C NMR (100 MHz): 140.6, 138.1, 128.3, 127.6, 127.5, 122.7, 73.0, 
71.2, 70.4, 35.4, 33.9, 26.5, 26.2, 23.1, 23.0. HRMS (CI) Calculated for C17H26O2 
135 
[M+H]+: 263.2011, Found: 263.2009. FTIR (neat): 3399, 2925, 2863, 1453, 1361, 1201, 
1094, 1027, 734, 696 cm-1. 
 
 
3.7 
(Z)-1-(Benzyloxy)-7-methyloct-5-en-3-ol (3.7): Rf = 0.25, 10% EtOAc/hexanes; Z:E 
ratio, 10:1; spectral data is reported for the major isomer;1H NMR (400 MHz): 7.34-7.33 
(m, 5H), 5.34 (t, J = 10.8 Hz, 1H), 5.26 (dt, J = 10.8, 7.2 Hz, 1H), 4.53 (s, 2H), 3.86-3.79 
(m, 2H), 3.71 (quintet, J = 5.2 Hz, 1H), 3.64 (td, J = 5.6, 5.2 Hz, 1H), 2.70 (dt, J = 6.0, 
2.0 Hz, 1H), 2.32-2.15 (m, 2H), 1.79-1.73 (m, 2H), 0.95 (d, J = 3.6 Hz, 3H), 0.93 (d, J = 
3.6 Hz, 3H). 13C NMR (100 MHz): 140.3, 137.9, 128.4, 127.7, 127.6, 122.6, 73.2, 71.0, 
69.0, 35.7, 35.3, 26.5, 23.1, 23.0. HRMS (CI) Calculated for C16H24O2 [M+H]+: 249.1855, 
Found: 249.1856. FTIR (neat): 3435, 2954, 2865, 1724, 1454, 1361, 1307, 1193, 1093, 
1027, 734, 696 cm-1. 
 
 
3.8 
(Z)-2-Methyldodec-3-en-6-ol (3.8): Rf = 0.30; 10% Et2O/Pentane; colorless oil; Z:E ratio, 
11:1; spectral data is reported for the major isomer; 1H NMR (400 MHz): 5.43-5.35 (m, 
1H), 5.26 (dt, J = 10.8, 7.6 Hz, 1H), 3.64-3.54 (m, 1H), 2.66-2.50 (m, 1H), 2.24-2.18 (m, 
2H), 1.64-1.22 (m, 10H), 0.96 (d, J = 2.8 Hz, 3H), 0.94 (d, J = 2.8 Hz, 3H), 0.87 (t, J = 
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6.8 Hz, 3H). 13C NMR (100 MHz): 141.5, 122.8, 71.6, 37.0, 35.6, 32.0, 29.5, 26.8, 25.9, 
23.4, 23.2, 22.8, 4.3. HRMS (CI) Calculated for C10H20O [M+H]+: 157.1514, Found: 
157.1517.FTIR (neat): 3345, 2956, 2928, 2859, 1465, 1047 cm-1. 
 
 
3.9 
(Z)-8-Methyl-1-phenylnon-6-en-4-ol (3.9): Rf = 0.25, 10% EtOAc/hexanes; colorless 
oil; Z:E ratio, 11:1; spectral data is reported for the major isomer ; 1H NMR (400 MHz): 
7.22-7.17 (m, 2H), 7.13-7.07 (m, 3H), 5.35-5.28 (m, 1H), 5.17 (dt, J = 10.8, 7.6 Hz, 1H), 
3.60-3.50 (m, 1H), 2.60-2.48 (m, 3H), 2.16-2.10 (m, 2H), 1.80-1.40 (m, 4H), 0.88 (d, J = 
4.0 Hz, 3H), 0.86 (d, J = 3.6 Hz, 3H). 13C NMR (100 MHz): 142.3, 141.1, 128.4, 128.2, 
125.6, 122.4, 71.2, 36.3, 35.9, 35.4, 27.6, 26.5, 23.1, 23.0. HRMS (CI) Calculated for 
C16H23O [M-H]+: 231.1749, Found: 231.1747. FTIR (neat): 3351, 3025, 2953, 2931, 
2864, 1453, 1086, 746, 697 cm-1. 
 
 
3.10 
(Z)-7-Methyl-1-phenylocta-5-en-3-ol (3.10): Rf = 0.28; 15% EtOAc/Hexanes; colorless 
oil; Z:E ratio, 7:1; spectral data is reported for the major isomer;1H NMR (400 MHz): 
7.24-7.18 (m, 2H), 7.16-7.08 (m, 3H), 5.36-5.29 (m, 1H), 5.18 (dt, J = 10.8, 7.2, 0.8 Hz, 
1H), 3.60-3.52 (m, 1H), 2.79-2.69 (m, 1H), 2.67-2.49 (m, 2H), 2.21-2.15 (m, 2H), 1.80-
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1.65 (m, 2H), 1.52 (bs, 1H), 0.89 (d, J = 4.8 Hz, 3H), 0.87 (d, J = 4.4 Hz, 3H). 13C NMR 
(100 MHz): 142.0, 141.2, 128.4, 128.3, 125.7, 122.3, 70.6, 38.3, 35.5, 32.1, 26.5, 23.1, 
23.0. HRMS (CI) Calculated for C15H23O [M+H]+: 219.1749, Found: 219.1747. FTIR 
(neat): 3348, 3026, 2954, 2929, 2866, 1495, 1454, 1052, 745, 698 cm-1. 
 
 
3.11 
(Z)-6-Methyl-1-phenylhept-4-en-2-ol (3.11): Rf = 0.30; 15% EtOAc/Hexanes; Z:E ratio, 
11:1; spectral data is reported for the major isomer;1H NMR (400 MHz): 7.32-7.28 (m, 
2H), 7.26-7.20 (m, 3H), 5.40 (dd, J = 10.4, 9.6 Hz, 1H), 5.31 (dt, J = 10.8, 7.6 Hz, 1H), 
3.88-3.80 (m, 1H), 2.84 (dd, J = 13.6, 4.8 Hz, 1H), 2.71 (dd, J = 13.6, 8.0 Hz, 1H), 2.66-
2.55 (m, 1H), 2.36-2.22 (m, 2H), 1.65 (bs, 1H), 0.97 (d, J = 4.4 Hz, 3H), 0.95 (d, J = 4.8 
Hz, 3H). 13C NMR (100 MHz): 140.9, 138.5, 129.3, 128.5, 126.4, 122.4, 71.4, 43.2, 34.7, 
26.6, 23.1, 23.0. HRMS (CI) Calculated for C14H19O [M-H]+: 203.1436, Found: 203.1435. 
FTIR (neat): 3400, 3027, 2867, 1496, 1454, 1079, 1046, 735, 699 cm-1. 
 
 
3.12 
(Z)-6-Methyl-1-(4-nitrophenyl)hept-4-en-2-ol (3.12): Rf = 0.30, 15% EtOAc/hexanes; 
Z:E ratio, 8:1; spectral data is reported for the major isomer;1H NMR (400 MHz): 8.16 (d, 
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J = 7.6 Hz, 2H), 7.41 (d, J = 8.4 Hz, 2H), 3.64-3.54 (m, 1H), 5.45 (dt, J = 10.4, 0.8 Hz, 
1H), 5.29 (td, J = 10.8, 8.0 Hz, 1H), 3.89 (septet, J = 4.4 Hz, 1H), 2.93 (dd, J = 13.6, 4.4 
Hz,  1H), 2.83 (dd, J = 14.0, 8.8 Hz, 1H), 2.63-2.54 (m, 1H), 2.36-2.24 (m, 2H), 0.97 (d, 
J = 3.2 Hz, 3H), 0.95 (d, J = 2.8 Hz, 3H). 13C NMR (100 MHz): 146.8, 146.7, 141.8, 
130.2, 123.5, 121.6, 71.7, 42.8, 35.1, 26.6, 23.0, 22.9. HRMS (CI) Calculated for 
C14H19NO3 [M+H]+: 250.1443, Found: 250.1443. FTIR (neat): 3296, 2953, 2926, 2867, 
1598, 1511, 1339, 1299, 1139, 1067, 886, 722 cm-1. 
 
 
3.13 
(Z)-1-Cyclopentyl-5-methylhex-3-en-1-ol (3.13): Rf = 0.28, 10% Et2O/pentane; 
colorless oil; Z:E ratio, 11:1; spectral data is reported for the major isomer;1H NMR (400 
MHz): 5.40 (t, J = 10.0 Hz, 1H), 5.26 (td, J = 10.0, 7.6 Hz, 1H), 3.40 (sextet, J = 3.6 Hz, 
1H), 2.62 (td, J = 9.6, 6.4 Hz, 1H), 2.27-2.24 (m, 1H), 2.21-2.16 (m, 1H), 1.89 (quintet, J 
= 8.4 Hz, 1H), 1.85-1.77 (m, 1H), 1.72- 1.52 (m, 6H), 1.41-1.36 (m, 1H), 1.27-1.20 (m, 
1H), 0.97 (d, J = 2.8 Hz, 3H), 0.95 (d, J = 2.8 Hz, 3H).13C NMR (100 MHz): 141.0, 
122.9, 75.4, 45.7, 34.2, 29.1, 28.7, 26.5, 25.7, 25.6, 23.1, 23.0. HRMS (CI) Calculated for 
C12H22O [M-H]+: 181.1592, Found: 181.1594. FTIR (neat): 3388, 2956, 2868, 1460, 
1444, 1377, 1071, 744, 722 cm-1. 
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3.14 
 (Z)-1-Chloro-8-methylnon-6-en-4-ol (3.14): Rf = 0.25, 10% Et2O/pentane; colorless 
oil; Z:E ratio, 6:1; spectral data is reported for the major isomer; 1H NMR (400 MHz): 
5.42 (t, J = 10.4 Hz , 1H), 5.26 (td, J = 11.2, 7.2 Hz, 1H), 3.66-3.62 (m, 1H), 3.59 (dt, J = 
6.4, 2.8 Hz, 2H), 2.65-2.56 (m, 1H), 2.26-2.22 (m, 2H), 2.05-1.93 (m, 1H), 1.91-1.80 (m, 
1H), 1.73-1.64 (m, 1H), 1.60-1.51 (m, 1H), 0.97 (d, J = 2.4 Hz, 3H), 0.95 (d, J = 2.4 Hz, 
3H). 13C NMR (100 MHz): 141.5, 122.0, 70.6, 45.1, 35.6, 33.8, 28.9, 26.5, 23.1, 23.0. 
HRMS (CI) Calculated for C10H19ClO [M-H]+: 189.1046, Found: 189.1049. FTIR (neat): 
3390, 2956, 2868, 1460, 1445, 1304, 1163, 1073, 934, 744, 651 cm-1. 
 
 
3.15 
(2E, 8Z)-10-Methylundeca-2,8-dien-6-ol (3.15): Rf = 0.25; colorless oil; Z:E ratio, 8:1; 
spectral data is reported for the major isomer; 1H NMR (400 MHz): 5.46-5.43 (m, 2H), 
5.41-5.36 (m, 2H), 5.28 (t, J = 7.6 Hz, 1H), 3.63-3.59 (m, 1H), 2.65-2.56 (m, 1H), 2.23 
(dq, J = 7.2, 1.2 Hz, 2H), 2.17-2.05 (m, 2H), 1.65 ( d, J = 4.8 Hz, 3H), 1.56-1.49 (m, 2H),  
0.96 (d, J = 2.8 Hz, 3H), 0.93 (d, J = 2.8 Hz, 3H). 13C NMR (100 MHz): 140.9, 130.8, 
125.3, 122.5, 70.9, 36.4, 35.3, 28.9, 26.5, 23.1, 23.0, 17.9. HRMS (CI) Calculated for 
C12H22O [M-H]+:181.1592, Found: 181.1591. FTIR (neat): 3341, 2956, 2931, 2868, 1457, 
1404, 1377, 1052, 965, 742 cm-1. 
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3.16 
(Z)-5-Methyl-1-phenylhex-3-en-1-ol (3.16): Rf = 0.30, 15% EtOAc/hexanes; colorless 
oil; Z:E ratio, 11:1; spectral data is reported for the major isomer;1H NMR (400 MHz): 
7.40-7.32 (m, 3H), 7.30-7.25 (m, 2H), 5.37 (dd, J = 11.2, 9.6 Hz, 1H), 5.26 (dt, J = 10.8, 
7.6 Hz, 1H), 4.69 (ddd, J = 8.0, 6.0, 2.4 Hz, 1H), 2.62-2.44 (m, 3H), 2.02 (d, J = 2.8 Hz, 
1H), 0.94 (d, J = 6.4 Hz, 3H), 0.86 (d, J = 6.4 Hz, 3H)13C NMR (100 MHz): 144.3, 141.5, 
128.6, 127.7, 126.0, 122.3, 74.1, 47.6, 26.8, 23.3, 23.2. HRMS (CI) Calculated for 
C13H17O [M-H]+: 189.1279, Found: 189.1280. FTIR (neat): 3367, 3062, 3004, 2955, 
2867, 1454, 1048, 758, 739, 699 cm-1. 
 
 
3.17 
 (Z)-1-(4-Bromophenyl)-5-Methylhex-3-en-1-ol (3.17): Rf = 0.25; 5% EtOAc/Hexanes; 
thick colorless oil; Z:E ratio, 7:1; spectral data is reported for the major isomer ; 1H NMR 
(400 MHz): 7.44 (d, J = 8.4 Hz, 2H), 7.24 (d, J = 8.4 Hz, 2H),  5.39 (t, J = 10.0 Hz, 1H), 
5.22 (td, J = 10.4, 7.2 Hz, 1H), 4.56 (t, J = 6.6 Hz, 1H), 2.58-2.39 (m, 3H), 2.05 (bs, 1H), 
0.93 (d, J = 6.4 Hz, 3H), 0.87 (d, J = 6.4 Hz, 3H). 13C NMR (100 MHz): 142.9, 141.6, 
131.3, 127.5, 121.5, 121.1, 76.5, 73.1, 37.4, 26.6, 23.0, 22.9. HRMS (CI) Calculated for 
C13H17BrO [M+H]+: 267.0385, Found: 267.0387. FTIR (neat): 3362, 2955, 2867, 1486, 
1296, 1101, 1070, 1009, 822, 780 cm-1. 
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3.18 
(Z)-1-(Benzyloxy)-8,8-dimethylnon-6-en-4-ol (3.18): Rf = 0.30, 10% EtOAc/hexanes; 
colorless oil; Z:E ratio, 7:1; spectral data is reported for the major isomer; 1H NMR (400 
MHz): 7.40-7.26 (m, 5H), 5.48 (dt, J = 12.4, 1.6 Hz, 1H), 5.21 (dt, J = 12.0, 7.6 Hz, 1H), 
4.52 (s, 2H), 3.66-3.58 (m, 1H), 3.51 (t, J = 6.0 Hz, 2H), 2.45-2.29 (m, 2H), 1.81-1.63 (m, 
3H), 1.55-1.45 (m, 1H), 1.11 (s, 9H). 13C NMR (100 MHz): 142.7, 138.4, 128.6, 127.9, 
127.8, 124.4, 73.2, 71.9, 70.7, 36.5, 34.4, 33.4, 31.4, 26.5. HRMS (CI) Calculated for 
C18H28O2 [M+H]+: 277.2168, Found: 277.2165. FTIR (neat): 3410, 3005, 2951, 2862, 
1454, 1361, 1201, 1096, 1027, 734, 699 cm-1. 
 
 
3.19 
(Z)-7-(Benzyloxy)-1-cyclohexylhept-1-en-4-ol (3.19): Rf = 0.25, 20% EtOAc/hexanes, 
colorless oil; Z:E ratio, 20:1; spectral data is reported for the major isomer;1H NMR (400 
MHz): 7.40-7.26 (m, 5H), 5.38 (dd, J = 11.2, 9.6 Hz, 1H), 5.28 (dt, J = 10.8, 7.6 Hz, 1H), 
4.520 (s, 2H), 3.65-3.65 (m, 1H), 3.51 (t, J = 6.0 Hz, 2H), 2.37-2.16 (m, 3H), 1.81-1.45 
(m, 9H), 1.34-0.98 (m, 6H). 13C NMR (100 MHz): 139.5, 138.4, 128.6, 127.9, 127.8, 
123.5, 73.2, 71.4, 70.7, 36.5, 35.8, 34.1, 33.5, 33.4, 26.5, 26.2, 26.1, 26.0. HRMS (CI) 
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Calculated for C20H31O2 [M+H]+: 303.2324, Found: 303.2325. FTIR (neat): 3413, 3002, 
2921, 2848, 1934, 1447, 1361, 1096, 735, 696 cm-1. 
 
 
3.20 
(Z)-7-(Benzoloxy)-cyclopentylhept-1-4-ol (3.20): Rf = 0.27, 10% EtOAc/hexanes; 
colorless oil Z:E ratio, 10:1; spectral data is reported for the major isomer;1H NMR (400 
MHz): 7.34-7.33 (m, 5H), 5.47 (t, J = 10.0 Hz, 1H), 5.32 (td, J = 11.2, 7.6 Hz, 1H), 4.51 
(s, 2H), 3.64-3.57 (m, 1H), 3.51 (t, J = 6.0 Hz, 2H), 2.70 (sextet, J = 8.4 Hz, 1H), 2.34-
2.18 (m, 1H), 1.79-1.47 (m, 14H). 13C NMR (100 MHz): 138.8, 138.2, 128.3, 127.6, 
127.5, 123.6, 72.9, 71.1, 70.4, 38.2, 35.5, 33.8, 33.7, 33.6, 26.2, 25.3, 25.2. 
 
 
3.21 
(Z)-1-(4-Bromophenyl)-5,5-dimethylhex-3-1-ol (3.21): Rf = 0.30, 15% EtOAc/hexanes; 
colorless oil; Z:E ratio, 7:1; spectral data is reported for the major isomer;1H NMR (400 
MHz): 7.49-7.44 (m, 2H), 7.26-7.21 (m, 2H), 5.51 (dt, J = 12.4, 1.6 Hz, 1H), 5.16 (ddd, J 
= 12.0, 7.6, 6.8 Hz, 1H), 4.66 (ddd, J = 8.4, 5.2, 3.2 Hz, 1H), 2.69 (dtd, J = 14.8, 8.0, 1.6 
Hz, 1H), 2.54 (dddd, J = 14.8, 6.8, 5.2, 2.0 Hz, 1H), 2.03(d, J = 3.2 Hz, 1H), 1.08 (s, 9H). 
13C NMR (100 MHz): 146.8, 143.6, 143.0, 131.3, 127.5, 122.9, 121.2, 73.6, 42.8, 38.1, 
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33.1. HRMS (CI) Calculated for C14H19BrO [M+H]+: 283.0619, Found: xx. FTIR (neat): 
3373, 3006, 2956, 2902, 2866, 1487, 1402, 1071, 1010, 826 cm-1. 
 
 
3.22 
(Z)-1-(4-Bromophenyl)-4-cyclohexylbut-3-en-1-ol (3.22) : Rf = 0.30, 15% 
EtOAc/hexanes; colorless oil; Z:E ratio, 7:1; spectral data is reported for the major 
isomer;1H NMR (400 MHz): 7.50-7.44 (m, 2H), 7.26-7.22 (m, 2H), 5.40 (dd, J = 11.2, 
9.6 Hz, 1H), 5.22 (dt, J = 10.8, 7.6 Hz, 1H), 4.68-4.63 (m, 1H), 2.57-2.40 (m, 2H), 2.23-
2.14 (m, 1H), 2.04 (d, J = 3.2 Hz, 1H), 1.74-1.52 (m, 4H), 1.46-1.39 (m, 1H), 1.32-0.98 
(m, 5H). 13C NMR (100 MHz): 142.9, 140.3, 131.3, 127.6, 121.9, 121.1, 73.1, 37.5, 36.4, 
33.1, 33.0, 26.0, 25.9, 25.8. HRMS (CI) Calculated for C16H20OBr [M-H]+: 307.0698, 
Found: 307.0704. FTIR (neat): 3361, 3004, 2921, 2848, 1486, 1447, 1070, 1009, 824, 
737 cm-1. HRMS (CI) Calculated for C20H32O2 [M-H]+: 303.2324, Found: 303.2325. 
FTIR (neat): 3414, 2946, 2859, 1452, 1361, 1094, 1027, 733, 696 cm-1. 
 
 
3.23 
(Z)-1-(4-Bromophenyl)-4-cyclopentylbut-3-en-1-ol (3.23). Rf = 0.30, 5% 
EtOAc/hexanes; colorless oil; Z:E ratio, 7:1; spectral data is reported for the major 
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isomer; 1H NMR (400 MHz): 7.46 (d, J = 8.4 Hz, 2H), 7.24 (d, J = 8.4 Hz, 2H), 5.50 (dd, 
J = 9.6, 1.2 Hz, 1H), 5.26 (dt, J = 10.4, 7.2 Hz, 1H), 4.65 (t, J = 6.8 Hz, 1H), 2.64 (q, J = 
7.6 Hz, 1H), 2.56-2.50 (m, 1H), 2.48-2.41 (m, 1H), 2.13 (bs, 1H), 1.77-1.50 (m, 8H). 13C 
NMR (100 MHz): 142.9, 139.6, 131.3, 127.5, 122.5, 121.1, 73.0, 38.2, 37.5, 33.6, 33.5, 
25.3, 25.0. HRMS (CI) Calculated for C16H23OBr [M-H]+: 309.0477, Found: 309.0483. 
FTIR (neat): 3382, 2950, 2864, 1951, 1485, 1449, 1120, 1009, 822, 722, 693 cm-1. 
 
 
deuterio-3.17 
(Z)-1-(4-Bromophenyl)-5-Methylhex-3-en-1-ol (deuterio-3.17): Rf = 0.25; 5% 
EtOAc/Hexanes; thick colorless oil; Z:E ratio, 10:1; spectral data is reported for the major 
isomer ; 1H NMR (400 MHz): 7.43 (d, J = 8.8 Hz, 2H), 7.22 (d, J = 8.8 Hz, 2H),  5.38 (t, 
J = 10.0 Hz, 0.43H), 5.23-5.21 (m, 0.63H), 4.65 (m, 0.77H), 2.57-2.39 (m, 2H), 2.17 (bs, 
1H), 0.93 (d, J = 6.8 Hz, 3H), 0.87 (d, J = 6.4 Hz, 3H). 13C NMR (100 MHz): 143.0, 
141.7, 132.0, 128.5, 121.2, 121.1, 73.1, 37.4, 29.7, 23.0, 22.9. HRMS (CI) Calculated for 
C13H14D2BrO [M+H]+: 269.0506, Found: 269.0510. FTIR (neat): 3359, 2956, 2924, 2866, 
1486, 1463, 1397, 1070, 1009, 820, 722 cm-1. 
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deuterio-3.25 
(E)-1-(4-Bromophenyl)-2-Methylbut-2-en-1-ol (deuterio-3.25): Rf = 0.20; 5% 
EtOAc/Hexanes; colorless oil; 1H NMR (400 MHz): 7.44 (d, J = 8.4 Hz, 2H), 7.23 (d, J = 
8.4 Hz, 2H),  5.68 (q, J = 3.2 Hz, 0.86H), 5.09 (s, 1H), 1.95 (bs, 1H), 1.66 (d, J = 3.2 Hz,  
2.2H), 1.42 (s, 3H). 13C NMR (100 MHz): 141.3, 137.1, 131.1, 127.8, 122.0, 120.9, 13.1, 
11.3. HRMS (CI) Calculated for C11H13DBrO [M+H]+: 242.0294, Found: 242.0291. 
FTIR (neat): 3364, 2919, 2854, 1484, 1439, 1394, 1070, 1006, 821 cm-1. 
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Direct Copper-Free Tandem Conjugate Addition-Cycloallylation using Diorganozinc Reagents: 
Allylation of Zinc Enolates 
4.1. INTRODUCTION 
 
For many years “tandem”, “domino” or “cascade” reactions have gained an enormous 
amount of attention from synthetic chemists due to their ability to build complex networks in a 
single operation.1,2 As part of our program of using enones as latent enolates, we have developed 
a variety of carbon-carbon bond forming processes via a tandem conjugate addition-electrophilic 
trapping reactions3 using transition metal as well as organocatalysis. By varying the nucleophilic 
initiator and electrophilic partner a variety of novel carbon-carbon bond forming methods have 
been developed.4-7 For example, silane mediated Co-catalyzed reductive aldol and Michael 
cyclizations,4 hydrogen mediated Rh-catalyzed reductive aldol cyclizations,5 and diastereo and 
enantioselective tandem conjugate addition-aldol cyclization using arylboronic acids have been 
studied.6 We have also developed a diastereo and enantioselective tandem conjugate addition of 
diorganozinc reagents followed by aldol, Dieckmann, Blaise and Michael type cyclizations under 
Cu catalysis.7  In addition to the above mentioned transformations, there are several transition 
metal catalyzed tandem conjugate addition-electrophilic trapping processes reported in the 
literature.8,12-16  
Asymmetric allylation of carbonyls, especially ketones is an important transformation in 
organic synthesis. Both direct9 and indirect10 methods of ketone allylation have been reported in 
the literature. As an extension to our previously reported processes,7 we wanted to examine a 
tandem conjugate addition-cycloallylation of zinc enolates using allylic carbonates as the 
electrophilic partner. It is known that under Cu- catalysis conditions11 Zn-enolates generated 
upon conjugate addition to enones could be trapped by reactive electrophiles like aldehydes12, 
tethered halides and tosylates,13oxacarbenium ions (via decomposition of acetals)14 and allylic 
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carboxylates (using Pd catalysis).12a, 15 , 16  The above mentioned processes involve the 
preformation of Zn-enolates stoichiometrically before electrophilic trapping. However, we have 
established that enolate preformation is necessarily not a precondition for anionic cascades by 
successful attempts of aldol, Dieckmann and Blaize cyclization under Cu-catalysis. Uncatalyzed 
conjugate addition of organozincs to enones is also known.17 In fact we have shown for the first 
time that Zn-enolates resulting upon conjugate addition of diorganozincs to enones could be 
trapped with even less reactive electrophiles like allylic carbonates in the absence of any Cu or 
Pd catalyst giving products of intramolecular ketone allylation.18 During this process it was also 
discovered that allylic carbonates engage in direct substitution with diorganozinc reagents under 
copper-free conditions.19 
4.2 OPTIMIZATION 
 
For our initial trials we started with mono-enone mono-allylic carbonate 4.1a as our test 
substrate and Et2Zn (diethylzinc) as the alkyl transfer reagent. Under the standard Cu-catalysis 
conditions (2.5 mol% of  Cu(OTf)2, 5 mol% of  P(OEt)3  at -78 oC in dichloromethane (0.1 M) 
using 300 mol% of Et2Zn no desired product was observed. Instead, a conjugate addition product 
was noticed without any cyclization. However, by warming the reaction mixture to room 
temperature, the desired cyclization product 4.1b was observed in 71% yield with 5.2:1 
diastereoselectivity (Table 4.1, entry 1). In order to examine if there was any background 
reaction we subjected the enone 4.1a to Et2Zn (300 mol%) in dichloromethane at room 
temperature and were able to isolate the cyclization product 4.1b in 14% yield (3.4:1 dr) (Table 
4.1, entry 2), which suggested that Cu catalyst is not necessary to effect this transformation. With 
this result in hand we set out to screen some additives to improve this transformation and found 
that ZnI2 indeed helped to improve the reaction. 
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Table 0.1. Conjugate addition-cycloallylation of 4.1a using Et2Zn.a 
Et2Zn (300 mol%)
Catalyst or Additive
DCM, T oC
O
Ph
O
Ph
CH3 4.1b
OCO2CH3
4.1a
Entry Catalyst/Additive T oC [DCM] Yield 1b (1a)
1
2
3
4
5
6
7
8
9
10
Cu(OTf)2, P(OEt)3
---
ZnI2 (25 mol%)
ZnI2 (100 mol%)
ZnI2 (100 mol%)
Bu4NI (100 mol%)
Zn(OTf)2 (100 mol%)
---
ZnI2 (100 mol%)
ZnI2 (100 mol%)
-78 to 25
25
25
25
25
25
25
35
35
50
0.1 M
0.1 M
0.1 M
0.1 M
0.2 M
0.1 M
0.1 M
0.1 M
0.1 M
0.1 M
71%
14%
41%
54%
50%
5%
41% (28%)
58%
72%
59%
dr
5.2:1
3.4:1
3.4:1
3.5:1
4.0:1
1.6:1
2.4:1
5.2:1
5.2:1
3.9:1
 
aSee experimental section for detailed experimental procedures. 
 
The yield of 4.1b increased from 14% to 54% when the reaction was conducted using one 
equivalent of ZnI2 (Table 4.1, entry 4).20 Iodide sources like tetrabutylammonium iodide (TBAI) 
suppressed the reaction (Table 4.1, entry 6). Other Lewis acidic zinc salts like Zn(OTf)2 
improved the yields of the reaction (Table 4.1, entry 6) but ZnI2 turned out to be superior. Lewis 
basic solvents like THF were detrimental to the reaction. Also reaction at higher concentration 
turned out to be low yielding (Table 4.1, entry 5). However, slight increase in temperature from 
25 oC to 35 oC improved the chemical yield from 50% to 72% (5.2:1 dr) (Table 1, entry 9). A 
control experiment was performed and the isolated yield of 4.1b was 58% and 72% for reactions 
conducted in the absence and presence of ZnI2, respectively, at 35 oC (Table 4.1, entries 8 and 9). 
The latter reaction conditions represented our standard protocol for conjugate addition-
cycloallylation (Table 4.1, entry 9). 
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4.3. SUBSTRATE SCOPE 
 
Using our standard reaction conditions (Table 4.1, entry 9), allylic carbonate tethered 
enones 4.1a-4.6a were cyclized to the corresponding cycloallylation products (4.1b-4.6c except 
4.6b) with good to moderate yields (52-97%) and poor to moderate selectivities (1.3:1 to 5.3:1 
dr) employing Et2Zn and i-Pr2Zn (Table 4.2, entry 9).  
Table 0.2. Tandem conjugate addition-cycloallylation with enones 4.1a-4.6a. 
 
The substrate scope turned out to be good with respect to enones containing aromatic 
(Table 4.2, 4.1b-4.1e), heteroaromatic (Table 4.2, 4.2b-4.3c) and aliphatic (Table 4.2, 4.4b-4.6c) 
substituents. Both five and six membered ring substrates were efficiently cyclized under standard 
reaction conditions (Table 4.2, 4.1b-4.1e). The reactions with Me2Zn were messy. During this 
generalization process an anomalous behavior for enone 4.6a was observed (Table 4.2, see 4.6b 
and 4.6c) under the standard reaction conditions employing diethyl and diisopropylzinc reagents 
in independent experiments. The reaction with i-Pr2Zn generated the usual cyclization product in 
153 
77% yield (2.6:1 dr) where as for that with Et2Zn no cyclization product was observed. To our 
surprise an allylic substitution product was observed via an SN2 type displacement of the 
carbonate group by Et2Zn. This was a very interesting result given the fact that a direct 
substitution of allylic carbonates or acetates by diorganozinc reagents in the absence of any 
transition metal catalyst to our knowledge is unknown. This result led us to explore a direct 
allylic substitution reaction using organozinc reagents.  
 
4.4 STEREOCHEMISTRY 
  The relative stereochemistry of the cyclization products was determined from 1H NMR 
and it turned out that for the five membered ring systems, a trans-cis isomer 4.2f was the major 
product and for six membered ring systems a trans-trans was favored (Scheme 4.1, top figure). 
The relative stereochemistry of the products was determined as follows.  
Hydrogenation of the cycloallylation product 4.2b under catalytic hydrogenation 
conditions using Pd/C (10 mol%) under atmospheric hydrogen in ethanol (0.2 M) at room 
temperature produced 4.2f and 4.2g in 92% yield (5.2:1 d.r) and it appeared that the major 
isomer 4.2f was the non-symmetric isomer and the minor isomer was symmetric (from 1H NMR). 
The stereochemical assignment of the six-membered ring products was based on examination of 
the coupling constants in the 1H NMR (Scheme 4.1, top figure). For example, in the 1H NMR 
spectrum of compound 4.2b, proton Ha appears as a triplet at  3.05 ppm with a coupling 
constant Ja,b = Ja,c = 10.8 Hz, suggesting a trans-diaxial relationship between the methine 
hydrogens Ha, Hb, and Hc (Scheme 4.1, top figure). The divergent stereochemical outcomes for 
five and six-membered ring systems can be explained by invoking the addition of the Z-enolate 
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to the tethered allylic carbonate, which resides in an extended conformation (Scheme 4.1, bottom 
figure). 
 
Scheme 0.1. Stereochemical assignment (top figure) and transition state models (bottom figure) 
for the five and six membered ring systems. 
 
4.5 DIRECT ALLYLIC SUBSTITUTION REACTIONS 
 
Transition metal catalyzed allylic substitution reaction is one of the most well-known and 
widely utilized reactions in organic synthesis.21 In literature there are several reports of transition 
metal catalyzed allylic substitution reactions employing dioranozinc reagents as alkyl donors.22 
Direct substitution of allylic halides and phosphanates with diorganozinc reagents in the presence 
of coordinating solvents like DMF and TMEDA is known.19 However, a direct allylic 
substitution of allylic carbonates with dioranozinc reagents without any transition metal catalyst 
in noncoordinating medium is unknown.  The divergent product outcome with enone substrate 
4.6a using Et2Zn and i-Pr2Zn reagents opened a new avenue for the development of a direct 
allylic substitution reaction. When allylic carbonate substrate 4.7a was subjected to the standard 
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reaction conditions using Et2Zn, a 1.7:1 mixture of branched and linear products (4.7b and 4.7c) 
was observed in 48% yield respectively. 
 
OCO2CH3
As AbovePh
CH3
OCO2CH3
Et2Zn (300 mol%)
DCM (0.1 M), 35 oC
Ph Ph 72% Yield
(1.7:1)
Ph
CH3
H3C
OCO2CH3
As AbovePh
Ph
Ph
As AbovePh Ph Ph
CH3
H3C
Ph Ph
CH3
H3C
46% Yield
(1:1.6)
CH3
52% Yield
(1:1.6)
CH3
CH3O2CO CH3
84% Yield
H3C
Ph
4.7 a
4.8a
iso-4.8a
4.9a
4.7b
4.8b
4.8b
4.9b
4.7c
4.8c
4.8c
Ph Ph 61% Yield
(1.7:1)
Ph
CH3
H3C
Iso-4.7a 4.7b 4.7c
As Above
CH3O2CO
CH3
CH3
 
Scheme 0.2. Direct substitution reactions of allylic carbonates 4.7a, iso-4.7a, 4.8a, iso-4.8a, and 
4.9a with diethylzinc. 
 
The yield of the reaction was better without ZnI2 (72%, 1.7:1 branched vs linear). The 
very similar reaction with an allylic acetate substrate gave diminished yields.23 Further reaction 
of allylic carbonate iso-4.7a with Et2Zn in the absence of ZnI2 produced an identical ratio (1.7:1) 
of branched and linear products (4.3b and 4.3c) in 61% yield (Scheme 4.2). A very similar 
behavior was observed with other allylic carbonate substrates 4.8a and iso-4.8a. These results 
suggest that both the isomeric allylic carbonate substrates might be reacting through a common 
intermediate such as a zinc -allyl 24  or equimolar distribution of both the -haptomers. 
However, in the case of allylic carbonate 4.9a both the allylic termini are identical hence there is 
no regioselectivity issue and this substrate is synthetically more useful.  
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4. 6 CONCLUSION 
 
In summary, we have shown that Zn-enolates resulting from conjugate addition of 
diorganozincs to enones could be trapped not only with reactive electrophiles like aldehydes, 
tosylates, halides and palladium -allyls but also with less reactive electrophiles like allylic 
carbonate tethered to enones. Hence, a novel tandem conjugate addition-cycloallylation method 
was disclosed leading to the products of ketone allylation in an intramolecular sense. Also, 
during these studies a direct copper-free allylic substitution reaction with allylic carbonate 
substrates using diorganozinc reagents was investigated. The identical reaction outcome with the 
isomeric allylic carbonates for example, with 4.3a and iso-4.3a using Et2Zn was mechanistically 
intriguing and suggested the presence of a common reactive intermediate for the substrates 
studied.              
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4.7 EXPERIMENTAL SECTION 
 
4.7.1 General: Commercial reagents were used without further purification unless 
otherwise stated. Anhydrous Zinc iodide (99.99+%) was purchased from Aldrich and used 
directly without any further purification. All reactions were conducted in oven-dried containers 
under inert atmosphere or argon.  Dichloromethane was distilled over calcium hydride prior to 
use. Analytical thin-layer chromatography (TLC) was carried out 
using 0.2-mm commercial silica gel plates (DC-Fertigplatten Krieselgel 60 
F254). Preparative column chromatography employing silica gel was performed 
according to the method of Still. 25  Solvents for chromatography 
were listed as volume/volume ratios. Melting points were determined on a 
Thomas-Hoover melting point apparatus in open capillary and are uncorrected. 
Infrared spectra were recorded on a Perkin-Elmer 1420 spectrometer.  High 
resolution mass spectra (HRMS, EI) were obtained on a Karatos MS9 and are 
reported as m/e (relative intensity). Accurate masses were reported for the 
molecular ion (M) or a suitable fragment ion. Proton nuclear magnetic 
resonance (1H NMR) spectra were recorded with a Mercury (400 MHz) spectrometer. Chemical 
Shifts were reported in delta (δ) units, parts per million (ppm) downfield from tetramethylsilane. 
Coupling constants were reported in Hertz (Hz). Carbon nuclear magnetic resonance (13C NMR) 
spectra were recorded using a Mercury 400 (100 MHz) spectrometer. Chemical shifts were 
reported in delta (δ) units, parts per million (ppm) relative to the center of the triplet at 77.00 
ppm for deuteriochloroform. 13C NMR spectra were routinely run with broadbrand decoupling. 
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4.7.2 Preparation of 4.3a: To a solution of carbonic acid 8-(1H-indol-3-yl)-8-oxo-octa-2,6-
dienyl ester methyl ester16b (240 mg, 0.76 mmol, 100 mol%) at 0 oC in dichloromethane (4.0 mL) 
were added tosyl chloride (220 mg, 1.15 mmol, 150 mol%), triethylamine (0.16 mL, 1.15 mmol, 
150 mol%) and a catalytic amount of DMAP (9.3 mg, 0.07 mmol, 10 mol%). The reaction 
mixture was stirred at ambient temperature for 2 h and quenched with aqueous ammonium 
chloride solution and extracted with dichloromethane (2 x 20 mL). The organic layer was 
washed with brine solution (20 mL), dried (Na2SO4), filtered and the resulting liquor was 
concentrated in vacuo. Purification of the oily residue by flash column chromatography (SiO2: 
20% EtOA/hexanes, Rf = 0.25) provides the title compound as an yellow solid (330 mg, 0.70 
mmol) in 92% yield as a mixture of E:Z (8:1) isomers. Spectral data is reported for the major 
isomer. 
O
OCO2CH3
NTs
 
4.3a 
 
Carbonic acid methyl ester-8-oxo-8[1-(toluene-4-sulfonyl)-1H-indol-3-yl]-octa-2,6-dienyl 
ester (4.3a): Mixture of E:Z (8:1) isomers. Spectral data is reported for the major isomer. Rf = 
0.25, 20% EtOAc/hexanes; yellow solid; 1H NMR (400 MHz, CDCl3): δ 8.35 (d, J = 7.2 Hz, 1H), 
8.23 (s, 1H), 7.91 (d, J = 8.0 Hz, 1H) 7.82 (d, J = 8.0 Hz, 2H), 7.37-7.30 (m, 2H), 7.25 (d, J = 7.2 
Hz, 2H), 7.07-7.00 (m, 1H), 6.76 (d, J = 15.5 Hz, 1H) 5.88-5.81 (m, 1H), 5.70-5.63 (m, 1H), 
4.58 (d, J = 6.0 Hz, 2H), 3.78 (s, 3H), 2.45-2.39 (m, 2H), 2.34 (s, 3H), 2.34-2.32 (m, 2H). 13C 
NMR (100 MHz, CDCl3): δ 185.1, 155.5, 146.4, 145.8, 135.0, 134.8, 134.4, 131.6, 130.2, 130.1, 
128.0, 127.1, 125.7, 124.7, 124.5, 123.2, 112.6, 112.9, 68.1,  56.5, 31.7, 30.7, 21.5.  HRMS 
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Calcd. for C25H25NO6S (M): 467.1403, Found: 467.1407. FTIR (NaCl Film): 3128, 2955, 1746, 
1664, 1615, 1536, 1478, 1445, 1328, 1268, 1175, 1139, 1088, 975, 751 cm-1.  
 
4.7.3 General procedure for tandem conjugate addition – cycloallylation reaction with 
diorganozinc reagents, preparation of 4.1b:  
 
To a suspension of the substrate 4.1a16b (50 mg, 0.18 mmol, 100 mol%) and zinc iodide 
(58 mg, 0.18 mmol, 100 mol%) in dichloromethane at 0 oC in a 15 mL sealed tube under argon 
atmosphere was added a 1.0 M diethylzinc solution in hexanes (0.54 mL, 0.54 mmol, 300 mol%) 
over a period of 5 min. Once the addition was complete, the reaction vessel was flushed with 
argon, sealed tightly and the reaction mixture was stirred at 35 oC for 10.5 h. The reaction 
mixture was cooled to room temperature, quenched with four drops of water and stirred for 30-
40 min. The reaction mixture was filtered through a pad of celite and the resulting liquor was 
concentrated in vacuo. Purification of the oily residue by flash column chromatography (SiO2: 
3% diethyl ether:hexanes, Rf = 0.30) provides the title compound as a colorless oil (30 mg, 0.13 
mmol) in 72% yield as a 5.2:1 mixture of diastereomers. 
 
 
4.1b 
(2-Ethyl-5-vinyl-cyclopentyl)-phenyl-methanone (4.1b): Rf = 0.30, 3% Et2O/hexanes, 
colorless oil; 5.2.1 mixture of diastereomers. Spectral data is reported for the major isomer  1H 
NMR (400 MHz, CDCl3): δ 7.88 (dd, J = 6.4, 1.2 Hz, 2H), 7.50 (dd, J = 7.2, 1.2 Hz, 1H), 7.44-
7.39 (m, 2H), 5.54 (ddd, J = 15.6, 8.4, 7.6 Hz, 1H), 4.71 (ddd, J = 15.6, 1.6, 0.8 Hz, 1H), 4.67 
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(ddd, J = 8.8, 1.6, 0.8 Hz, 1H), 3.52 (t, J = 6.8 Hz, 1H), 3.04-2.78 (m, 1H), 2.45 (dt, J = 15.6, 8.0 
Hz, 1H), 2.09-2.02 (m, 1H), 1.98-1.92 (m, 1H), 1.69-1.62 (m, 1H), 1.48-1.40 (m, 1H), 1.31-1.22 
(m, 2H), 0.84 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 201.8, 139.1, 138.2, 132.5, 
128.4, 128.2, 114.5, 56.8, 48.3, 43.3, 32.7, 31.1, 28.4, 12.8. HRMS Calcd. for C16H20O (M): 
228.1514, Found: 228.1511; FTIR (NaCl Film): 2955, 2928, 2867, 1677, 1594, 1450, 1372, 1268, 
1215, 1180, 914, 690 cm-1. 
 
 
4.1c 
(2-Isopropyl-5-vinyl-cyclopentyl)-phenyl-methanone (4.1c): Rf = 0.30, 2% Et2O/hexanes;  
colorless oil; 3.8:1 mixture of diastereomers. Spectral data is reported for the major isomer. 1H 
NMR (400 MHz, CDCl3): δ 7.85 (dd, J = 6.6, 1.2 Hz, 2H), 7.50 (dd, J = 9.6, 1.2 Hz, 1H), 7.45-
7.38 (m, 2H), 5.52 (ddd, J = 16.8, 10.0, 9.8 Hz, 1H), 4.78 (ddd, J = 16.4, 1.6, 0.8 Hz, 1H), 4.69 
(ddd, J = 10.0, 1.6, 0.4 Hz, 1H), 3.69 (dd, J = 9.6, 8.4 Hz, 1H), 2.94 (dt, J = 15.6, 9.2 Hz 1H), 
2.48 (dt, J = 15.6, 8.0 Hz, 1H). 2.23-1.92 (m, 1H), 1.91-1.83 (m, 1H), 1.78-1.61 (m, 1H), 1.54-
1.45 (m, 1H), 1.41-1.31 (m, 1H), 0.85 (d, J = 7.2 Hz, 3H), 0.74 (d, J = 6.8 Hz, 3H). 13C NMR 
(100 MHz, CDCl3): δ 202.4, 138.9, 138.2, 132.5, 128.4, 128.2, 114.8, 54.1, 49.2, 49.1, 33.3, 32.9, 
29.7, 21.8, 20.4. HRMS Calcd. for C17H22O (M): 242.1671, Found: 242.1662.  FTIR (NaCl 
Film): 2968, 2930, 2876, 1679, 1591, 1452, 1378, 1264, 1215, 1000, 914, 690 cm-1. 
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4.1d 
(2-Ethyl-6-vinyl-cyclohexyl)-phenyl-methanone (4.1d):Rf = 0.24, 2% Et2O/hexanes; colorless 
oil; 2.5:1 ratio mixture of diastereomers. Spectral data is reported for the major isomer. 1H NMR 
(400 MHz, CDCl3): δ 7.94-7.85 (m, 2H), 7.52 (t, J = 6.4 Hz, 1H), 7.46-7.41 (m, 2H), 5.54-5.44 
(m, 1H), 4.87 (d, J = 17.2 Hz, 1H), 4.69 (d, J = 10.4 Hz, 1H), 3.05 (t, J = 10.8 Hz, 1H), 2.85 (d, J 
= 6.8 Hz, 1H), 2.45-2.37 (m, 1H). 1.97-1.20 (m, 6H), 0.89-0.84 (m, 2H), 0.76 (t, J = 7.2 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 206.0, 141.0, 132.6, 128.4, 128.1, 127.9, 114.6, 55.0, 46.4, 42.3, 
32.2, 30.2, 27.6, 25.0, 11.2. HRMS Calcd. for C17H22O (M): 242.1671, Found: 242.1670; FTIR 
(NaCl Film): 2952, 2930, 2860, 1677, 1450, 1362, 1258, 1205, 1172, 1001, 915, 696, 660 cm-1. 
 
 
4.1e 
(2-Isopropyl-6-vinyl-cyclohexyl)-phenyl-methanone (4.1e): Rf = 0.26, 2% Et2O/hexanes; 
colorless oil; 1.4:1 mixture of diastereomers. Spectral data is reported for the major isomer. 1H 
NMR (400 MHz, CDCl3): δ 7.96-7.89 (m, 2H), 7.53 (t, J = 6.4 Hz, 1H), 7.47-7.42 (m, 2H), 5.53 
(ddd, J = 17.4, 10.4, 8.4 Hz, 1H), 4.88 (ddd, J = 17.2, 2.8, 2.0 Hz, 1H), 4.69 (dd, J = 10.0, 1.6 Hz, 
1H), 3.23 (t, J = 10.4 Hz, 1H), 2.47-2.39 (m, 1H), 1.89-1.71 (m, 4H), 1.43-1.17 (m, 4H), 0.83 (d, 
J = 6.8 Hz, 3H), 0.68 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3, reported for both the 
isomers): δ 202.0, 201.7, 141.1, 139.3, 132.7, 132.6, 128.6, 128.5, 128.1, 128.0, 127.9, 115.3, 
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114.6, 109.7, 51.2, 47.0, 46.5, 41.5, 38.4, 32.3, 32.2, 29.0, 27.7, 25.1, 23.9, 23.6, 22.2, 21.5, 21.3, 
20.6, 16.3, 16.1. HRMS Calcd. for C18H24O (M): 256.1827, Found: 256.1830. FTIR (NaCl Film): 
2957, 2929, 2864, 1677, 1449, 1367, 1337, 1258, 1205, 1178, 1000, 916, 695, 660 cm-1. 
 
 
4.2b 
(2-Ethyl-5-vinyl-cyclopentyl)-furan-2-yl-methanone (4.2b): Rf = 0.30, 5% EtOAc/hexanes; 
yellow oil; 3.1:1 mixture of diastereomers. Spectral data is reported for the major isomer. 1H 
NMR (400 MHz, CDCl3): δ 7.51 (dd, J = 2.0, 0.8 Hz, 1H), 7.10 (dd, J = 3.6, 0.8 Hz, 1H), 6.46 
(dd, J = 3.6, 2.0 Hz, 1H), 5.58 (ddd, J = 17.2, 10.4, 9.6 Hz, 1H), 4.80 (ddd, J = 16.8, 2.0, 0.8 Hz, 
1H), 4.73 (dd, J = 10.4, 2.0 Hz, 1H), 3.34 (t, J = 8.8 Hz, 1H), 2.99 (quintet, J = 8.4 Hz, 1H), 2.44 
(sextet, J = 8.4 Hz, 1H). 2.06-1.98 (m, 1H), 1.93-1.85 (m, 1H), 1.68-1.59 (m, 1H), 1.45-1.37 (m, 
1H), 1.30-1.22 (m, 2H), 0.83 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 191.0, 153.7, 
146.0, 138.9, 116.7, 114.6, 112.0, 56.9, 48.2, 42.9, 32.6, 31.3, 28.5, 12.7. HRMS Calcd. for 
C14H18O2 (M): 218.1307, Found: 218.1302. FTIR (NaCl Film): 2957, 2929, 2864, 1677, 1449, 
1367, 1337, 1258, 1205, 1178, 1000, 695, 660 cm-1. 
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4.2c 
(2-Isopropyl-5-vinyl-cyclopentyl)-furan-2-yl-methanone (4.2c): Rf = 0.30; 5% 
EtOAc/hexanes; yellow oil; 2.6:1 mixture of diastereomers. Spectral data is reported for the 
major isomer. 1H NMR (400 MHz, CDCl3): δ 7.56 (dd, J = 2.0, 0.4 Hz, 1H), 7.13 (dd, J = 3.6, 
0.4 Hz, 1H), 6.50 (dd = 3.6, 0.8 Hz, 1H), 5.58 (ddd, J = 17.2, 10.4, 8.8 Hz, 1H), 4.83 (ddd, J = 
17.2, 9.2, 1.2 Hz, 1H), 4.76 (dd, J = 9.2, 1.2 Hz, 1H), 3.53 (dd, J = 9.6, 7.6 Hz, 1H), 2.94 (ddd, J 
= 16.4, 9.6, 6.8 Hz, 1H), 2.44 (ddd, J = 16.0, 9.6, 7.6 Hz, 1H). 2.0-1.95 (m, 1H), 1.88-1.81 (m, 
1H), 1.72-1.63 (m, 1H), 1.56-1.48 (m, 1H), 1.39-1.33 (m, 1H), 0.88 (d, J = 7.4 Hz, 3H), 0.80 (d, 
J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 191.5, 153.6, 146.1, 138.6, 116.8, 114.8, 112.1, 
54.3, 49.1, 48.6, 33.1, 32.9, 29.9, 21.6, 20.4. HRMS Calcd. for C15H20O2 (M): 232.1463, Found: 
232.1457. FTIR (NaCl Film): 2957, 2929, 2864, 1677, 1449, 1367, 1337, 1258, 1205, 1178, 
1000, 695, 660 cm-1. 
 
 
4.3b 
(2-Ethyl-5-vinyl-cyclopentyl)-[1-(toluene-4-sulfonyl)-1-H-indol-3-yl]-methanone (4.3b): Rf = 
0.23, 5% EtOAc/hexanes; yellow oil; 2.6:1 mixture of diastereomers. Spectral data is reported 
for the major isomer. 1H NMR (400 MHz, CDCl3): δ 8.34 (dd, J = 7.2, 2.4 Hz, 1H), 8.16 (s, 1H), 
7.90 (dd, J = 6.4, 1.2 Hz, 1H), 7.80 (d, J = 8.4 Hz, 2H) 7.37-7.31 (m, 2H), 7.26 (d, J = 8.4 Hz, 
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2H), 5.56 (td, J = 17.8, 9.2 Hz, 1H), 4.81 (ddd, J = 17.8, 2.0, 0.8 Hz, 1H), 4.66 (dd, J = 10.4, 2.0 
Hz, 1H), 3.33 (dd, J = 9.2, 8.0 Hz, 1H), 3.05-2.96 (m, 1H), 2.59-2.49 (m, 1H), 2.36 (s, 3H), 2.13-
2.06 (m, 1H), 1.99-1.91 (m, 1H), 1.75-1.65 (m, 1H), 1.52-1.43 (m, 1H), 1.38-1.19 (m, 2H), 0.88 
(t, J = 7.6 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 197.8, 145.8, 139.2, 134.8, 134.5, 132.0, 
130.1, 127.8, 127.0, 125.6, 124.7, 123.2, 122.7, 114.7, 112.9, 58.6, 49.0, 43.4, 32.9, 31.5, 28.6, 
21.5, 12.8. HRMS Calcd. for C25H27NO3S (M): 421.1712, Found: 421.1708; FTIR (NaCl Film): 
3500, 2955, 2869, 1660, 1536, 1445, 1380, 1172, 1138, 1089, 992, 913, 736, 660, 576 cm-1. 
 
 
4.3c 
(2-Isopropyl-5-vinyl-cyclopentyl)-[1-(toluene-4-sulfonyl)-1-H-indol-3-yl]-methanone 
(4.3c): Rf = 0.26, 5% EtOAc/hexanes; yellow oil; 2.9:1 mixture of diastereomers. Spectral data 
is reported for the major isomer. 1H NMR (400 MHz, CDCl3): δ 8.34 (dd, J = 7.2, 2.4 Hz, 1H), 
8.17 (s, 1H), 7.90 (dd, J = 6.5, 1.2 Hz, 1H), 7.80 (d, J = 8.4 Hz, 2H) 7.34 (m, 2H), 7.26 (d, J = 
8.4 Hz, 2H), 5.52 (td, J = 16.8, 10.4 Hz, 1H), 4.87 (ddd, J = 16.8, 2.0, 0.4 Hz, 1H), 4.65 (dd, J = 
10.4, 1.6 Hz, 1H), 3.47 (dd, J = 9.6, 7.2 Hz, 1H), 2.98-2.89 (m, 1H), 2.53-2.45 (m, 1H), 2.35 (s, 
3H), 2.06-1.93 (m, 1H), 1.90-1.83 (m, 1H), 1.74-1.64 (m, 1H), 1.59-1.50 (m, 1H), 1.43-1.33 (m, 
1H), 0.90 (d, J = 6.8 Hz, 3H), 0.81 (d, J = 6.4 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 198.4, 
145.8, 139.1, 134.9, 134.4, 132.0, 130.1, 127.8, 127.0, 125.6, 124.7, 123.2, 122.6, 114.9, 112.9, 
56.3, 49.8, 49.2, 33.5, 33.1, 30.2, 21.8, 21.6, 20.5. HRMS Calcd. for C26H29NO3S (M): 435.1868, 
Found: 435.1871. FTIR (NaCl Film): 3495, 2955, 2869, 1662, 1536, 1445, 1380, 1172, 1138, 
1089, 995, 913, 736, 660, 576 cm-1. 
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4.4b 
(2-Ethyl-5-vinyl-cyclopentyl)-ethanone (4.4b): Rf = 0.30, 5% Et2O/hexanes; colorless oil; 4:1 
mixture of diastereomers. Spectral data is reported for the major isomer. 1H NMR (400 MHz, 
CDCl3): δ 5.60 (ddd, J = 17.2, 10.0, 8.6 Hz, 1H), 5.91 (ddd, J = 17.0, 2.0, 0.8 Hz, 1H), 4.85 (dd, 
J = 10.4, 1.6 Hz, 1H), 2.94-2.74 (m, 1H), 2.68 (t, J = 8.8 Hz, 1H), 2.31-2.22 (m, 1H), 2.10 (s, 
3H), 2.02-1.78 (m, 2H), 1.58-1.49 (m, 1H), 1.40-1.32 (m, 1H), 1.22-1.14 (m, 2H), 0.82 (t, J = 7.8 
Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 210.2, 139.0, 114.9, 62.6, 47.3, 42.0, 32.2, 31.6, 30.9, 
28.4, 12.6. HRMS Calcd. for C11H18O (M): 166.1358, Found: 166.1352; FTIR (NaCl Film): 
2954, 2868, 1701, 1465, 1421, 1360, 1161, 999, 916, 731 cm-1. 
 
 
4.4c 
(2-Isopropyl-5-vinyl-cyclopentyl)-ethanone (4.4c): Rf = 0.30, 3% Et2O/hexanes; yellow oil; 
4.0:1 mixture of diastereomers. Spectral data is reported for the major isomer. 1H NMR (400 
MHz, CDCl3): δ 5.62 (ddd, J = 17.5, 10.0, 8.4 Hz, 1H), 5.10 (ddd, J = 17.2, 2.0, 0.8 Hz, 1H), 
4.90 (dd, J = 10.4, 1.6 Hz, 1H), 2.93-2.75 (m, 1H), 2.43 (t, J = 9.2 Hz, 1H), 2.27-2.19 (m, 1H), 
2.08 (s, 3H), 1.93-1.73 (m, 2H), 1.60-1.39 (m, 2H), 1.32-1.22 (m, 1H), 0.90 (d, J = 6.9 Hz, 3H), 
0.83 (d, J = 6.5 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 210.8, 138.8, 115.2, 60.0, 48.2, 48.0, 
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32.9, 32.7, 31.9, 29.6, 21.5, 20.3. HRMS Calcd. for C12H20O (M): 180.1514, Found: 180.1518; 
FTIR (NaCl Film): 2956, 2869, 1707, 1465, 1421, 1360, 1161, 999, 915, 733 cm-1.  
 
 
4.5b 
Cyclopropyl-(2-ethyl-5-vinyl-cyclopentyl)-methanone (4.5b). Rf = 0.25, 5% Et2O/pentane; 
colorless oil; 1.3:1 mixture of diastereomers. Spectral data is reported for the major isomer. 1H 
NMR (400 MHz, CDCl3): δ 5.67 (td, J = 17.2, 9.6 Hz, 1H), 5.01 (ddd, J = 17.2, 2.0, 0.4 Hz, 1H), 
4.98 (d, J = 10.4 Hz, 1H), 3.01-2.93 (m, 1H), 2.87 (t, J = 8.4 Hz, 1H), 2.37-2.27 (m, 1H), 2.02-
1.82 (m, 3H), 1.62-1.17 (m, 5H), 1.01 (t, J = 4.0 Hz, 1H), 0.96 (dd, J = 6.8, 4.4 Hz, 1H), 0.89-
0.78 (m, 4H). 13C NMR (100 MHz, CDCl3): δ 211.9, 139.5, 114.5, 62.9, 47.4, 42.3, 32.2, 31.1, 
28.6, 21.9, 12.6, 10.8, 10.7. HRMS Calcd. for C13H20O (M): 192.1514, Found: 192.1511; FTIR 
(NaCl Film): 2952, 2928, 1691, 1382, 1000, 1007, 913 cm-1. 
 
 
4.5c 
Cyclopropyl-(2-isopropyl-5-vinyl-cyclopentyl)-methanone (4.5c): Rf = 0.30; 5% 
Et2O/pentane; colorless oil; 1.5:1 mixture of diastereomers. Spectral data is reported for the 
major isomer. 1H NMR (400 MHz, CDCl3): δ 5.63 (ddd, J = 17.2, 10.0, 8.0 Hz, 1H), 5.0 (ddd, J 
= 17.2, 2.0, 1.2 Hz, 1H), 4.95 (dd, J = 10.4, 1.6 Hz, 1H), 3.10 (dd, J = 9.2, 7.6 Hz, 1H), 3.01-2.93 
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(m, 1H), 2.37-2.27 (m, 1H), 2.03-1.82 (m, 3H), 1.62-1.16 (m, 5H), 1.01-0.95 (m, 2H), 0.87 (d, J 
= 6.4 Hz, 3H), 0.83 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 212.6, 139.3, 114.6, 
60.7, 49.8, 32.9, 32.3, 29.7, 22.1, 21.5, 20.4, 20.2, 11.3, 10.9. HRMS Calcd. for C14H22O (M): 
206.1671, Found: 206.1666. FTIR (NaCl Film): 2956, 2928, 1691, 1386, 1225, 1075, 913 cm-1. 
 
 
4.6b 
Deca-2,6-dienoic acid ethyl ester (4.6b). Rf = 0.28; 5% Et2O/pentane; yellow oil; 1H NMR (400 
MHz, CDCl3): δ 6.95 (dt, J = 15.6, 6.4 Hz, 1H), 5.81 (d, J = 16.0 Hz, 1H), 5.48-5.34 (m, 2H), 
4.17(q, J = 6.8 Hz,  2H), 2.25 (q, J = 7.2 Hz, 2H), 2.16-2.12 (m, 2H), 1.95 (q, J = 6.8 Hz, 2H), 
1.35 (q, J = 7.2 Hz, 2H), 1.28 (t, J = 7.2 Hz, 3H). 0.87 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): δ 166.7, 148.7, 131.5, 128.5, 121.4, 60.1, 34.6, 32.2, 31.0, 22.5, 14.2, 13.6. HRMS 
Calcd. for C12H20O2 (M): 196.1463, Found: 196.1466. FTIR (NaCl Film): 2958, 2873, 1677, 
1596, 1446, 1377, 1260, 1212, 1002 cm-1. 
 
 
4.6c 
2-Isopropyl-5-vinyl-cyclopentanecarboxylic acid ethyl ester (4.6c): Rf = 0.24, 5% 
EtOAc/hexanes; colorless oil; 2.6:1 mixture of diastereomers. Spectral data is reported for the 
major isomer. 1H NMR (400 MHz, CDCl3): δ 5.71 (m, 1H), 4.95 (ddd, J = 14.4, 2.0, 0.8 Hz, 1H), 
4.91 (dd, J = 10.0, 1.6 Hz, 1H), 4.17-4.06 (m, 2H), 2.84-2.69 (m, 1H), 2.67-2.62 (m, 1H), 2.33-
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2.08 (m, 2H), 2.26-2.13 (m, 1H), 1.97-1.74 (m, 2H), 1.70-1.43 (m, 3H), 1.18 (t, J = 7.2 Hz, 1H), 
0.83 (d, J = 6.8 Hz, 6H). 13C NMR (100 MHz, CDCl3): δ 175.1, 138.6, 115.0, 59.9, 52.4, 49.8, 
47.8, 32.9, 32.0, 29.9, 21.1, 20.4, 14.3. HRMS Calcd. for C13H22O2 (M): 210.1620, Found: 
210.1619. FTIR (NaCl Film): 2956, 2869, 1707, 1639, 1465, 1360, 1161, 999, 915, 733 cm-1. 
 
Preparation of 4.1f: To a solution of compound 1b (40 mg, 0.17 mmol, 100 mol%) in ethanol 
(2.0 mL) in a 10 mL round bottomed flask, was added catalytic amount of palladium catalyst on 
charcoal (18 mg, 0.017 mmol, 10 mol%) and stirred under hydrogen atmosphere at ambient 
temperature for 48 h. The reaction mixture was filtered through a celite pad with the aid of ethyl 
acetate (20 mL). The organic layer was concentrated in vacuo. Purification by flash column 
chromatography (SiO2: 2% ethyl acetate:hexanes, Rf = 0.30)  provides the title compound as a 
colorless oil (37 mg, 0.16 mmol) in 92% yield as a 5:1 mixture of diastereomers. Spectral data is 
reported for the major isomer. 
 
4.1f 
(2,5-Diethyl-cyclopentyl)-phenyl-methanone (4.1f): Rf = 0.30; 2% EtOAc:hexanes; colorless 
oil; 5:1 mixture of diastereomers. Spectral data is reported for the major isomer. 1H NMR (400 
MHz, CDCl3): δ 7.96 (dd, J = 8.0, 0.8 Hz, 2H), 7.53-7.45 (m, 1H), 7.45-7.41 (m, 2H), 3.48 (t, J = 
8.4 Hz, 1H), 2.46-2.36 (m, 1H), 2.31-2.17 (m, 1H), 2.02-1.87 (m, 2H), 1.50-1.34 (m, 2H). 1.28-
1.18 (m, 2H), 1.13-0.99 (m, 2H), 0.84 (t, J = 7.2 Hz, 3H), 0.78 (t, J = 7.2 Hz, 3H). 13C NMR 
(100 MHz, CDCl3): δ 206.9, 148.7, 131.5, 128.5, 121.4, 60.1, 40.4, 39.2, 32.2, 31.0, 22.5, 21.9, 
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14.2, 13.5. HRMS Calcd. for C16H22O (M): 230.1671, Found: 230.1677; FTIR (NaCl Film): 
2958, 2929, 1723, 1655, 1311, 1265, 1196, 1162, 1043, 970 cm-1. 
4.7.4 General procedure for the allylic substitution of allylic carbonates with diorganozinc 
reagents, preparation of 4.7b and 4.7c: 
 
In a 15-mL sealable test tube charged with carbonate 4.7a (100 mg, 0.52 mmol, 100 
mol%) was added dichloromethane (5.2 mL). The vessel was purged with argon gas and kept 
under a blanket of argon gas. The reaction mixture was cooled to 0 oC and a 1.0 M diethylzinc 
solution in hexanes (1.56 mL, 1.56 mmol, 300 mol%) was added over a period of 5 min. Once 
the addition was complete, the vessel was immediately sealed and the reaction mixture was 
warmed to 35 oC. The reaction mixture was allowed to stir for 16 hours, at which point 5 drops 
of water was added to the reaction mixture. The reaction mixture was filtered through a pad of 
silica gel with the aid of dichloromethane and the solution was concentrated in vacuo. 
Purification of the residue by flash column chromatography (SiO2: neat hexanes) provides 4.7b 
and 4.7c (54 mg, 0.36 mmol) in 72% yield as a 1.7:1 mixture of regioisomers. 
 
In accordance with the general procedure, substrate iso-4.7a (100 mg, 0.52 mmol, 100 
mol%) was exposed to diethylzinc (1.56 mL, 1.56 mmol, 300 mol%). Purification by flash 
column chromatography (SiO2: neat hexanes, Rf = 0.50) provides 4.7b and 4.7c as a colorless oil 
(47 mg, 0.31 mmol) in 61% yield as 1.7:1 mixture of regioisomers. 
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4.7b 
3-Phenyl-1-pentene (4.7b): Rf = 0.50, 100% hexanes; a colorless oil; the NMR data obtained for 
8b are identical to those previously reported.26 δ 7.41-7.29 (m, 5H), 6.31-5.68 (m, 1H), 4.81-4.22 
(m, 2H), 3.12 (q, J = 7.5 Hz, 1H), 1.65 (quintet, J = 7.5 Hz, 2H), 0.99 (t, J = 7.5 Hz, 3H). 13C 
NMR (100 MHz, CDCl3): δ 137.9, 130.9, 129.8, 128.4, 126.7, 125.9, 35.1, 22.5, 13.7. 
 
 
4.7c 
(E)-1-Phenyl-1-pentene (4.7c): Rf = 0.50, 100% hexanes; a colorless oil; the NMR data 
obtained for 8c are identical to those previously reported.27 1H NMR (400 MHz, CDCl3): δ 7.27-
7.18 (m, 5H), 5.99 (d, J = 16.0 Hz, 1H), 5.11-5.02 (m, 1H), 1.99-1.71 (m, 4H), 0.91 (t, J = 7.2 
Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 144.4, 142.2, 128.3, 127.6, 126.0, 114.0, 51.7, 28.2, 
12.1. 
 
In accordance with the general procedure, substrate 4.8a (100 mg, 0.48 mmol, 100 mol%) 
was exposed to diethylzinc (1.45 mL, 1.45 mmol, 300 mol%). Purification by flash column 
chromatography (SiO2: neat hexanes, Rf = 0.60) provides 4.8b and 4.8c as a colorless oil (36 mg, 
0.22 mmol) in 46% yield as a 1:1.6 mixture of regioisomers. 
 
In accordance with the general procedure, substrate iso-4.8a (100 mg, 0.48 mmol, 100 
mol%) was exposed to diethylzinc (1.45 mL, 1.45 mmol, 300 mol%). Purification by flash 
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column chromatography (SiO2: neat hexanes, Rf = 0.60) provides 4.8b and 4.8c as a colorless oil 
(41 mg, 0.25 mmol) in 52% yield as a 1:1.6 mixture of two regioisomers. 
 
 
4.8b 
(E)-4-Phenyl-2-hexene (4.8b): Rf = 0.60, 100% hexanes; a colorless oil; the NMR data for 9b 
are identical to those previously reported.28 1H NMR (400 MHz, CDCl3): δ 7.44-7.27 (m, 5H), 
6.39 (d, J = 15.9 Hz, 1H), 6.26 (dd, J = 15.7, 7.8 Hz, 1H), 2.94-2.76 (m, 1H), 1.45 (quintet, J = 
7.2 Hz, 2H), 1.11 (d, J = 6.9 Hz, 3H), 0.95 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 
138.0, 136.8, 128.4, 128.1, 126.7, 125.9, 38.9, 29.8, 20.2, 11.8. 
 
 
4.8c 
(E)-1-Phenyl-3-methyl-1-pentene (4.8c): Rf = 0.60, 100% hexanes; a colorless oil; the NMR 
data obtained for 9c are identical to those previously reported.28 1H NMR (400 MHz, CDCl3): δ 
7.26-7.16 (m, 5H), 5.66-5.40 (m, 2H), 3.11(q, J = 7.5 Hz, 1H), 1.80-1.64 (m, 5H), 0.88 (t, J = 7.5 
Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 145.4, 135.1, 128.3, 127.5, 125.9, 124.6, 50.8, 28.9, 
18.0, 12.2. 
 
In accordance with the general procedure, substrate 4.9a (100 mg, 0.37 mmol, 100 mol%) 
was exposed to diethylzinc (1.19 mL, 1.19 mmol, 300 mol%). Purification by flash column 
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chromatography (SiO2: neat hexanes, Rf = 0.60) provides 4.9b as a colorless oil (70 mg, 0.31 
mmol) in 84% yield. 
 
 
4.9b 
(E)-1,3-Diphenyl-1-pentene (4.9b): Rf = 0.60, 100% hexanes; a colorless oil; the NMR data 
obtained for 3b are identical to those previously reported.29  1H NMR (400 MHz, CDCl3): δ 7.40-
7.16 (m, 10H), 6.41 (d, J = 16 Hz, 1H), 6.33 (dd, J = 15.8, 7.6 Hz, 1H), 3.31 (quintet, J = 7.6 Hz, 
1H), 1.90-1.79 (m, 2H), 0.92 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 144.4, 137.6, 
134.2, 129.4, 128.4, 127.7, 127.0, 126.2, 126.1, 51.0, 28.8, 12.3. 
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